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Abstract 
Inside the biological milieu, nanoparticles come in myriad shape and size those upon 
interaction with different biomolecules form nano-biomolecular complexes. The interface 
formed as a result of nanoparticle and biomolecular interactions determines fate of both 
the nanoparticle and biomolecules inside the biological milieu. Accordingly, investigating 
the interaction pattern at different interfaces will help in optimizing the use of nanoparticle 
for relatively wider biomedical applications. Hence, the thesis intends to study the effects 
of different photocatalytic nanoparticle interfaces on biological membranes, like 
prokaryotic and eukaryotic membranes, and biomacromolecules, like nucleic acid and 
protein. To this end, photocatalytic nanoparticles, such as zinc oxide (ZnONP), iron oxide 
(IONP) and silver (AgNP) nanoparticles, were synthesized using chemical synthesis or 
green synthesis methods. Initially, the effects of interfacial potential and interfacial 
functional groups were studied against Gram-positive and Gram-negative bacteria. The 
studies demonstrated that the interfacial potential and surface functionality significantly 
affect interaction pattern at the interface, which defines anti-bacterial/cytocompatible 
property of nanoparticles. In addition, second part of the thesis explored the effect of 
nanoparticle surface defects on cytotoxic and antimicrobial propensities of nanoparticle. 
The study revealed that energy band gap reduction significantly enhances the oxidative 
stress in cells, leading viable cells into non-viable cells. The second part, unlike the first 
part of the thesis where the focus was cell membrane functionality, focused on the 
interface effects on nucleic acid. Third objective of the thesis observed photocatalytic 
nanoparticle interaction with antimicrobial peptide (AMP), like nisin, and its effect on the 
peptide conformational and functional dynamics. The interaction leading into nisin 
assembly onto AgNP interface enhanced the efficacy of peptide by many folds, without 
significant change in peptide conformation. Whereas in fourth objective, interaction with 
globular protein, like lysozyme, showed that the assembly onto ZnONP interface led into 
conformational rearrangement that hinders the amyloidogenic propensity of lysozyme in 
studied conditions. Nevertheless, with increase in ZnONP fraction in the conjugate 
mixtures, the protein attains relatively more regular conformation than partially unfolded 
conformation at pH 9. Insignificant conformational changes in lysozyme assembled onto 
ZnONP interface was observed at pH 7.4. Thus, the findings, altogether, suggested that 
the physico-chemical properties of photocatalytic nanoparticle interface significantly 
affect the fate of biomembrane and biomacromolecules inside the biological milieu. 
Key Words: nanoparticle; Biomacromolecule; surface potential; nano-bio complex; 
interface. 
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Introduction 
1.1. Nanoparticle 
Fifty seven years ago, on the evening of 29
th
 December 1959, best known paper of 
nanotechnology entitled “There’s Plenty of Room at the Bottom” was delivered by 
physicist professor Richard Feynman to the American Physical Society at the California 
Institute of Technology in Pasadena
1
. In the paper, Dr. Richard Feynman described about 
the possibilities, if we could learn to control single atoms and molecules
1
. The work led 
the community into the era of nanotechnology. Hence, the essence of nanotechnology is 
based on the ability to work at the molecular and atomic level to formulate fundamentally 
new molecular structure with advance physico-chemical properties
1-2
. The combination of 
science and technology for the nature of material at nanoscale provides a strong 
foundation for nanotechnology
3
. The growth of nanotechnology is a convergence and 
divergence process. For example, the convergence in understanding of nanotechnology 
reached its maximum strength by 2000 AD, and one may expect divergence in 
applications of nanotechnology in coming decades
3
. 
Among various nanotechnology fields, nanobiotechnology has been considered as 
a most emerging field, all because of its various applications in molecular diagnostics, 
material sciences, and bioengineering. The definition of nanoparticles has been suggested 
by National Nanotechnology Initiative (N.N.I.), U.S.A. According to N.N.I., particles with 
size range from 1 to 100 nm in at least one dimension are called nanoparticles
4
. Moreover, 
the widely applied term ‘nano’ is adapted from a Greek word, meaning ‘dwarf’. ‘Nano’ is 
also used as a prefix for 10
-9 
magnitude
5
. Nanoparticles have drawn great scientific interest 
as they bridge the physico-chemical gap developed between bulk (macroscopic) material 
and atomic or molecular structure
5
. The unique characteristic properties of nanoparticle 
are quite different from macroscopic material. The differences are mainly developed from 
high surface to volume ratio as well as improved percentage of grain boundaries of 
nanoparticles
6
. These unique features of nanoparticles have drawn the attention of various 
research groups to employ nanoparticles in various fields of science and technology. 
Hence, to do so, the synthesis of different nanoparticles with advanced physico-chemical 
properties has become a major interest in current era.  
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1.2. Synthesis of nanoparticles 
Different protocols have been optimized to synthesize different types of nanoparticles that 
meet the requirements of different nanoparticle-mediated applications. The synthesis 
protocols are broadly divided into two categories such as top-down (physical process) and 
bottom-up (chemical and biological processes) approaches
7-8
. Generally, in top-down 
approach, the nanoparticles are formulated from their bulk material or constituents. 
Examples of some top-down approaches are high energy ball milling, where the 
nanoparticles are produced from the milling of their respective bulk material. Another 
approach is wire explosion method, conducting metal nanoparticles are produced from an 
explosion due to a sudden high current pulses. In inert-gas condensation method, 
evaporated atoms from bulk material are condensed in a matrix, and the respective 
nanoparticle growth is achieved. Laser ablation approach is another physical method for 
nanoparticle synthesis, where higher energy laser is used to induce evaporation. In the top-
down approaches, shape, size and composition of nanoparticles can be monitored by 
controlling different physico-chemical parameters. The methods produce lager quantity of 
nanoparticles, however with polydisperse nature
7
. 
In the later approach, i.e. in bottom-up (chemical or biological processes) 
approaches, the elements generated from respective ion reduction, assemble into 
nanoparticles. Since the process is initiated from atoms, the processes are also known as 
bottom-up approaches
7-8
. Few examples, in chemical approaches, the reducing agent like 
sodium borohydride (NaBH4) helps in reduction of metal ions into atoms, and the reduced 
atoms assemble to form nanosize crystals, hence nanoparticles. Photochemical synthesis is 
another method for nanoparticle synthesis, which is assisted by light. Nanoparticles are 
synthesized with the help of ultrasound in sonochemical routes. Microemulsion is an 
approach for synthesis of nanoparticles using water in oil or oil in water emulsions. 
Additionally, in solvothermal synthesis, the synthesis of nanoparticles happens in a closed 
system from solvents at lower temperature, for example the coacervation or emulsion 
methods for protein nanoparticle synthesis. 
It is reported that decreasing hydrophobic interaction during protein unfolding 
triggers the protein nanoparticle formation
9
, which is an example of bottom-up approach. 
The protein nanoparticles are formed due to the conformational changes of protein, which 
depends upon its composition, cross linking, concentration, different chemical conditions 
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like pH, ionic strength, type of solvents etc
10
. During unfolding process, protein expresses 
different interactive groups like disulfides, thiols, hydroxides etc. Interestingly, thermal 
and chemical cross linking of the groups lead to formation of protein nanoparticles with 
entrapped drug molecule (Figure 1.1). 
 
Figure 1.1. Protein nanoparticles prepared by (a) coacervation or phase separation, (b) 
emulsion/solvent extraction method and, (c) complex coacervation method, reproduced from 
Lohcharoenkal, W. et al10. 
Coacervation/desolvation process is one of the two well-known methods for 
protein nanoparticle synthesis. The process is based on differential solubility of proteins in 
different solvents, which is a function of solvent pH, polarity, ionic strength and 
electrolytes presence. As shown in figure 1.1, the process helps in reduction of protein 
solubility, which leads to phase separation. The de-solvating agent helps in protein 
conformational change leading into protein coacervation or precipitation. Size of the 
protein nanoparticle, formed in the process, can be controlled by controlling the 
processing parameters like pH, ionic strength etc. The formed nanoparticles are cross 
linked by different agents like glutaraldehyde and glyoxal
11
. In addition to coacervation 
method, emulsion/solvent extraction is another method for preparation of protein 
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nanoparticles. In this method, a high speed homogenizer/ultrasonic shear are being used to 
emulsify the aqueous solution of protein in oil. As shown in figure 1.1, the protein 
nanoparticles are formed at the interface of water/oil, upon emulsification. Additionally, 
phosphatidylcholine and/or span-80 are generally used as stabilizers for formed protein 
nanoparticle using the method
10, 12
. The organic solvents are used to remove the oil phase 
of the solution leading to formation of protein nanoparticles. The method is generally used 
to prepare different protein nanoparticles like albumin, whey protein etc. 
Although, various physical and chemical methods have been optimized for 
synthesis of nanoparticles, the use of strong and weak chemical reducing agents along 
with protective agents like sodium borohydride, sodium citrate, and alcohols for synthesis 
of nanoparticles are not advisable. Most of these chemicals are expensive, toxic, 
flammable, and possess various environmental issues. Additionally, the processes show 
low production rate
8
. In many cases, elevated temperatures are required for synthesis of 
nanoparticles
8, 13
. Hence, in order to avoid the limitations of physical and chemical 
methods, biological methods (also known as green synthesis method) have been adopted 
for synthesis of metal and metal oxide nanoparticles, a step to avoid toxic chemicals and to 
make the synthesis process eco-friendly
14-15
. In addition, the biological methods are less 
toxic, safe, and energy efficient than the other two methods. Biological agents, commonly 
used for synthesis of nanoparticles, are plant extracts, extracts from microorganisms and 
fungi etc
14
. It is also reported that the biological agents help in reduction of metal ions at a 
faster rate than in other two methods, and require ambient temperature and pressure
8
. 
Additionally, shape and size of nanoparticles can be modulated by change in metal to 
extract ratios, pH, temperature of the reduction reaction, agitation etc. In this approach, 
metallo-enzyme present in biological agents reduces metal ions into respective elements or 
molecule, and the resultant elements are capped at nanosize by same biomolecules or other 
present in the reducing medium. Hence, nanoparticles synthesized by the method have 
functionalized surface because of absorption of different cellular moieties as a capping 
agent or stabilizer
8
. 
1.3. Different kinds of nanoparticles 
According to different applications of nanotechnology, different methods have been 
optimized to fabricate different kind of nanoparticles. Different nanoparticles are 
metal/metal oxide nanoparticles for antimicrobial-/magnetic-/photocatalytic-/heavy metal 
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adsorption applications, liposome nanoparticle for microRNA/drug delivery application, 
protein nanoparticle for biocompatible drug delivery application etc. Following is the 
description of different kinds of nanoparticles. 
1.3.1. Zinc oxide nanoparticle (ZnONP) 
Due to presence of wide band gap (3.37 eV) as well as large excitation binding energy (60 
meV at room temperature), ZnONP possesses unique features like UV light absorption, 
semiconducting, catalytic, and antimicrobial properties etc
16-17
. In addition, ZnONP 
possesses unique features that are completely different from bulk ZnO material like 
proportion of atoms on the surface of ZnONP, electronic band gap etc
17
. Hence, ZnONP 
are widely used in different fields such as water and air disinfection, anticancer agents, 
antimicrobial agents, remediation of hazardous waste etc
16
. Along with these applications, 
these nanoparticles are also used for solar cells, photocatalytic applications, antivirus 
agent in coating, biosensors, biological imaging, etc
16, 18-19
. 
1.3.2. Iron oxide nanoparticle (IONP) 
Due to supermagnetic nature of iron oxide nanoparticles (IONPs), they are widely used as 
passive and active targeted imaging agents
20
. The superparamagnetic iron oxide 
nanoparticles (SPIONs) contain iron oxide as the core, and an outer layer of dextran or 
other biocompatible compounds to make the core stable in physiological medium
21-23
. The 
commonly used SPIONs are magnetite (Fe3O4) and maghemite (γFe2O3). Interestingly, 
these SPIONs exhibit superparamagnetism in size dependent manner, so that in presence 
of external magnetic field they become magnetized and become neutral upon removal of 
the field. Additionally, SPIONs are degraded into iron and/or iron oxide molecules, which 
are metabolized further and stored in cells in bound form with ferritin, and finally 
incorporated into hemoglobin
24
. Since different magnetic nanoparticles, like SPIONs, are 
biocompatible in nature, chemically stable, and possess magnetic behavior, they are 
widely used in different biomedical applications
25
. These nanoparticles are also used for 
delivery of various drugs to their targeted tissues by employing external magnetic field
25
. 
Additionally, they are used in analytical chemistry, antigen diagnosis, tissue repair, 
pathogen detection, protein separation etc
24-26
. 
1.3.3. Silver nanoparticle (AgNP) 
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Even before the evolution of nanotechnology, silver metal had been used in various 
applications. Moreover, the understanding of nanotechnology has enhanced the 
applications of silver by many fold, but as AgNP
8
. Recently, because of antimicrobial 
property the efforts are being made to incorporate AgNP into different medical devices, 
surgical instruments, surgical masks etc
27
. In addition, many studies have reported the 
wound healing capacities of ionic silver; silver sulfadiazine is being replaced by AgNP to 
treat wounds
27-29
. Due to enhanced physico-chemical properties of AgNP, they are widely 
used in biomedical imaging, nanomedicine, biosensing, catalysis, drug delivery, 
nanodevice fabrications etc
27, 30
. Additionally, due to strong antimicrobial activity, the 
nanoparticle is widely used in production of sterile materials
8
. AgNP is synthesized from 
the reduction of silver salt with the help of different reducing agents like sodium citrate, 
sodium borohydride etc
27
. However, different stabilizing agents, such as polyvinyl 
alcohol, bovine serum albumin (BSA), cellulose, citrate etc., are used during the synthesis 
of AgNPs. Commonly used methods for the nanoparticle synthesis are chemical reduction 
in solution, sonochemical method, microwave assisted method, microemulsion method 
etc
31
. Along with these synthesis approaches, production of AgNPs using green synthesis 
methods have also drawn the attention of various research groups. 
1.3.4. Liposome 
Liposome is considered as one of the first nanoparticles formulation which were described 
in 1965 as a cellular membrane model
20, 32
. These are spherical vesicles containing a single 
or multiple bilayer of lipids, and self-assemble upon suspension into aqueous solution
33
. 
The unique features of liposome, which increases its use in biological applications are 
diverse ranges of available compositions, able to carry and protect encapsulated/adsorbed 
molecules, biocompatible, and biodegradable nature
20, 33-34
. Hence, the liposomes are used 
as transfection agents for different genetic materials like microRNA into a cell. The 
process is commonly known as lipofection
35
. The process forms aggregates of cationic 
lipids with anionic genetic material. Similarly, the liposomes are also used as therapeutic 
drug carriers
32
.  
1.3.5. Albumin functionalized NPs 
In biomedical sciences, nanoparticles are widely used as drug delivery agents, since 
nanoparticles have the potential to protect the target drug from degradation, enhance the 
drug absorption efficacy, improve intracellular penetration and distribution, and modify 
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drug tissue distribution profile
36
. In addition, nanoparticles are widely accepted agents for 
drug delivery since they withstand different physiological stress, improve biological 
stability, high possibility of oral delivery etc
36
. Among different nanoparticles, protein-
based nanoparticles have drawn the attention of researchers for their better stability during 
storage as well as non-cytotoxic nature
36
. Albumin is being used as a drug delivery vehicle 
for cancer treatment, since it act as a natural carrier for different hydrophobic molecules 
like water insoluble plasma substances, vitamins, and hormone etc
37
. Albumin bound 
nanoparticles are important class of nanoparticles which carry the hydrophobic molecules 
in bloodstream using endogeneous albumin pathways 
38
. Albumin binds hydrophobic 
molecules non-covalently and avoids solvent based toxicity
39
. Hence, albumin based 
nanoparticles are used as drug delivery vehicles.  
1.3.6. Polymeric NPs  
Polymeric nanoparticles are another group of nanoparticles those are formed from the 
polymers having biocompatible and biodegradable properties, and are extensively used as 
therapeutic drug carriers, for example dendrimer encapsulated nanoparticles (DEN), 
protein nanoparticles (pNP) etc
40
. These are formulated from block–copolymers having 
different hydrophobicity. In an aqueous environment these co-polymers spontaneously 
self-assembled into core-shell micelle
41
. The hydrophilic and hydrophobic drugs, proteins, 
and nucleic acids can be encapsulated on the polymeric nanoparticles for different 
biological applications
42
. Polymeric nanoparticles are very much important because they 
help in safety and efficacy of drug they usually carry. Protein nanoparticle, one of the 
polymeric nanoparticles, are being treated as potential delivery agent for the anticancer 
drugs, since pNPs are relatively safe, easy to prepare and to control size distribution
43
. For 
example, albumin-based nanocarrier system has made an impact for cancer treatment
10
. 
Balancing of attractive and repulsive forces in protein is the key factor for formulation of 
protein nanoparticle. On the other hand, DEN is primarily used as a catalyst, because of 
very high surface to volume ratio, highly monodisperse nature
40
. DEN is made of 
dendrimer, commonly used dendrimer like poly(aminoamine), which is attached 
terminally to a metal ion. In presence of reducing agents like sodium borohydride, 
reduction of metal ions into metal element leads into dendrimer encapsulated nanoparticle 
formation. Size of the nanoparticle can be easily controlled by choosing the degree of 
aminoamines polymerization
40
. 
1.3.7. Quantum dot 
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Quantum dots are generally semiconductor particles having size less than 10 nm. These 
were first discovered in 1980. Quantum dots are well known for unique electronic and 
optical properties
44
. Among different physico-chemical properties, the particles have very 
broad absorption spectra and possess very narrow emission spectra. Quantum dots possess 
long lifetime, emit bright colors, and efficiency of the quantum dots is high. Hence the 
quantum dots are widely used in different optical applications. Additionally, these are 
widely used in biological fields for cell labeling, biomolecule tracking etc
45-47
. In addition, 
QDs have numerous advantages than other fluorophores like organic dyes, fluorescent 
proteins etc
48
. It is important to note that, conventional dyes commonly suffer from narrow 
excitation spectra and require specific light wavelength for excitation, which varies from 
one dye to another, whereas QDs having broad absorption spectra require wide range of 
light wavelengths for excitation. This property of QDs can be exploited to excite different 
colored QDs by a single wavelength simultaneously
48
. 
1.4. Physico-chemical properties of nanoparticles 
1.4.1. Shape, size, and curvature 
Shape, size and curvature of nanomaterials greatly influence the internalization of 
nanomaterials inside a cell. It has been reported that kinetic of nanomaterials cellular 
uptake vary with the shape and size of nanomaterials
49
. When discussing about the 
internalization of nanomaterials based on their shape, it has been reported that spherical 
particle of same size are internalized quickly than the rod shape, since longer membrane 
wrapping time is required for rod shape nanomaterial than spherical shape. In other ways, 
size and curvature also play crucial roles for cellular uptake of nanomaterials, as size and 
curvature of nanoparticle strongly affect the binding and activation of membrane 
receptors, and subsequently affect the respective protein expression, hence affect the 
cellular uptake
50
. From various in vitro and in vivo studies, it was found that nanomaterials 
inside a biological milieu display variant outcomes due to aggregation of nanomaterials 
into various sizes. However, the shape and size of nanomaterials greatly influence the 
toxicity/compatibility of nanomaterials towards mammalian and/or bacterial cells. 
The interaction of proteins on nanoparticles surface is also affected by different 
physico-chemical parameters of nanoparticles. The conjugation of proteins with colloidal 
nanoparticles has been widely studied from the development of immune probes in 1970s. 
Some experiments regarding adsorption of proteins or peptides on different size of gold 
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(Au) or silicon oxide (SiO2)
 
nanoparticles have been performed. It has been studied that 
some proteins like lysozyme, catalase, trypsin and horseradish peroxidase bind strongly to 
SiO2NP generally in the size range from 9 to 40 nm
51
. From these studies, it has been 
reported that there was partial loss of protein structure and a significant loss of enzymatic 
activity
51
. Based on these ideas Vertegel et al have studied different size silica 
nanoparticles effects on the activity of adsorbed lysozyme
51
. The work observed that the 
lysozyme-silica nanoparticles interaction is strongly influenced by the nanoparticle size 
(Figure 1.2)
51
. 
 
Figure 1.2. Schematic diagram of lysozyme interaction with silica nanoparticles of varying sizes. 
Reproduced from Vertegel, A.A. et al51. 
Figure 1.2 shows schematic representation for interaction of lysozyme with different size 
of silica nanoparticles. Generally, smaller nanoparticles possess high surface curvature and 
larger nanoparticles possess smaller surface curvature. Hence, when a protein interacts 
with a smaller nanoparticle, the interaction is weak (both columbic and hydrophobic), 
since the edge of the protein molecules are at a greater distance from nanoparticle surface, 
and vice versa for larger nanoparticles. Therefore, for small nanoparticles the structure of 
protein remains intact, and for larger it change depending upon the interaction pattern. 
Similar results were found for interaction of silica nanoparticle with RNaseA as studied by 
Shang et al
52
. Hence, these studies concluded that the size and curvature of nanoparticles 
significantly influences the structural dynamics of proteins upon interaction. 
1.4.2. Surface concentration 
Apart from size and curvature, the surface concentration also plays a major role in 
defining conformational dynamics of proteins upon interaction with surface/interface. 
Higher surface concentration of nanoparticles facilitates more proteins to be adsorbed onto 
the nanoparticles surface, so that a crowded environment is created which favors the 
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protein-protein interaction. But at lower surface concentration, the interaction between 
nanoparticles and proteins become more prominent
53
. Figure 1.3 shows the unfolding 
kinetics of lysozyme upon binding with different concentrations of silica nanoparticles. 
Wu et al calculated the unfolded fraction of adsorbed lysozyme at different concentrations 
of silica nanoparticles keeping the concentration of protein constant
54
. As shown in the 
figure, lysozyme at low nanoparticle surface concentration was unfolded to a greater 
amount than higher surface concentrations in equilibrium state. The result confirmed the 
existence of a higher energy barrier in a crowded environment that helps in unfolding of 
protein
54
. 
 
Figure 1.3. Unfolding kinetics of lysozyme adsorbed onto silica nanoparticle surface at different 
surface concentration at neutral pH and low salt concentration. The normalized tryptophan 
fluorescence intensity of lysozyme at 380 nm indicates the unfolded protein fraction with varying 
surface concentrations. Reproduced from  Narsimhan, W. X. et al54. 
At a lower nanoparticle surface concentration, the molecular interactions exist 
between proteins and hydrophobic surface of silica nanoparticle. The interaction potential 
induces the unfolding of protein molecules due to available free space and absence of 
energy barrier. But at higher nanoparticle surface concentration, i.e. in crowed 
environment, the distance between the neighboring protein molecules will be small. The 
interaction exists between protein molecules on the nanoparticle surface, hence the 
unfolding behavior is limited. The energy barrier raised from the interaction from protein 
molecule decreases the extent of unfolding at higher nanoparticle surface concentration 
54
. 
1.4.3. Surface functionality 
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Inside the biological milieu, the interaction of nanomaterials with different biomolecules 
depends on the properties of nanomaterials like shape, size, surface charge etc. Here, first 
we will discuss how the neutral surface charge influences the interaction of nanoparticles 
with cell membrane. In addition to shape and size of nanomaterials, the accessible surface 
functional groups present over the nanomaterial surface dictate many important properties 
of nanomaterials, like solubility, nanomaterial cell surface interaction etc, including the 
internalization of the nanoparticle. Moreover, upon nanomaterial administration into a 
biological medium, nanomaterial absorb serum proteins which help the nanomaterial for 
internalization by receptor mediated endocytosis
55
. 
However, for many biological applications, surface functionality of nanoparticles 
possessing potential not to interact with the cell membrane is also desirable. For example, 
non-specific absorption of protein onto nanoparticle surface can happen during the in vivo 
applications, which lead to the aggregation and clearance from the reticular-endothelial 
system. Hence, the absorption hinders the potential of nanoparticle for drugs/genes 
delivery to target site. The nanoparticle can also binds to cellular membrane non-
specifically, which reduces its efficiency for targeting. Hence, various research groups 
have taken attempts to avoid the issue by coating nanoparticles with neutral ligands, like 
poly(ethylene glycol), PEG. For example, Xie, J. et al have coated Fe3O4 nanoparticles 
with PEG which resulted in negligible aggregation of nanoparticles in culture medium, 
and reduction in uptake of nanoparticles by macrophage cells non-specifically
56
. 
1.4.4. Surface potential 
In comparison to charged surfaces, nanomaterial with neutral surface is relatively good 
delivering agents, since charged surfaces have many non-specific binding partners in a 
biological milieu. Hence, most of the charged accessible functional groups are generally 
responsible for nanomaterial interaction with cells (Figure 1.4) 
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Figure 1.4. Illustration of gold nanoparticle, with different surface charges, interaction with SK-
BR-3 breast cancer cell. (a) Low affinity interaction of cell membrane with citrate-coated and PVA 
coated gold nanoparticles, (b) high affinity interaction of poly(allyamine hydrochloride)-coated 
gold nanoparticles. Reproduced from Verma, A. et al49.  
Based on the surface charge of nanomaterials, cationic charged nanoparticles have 
shown stronger interaction with anionic cell membrane via electrostatic interaction, and 
translocate easily into the cell membrane (Figure 1.4). Due to stronger interaction of 
cationic nanoparticles with anionic membrane, these nanoparticles are exploited as 
synthetic agents for drug and gene delivery
49
. However, various studies have approved the 
internalization of negatively charged nanoparticles through the cell membrane, despite of 
the unfavorable interactions between the interfaces. In this context, Harush-Frenkel et al. 
have performed studies on endocytosis of charged nanoparticles through the cell 
membrane. They observed that the positively charged particle translocated easily via 
clathrin-mediated pathway, whereas the particles with negative charge showed less 
efficiency for endocytosis
57
. Surprisingly, the nanoparticles with negative charge bind 
non-specifically with some positive particles on the plasma membrane (relatively less than 
negatively charged domain), and get internalized through endocytosis
49, 57
. 
1.5. Physico-chemical properties of biological membranes 
and biomacromolecules 
1.5.1. Cell membrane 
Generally, the cell membranes of both prokaryotic and eukaryotic system are complex as 
well as dynamic in nature, which is made up of different phospholipid molecules. In 
addition, it contains different components such as lipopolysaccharides, extracellular 
polymeric substances, and protein, embedded and/or superficially attached to the 
membrane
58
. Besides providing the buffer against mechanical stress to cell, cell membrane 
helps in separating the intracellular components from extracellular environment. 
Additionally, the cell membrane maintains an anisotropic fluid phase which helps in 
supporting proteins as well as in regulating molecular transport into and out of the cell
58
. 
Depending upon interfacial composition of membrane, the prokaryotic cells have been 
divided majorly in two categories, Gram-positive and Gram-negative bacteria. Both kind 
of bacterial interface behave differently to different surfaces like nanoparticle interface, 
adherent surfaces etc. 
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1.5.2.  Bacterial cell wall 
The primary role of the bacterial cell wall is to provide shape, strength, and rigidity to the 
cell. Additionally, it protects the cell from the mechanical damage and osmotic rupture
59
. 
Based on their structure and functions, the bacterial cell walls are categorized as Gram-
positive and Gram-negative bacteria (Figure 1.5). The cell membrane of Gram-positive 
bacterium contains a thicker layer (20-50 nm) of peptidoglycan attached to the teichoic 
acids. These teichoic acids are generally embedded in the peptidoglycan layer, whereas the 
lipoteichoic acids are found to be extended into the cytoplasmic membrane of the 
bacteria
59-60
. However, the cell membrane of Gram-negative bacterium contains a 
relatively thinner layer of peptidoglycan, and an additional outer membrane covers the cell 
membrane. The outer membrane of these bacteria is linked to a thinner peptidoglycan 
layer by lipoproteins. The peptidoglycan layer is placed within the periplasmic space 
formed between the outer and cytoplasmic membranes. In addition, porins and 
lipopolysaccharide molecules are also found in outer membrane. Hence, Gram-negative 
cell membrane is more complex both, structurally and chemically, compared to Gram-
positive. Due to presence of lipopolysaccharide molecules in outer membrane, the surface 
potential of Gram-negative bacterium is more negative than Gram-positive bacterium. 
However, surface functionality, because of peptidoglycan, is more diverse in Gram-
positive bacterium than gram-negative bacterium
59
. 
 
Figure 1.5. Structure of bacterial cell, (a) Gram-positive and (b) Gram-negative bacterium. 
Reproduced from Hajipour, M. J. et al59. 
1.5.3. Eukaryotic cell membrane 
The basic frame work model to understand the structure and function of eukaryotic cell 
membrane was the Fluid—Mosaic Membrane Model, first introduced in 197261. It is 
composed of phospholipid bilayers with embedded proteins (Figure 1.6). Generally 70% 
of total lipids present in mammalian cells are phospholipids
62
. Phospholipids contain one 
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polar part and another non-polar part, hence amphiphilic in nature
63
. Although, plasma 
membrane is predominantly composed of phospholipids, the lipids have different 
functional roles, beyond forming the lipid bilayers.  
 
Figure 1.6. Structure of eukaryotic membrane, reproduced from Lombard, J. et al63. 
Plasma membrane, which is selectively permeable membrane, acts as a boundary 
for the cell, and maintains a viable intracellular environment. When discussing about the 
permeability of membrane, it comes into focus that membrane allows small and nonpolar 
molecules like O2 and CO2 to diffuse through it. Whereas, polar molecules like ions and 
nanoparticles of relatively larger size are restricted to diffuse across the lipid bilayer. 
Generally, proteins of nano-scale size and important ions diffuse across the lipid bilayer 
through different passive membrane-transport protein channels. Other nanoscale 
molecules and supra molecular assemblies are transported through a process of 
endocytosis, where the particles are enclosed in membrane vesicles, and the cellular 
uptake happens
49
. It is reported that, in case of some nanoparticles, the nanoparticles are 
confined in membrane bound vesicles (endolysosomes), which restrict their path to reach 
the cytosol. However, the process is not limited to all nanoparticles. Additionally, it is 
reported that many nanoparticles possess the inherent property to penetrate the cell 
membrane. In those cases, the nanoparticles form pores in cell membrane which lead to 
cellular toxicity, since they destroy the balance of intracellular and extracellular ions, 
proteins, and other vital macromolecular concentrations that are essential for the normal 
function of a cell
49
. Additionally, different approaches have been adopted for transporting 
nanoparticles into a cell cytoplasm, like (i) endosome disruption and entry of NP into the 
cytosol through spong-effect mechanism
64
, or using chloroquine
65
 (ii) direct 
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microinjection of nanomaterials into cells
66-67
, (iii) use of electroporation
68
, and (iv) 
conjugation of nanoparticle with natural cell-penetrating/fusogenic chaperons 
49, 69
. 
However, the interaction of nanoparticles with cell membrane depends on the chemical 
functionalities of surface, shape and size
49
.  
1.5.4. Nucleic acids biomacromolecules 
Nucleic acids which are principal constituents of all living organisms are 
considered to be possessing significant importance as protein, which are involved in cell 
division, growth
70
. Nucleic acids are also considered as biological information storage 
block which are relatively physico-chemically stable, and possess the potential of self 
organization
71
. The DNA (deoxyribonucleic acid), a long chain polymer made from 
nucleotide, is commonly known as hereditary material. Generally, nucleotide consists of 
sugar, heterocycle, and phosphate. The ribose or deoxyribose, and sugar are found in 
cyclic, and furanoside form. These are connected by -glycosyl linkage and produce four 
normal nucleosides such as adenosine, guanosine, cystidine, and thymidine etc. Using the 
process of hybridization, a single stranded DNA binds its complementary strand and forms 
1 to 3 dimensional structutre
71
. From the last decade, the scientists are trying to interact 
various nanoparticles with DNA by both covalent and non-covalent interactions for 
different therapeutic approaches
72
. However, the DNA macromolecule is considered as 
suitable material for fabrication of nanostructures, and utilization of DNA has gained 
interest for highly specific molecular recognition which is based on the DNA 
hybridization
73
. In addition, for specific bindings of DNA with different nanoparticles, 
DNA molecules can be modified with different functional groups
73
. Interestingly, in 
biomedical sciences, DNA/RNA molecules are the important molecules which play key 
role as carriers for genetic information as well as they also provide specific interactions 
with different target molecules like complementary DNA molecules, cell receptors, and 
proteins
73
. Hence, nucleic–nanoparticle interaction plays vital role in biomedical sciences. 
1.5.5. Protein biomacromolecules 
Protein, one of the essential biomolecules to sustain life, consists of long chains of amino 
acids. Upon synthesis, nascent protein attains tertiary structure, which defines the 
functional attributes of the protein. The tertiary structure of protein is governed by a 
network of interaction, predominantly non-covalent interactions like hydrogen bonds, 
electrostatic interactions, salt bridge, van der Waals interactions, hydrophilic/hydrophobic 
effects, dipole-dipole interactions etc. The network of interactions, governing tertiary 
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structure, is so fragile that perturbation of even one non-covalent interaction may lead into 
conformational rearrangement or complete loss of the function. Furthermore, 
conformational changes of proteins are associated with different properties of proteins like 
self-assembly, tendency to aggregate, transportation, and cytotoxicity
74
. Since the 
biomolecule is most dynamic and functional entity of a cell, any additives to cell, like 
nanoparticles, drugs, will likely to interact and affect the structure and function of the 
biomolecule. In past decades, folding have received enormous attention of different 
researchers to understand different biological phenomenon like from genetic information 
to molecular diagnostics
74
. 
1.5.5.1. Protein folding 
Protein folding is one of the most fundamental and spontaneous phenomenon occurring in 
a cell, where the entire polypeptide chain efficiently folds into a physiologically active 
conformation (called native conformation), and execute different functions needed for cell 
survivality
75
. Various studies are being carried out to understand the mechanism of protein 
folding along with the kinetic and thermodynamic analysis of the intermediates
76
. The 
“folding funnel” or “energy landscape theory” of protein folding elucidates a statistical 
description of free energies of all the molecular configurations (Figure 1.7).  
 
Figure 1.7. Schematic figure showing energy landscape of protein folding and aggregation. 
Although, the surface shows multiple conformations, however with the help of intramolecular 
contact formations, conformations ‘funnelling’ towards native state or with the help of 
intermolecular contact the conformations ‘funnelling’ towards amyloid fibrils. Reproduced from 
Jahn, T. R. et al76. 
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The unfolded protein starts from the top of the funnel, and as it descends the 
funnel, the free energy is lowered due to the formation of intramolecular interactions. The 
reduced number of possible conformations at each stage simplifies the folding process and 
finally reaches the unique natively folded conformations of the lowest energy level. 
However, in case of larger proteins and a few small proteins, the folding funnel does not 
remain “smooth” but becomes “rugged”. This happens due to the presence of  transiently 
stable intermediate conformation(s) in the folding pathway of such proteins
77
. Sometimes 
during the folding process, protein gets kinetically trapped in the local energy minima as 
an intermediate state and needs to cross a certain energy barrier in order to reach the native 
state at bottom of the folding funnel. These transiently populated states, known as 
intermediate states are partially folded protein conformations, and are required to traverse 
during the folding into native state. The folding pathway traversed by such proteins is 
termed as ‘Non-cooperative’ or ‘Multistate folding’. In some cases, these intermediates 
may lie off the productive folding pathway, and are known as “off pathway 
intermediates”. Once these intermediates accumulate above a threshold concentration 
during the folding process, owing to their exposed hydrophobic core, the intermediate(s) 
interact with each other to form aggregates. Thereby, the process shifts the equilibrium 
towards protein aggregation, where intermolecular interactions rule over the 
intramolecular interactions. The aggregates are generally categorized as either amorphous 
or highly ordered amyloid fibril (Figure 1.7)
76
.  
1.5.5.2. Protein misfolding and diseases 
As mentioned above, perturbation of the interaction network is easy for most of the 
proteins, and can be misarranged/broken by slight change in local chemico-physical 
environment of the protein, resulting in partially unfolded to completely unfolded 
conformations. In both the conformations, protein loses its physiological function(s), 
resulting in degradation by proteostasis network of the cell. However, when these 
confirmation goes uncheck of proteostasis network in cells, exposed hydrophobic core 
drive the conformation into self-assembly of monomers into pathogenic amyloid fibrils
78
. 
During the self-assembly into amyloid fibrils, the process is accompanied by different 
intermediates with cytotoxic propensity
79-80
. The cytotoxic nature of intermediate(s) result 
in several degenerative diseases like Alzheimer’s disease, Huntington’s disease, 
Parkinson’s disease, amyloid polyneuropathy, diabetes type-2, spongiform 
encephalopathy etc
78
. The degenerative diseases associated with amyloid fibrils are 
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generally of three types: (1) neurodegenerative diseases like Alzheimer’s diseases: 
amyloid fibril mainly degenerate the brain cells, (2) non-neuropathic localized 
amyloidosis: the fibril-mediated cell death occurs to a kind of cells other than neuronal 
cells, (3) non-neuropathic systemic amyloidosis: amyloid fibrils cause cell death to 
multiple kind of cells other than neuronal cells
78
.  
Since the root of amyloid disease is formation of misfolded protein conformation 
with amyloidogenic propensity, development of effective drugs against the conformation 
has been a key issue for last decade. In spite of many attempts, the scientific community 
have failed to develop therapeutic agents to combat/hinder the amyloid fibrillation. These 
insoluble deposits (fibrillar assemblies) are irreversible aggregates of misfolded proteins. 
Thus, the reversal of protein aggregation would have been an attractive strategy for 
development of therapeutic agents against the diseases
81
. Accordingly, first vaccine 
“Doblin-based Elan Pharmaceuticals’ AN-1792” was developed against Alzheimer’s 
diseases. The vaccine helped in dissolution of visible aggregate, and resulted in recovery 
of dementia in tested mice models. However, its trial on human proved disaster with 
meningoencephalitis and microbleed as the side effects in treated patients
82-84
. 
Development of second generation vaccines with different approaches against amyloid 
diseases are still in clinical trials
85
. In last decade, scientists have also looked several other 
types of molecules with tendency to induce anti-amyloidogenic conformations/conditions, 
like synthetic peptides, heat shock proteins, and chemical compounds (resveratrol)
86-88
. 
Apart from the studies, recently nanoparticles have been suggested as one of a possible 
inhibitor of amyloid fibrillation
81, 89-91
. 
1.6. Nanoparticle interfacial interaction with biological 
membranes and biomacromolecules 
In current era, nanoparticle is considered as promising tool with different applications in 
biomedical science, like biosensing, drug delivery, imaging etc. However, it is a matter of 
intensive research to understand the synthetic materials interaction with different 
biomolecules, cells, and tissues before considering the applications in biological 
sciences
92
. In biological medium nanoparticles come in myriad shape and size, and 
interact with different biomolecules forming nano-bio complexes. The physico-chemical 
properties of both the nanoparticle and biomolecule are affected by interaction patterns at 
nano-bio interface
93
. Additionally, the interface helps in thermodynamic exchanges 
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between nanomaterial and different biological components, like membranes, proteins, 
phospholipids, DNA etc
93
. As shown in figure 1.8, the different components developed as 
a result of nanoparticle biomolecule interactions are (i) surface of nanoparticle, (ii) solid-
liquid interface, (iii) contact zone of solid liquid interfaces with biological substrates
93
. 
However, the most important factors determining the surface properties of nanopaticle are 
chemical composition of material, shape and size, angle of curvature, porosity, surface 
crystallinity, roughness, functionalization, heterogeneity, hydrophilicity/hydrophobicity 
etc
93
. However, when the nanoparticle is dispersed in a medium, the developed 
quantifiable properties, like effective surface charge (zeta potential), aggregation 
propensity of particle, stability, biodegradability, state of dispersion, rate of dissolution, 
hydration and functionality of interface depend on the characteristics of the suspending 
medium
93
. Additionally, ionic strength, pH, temperature, and presence of organic 
molecules also affect the particle properties
94
. The acquired properties of nanoparticles 
contribute actively for the interaction of nanoparticles with the biological medium. 
However, forces like long-range forces, which arises from van der Waals (attractive in 
nature) and electrostatic double layer interactions, and short range forces, which arise from 
charge, solvent interaction, steric hindrance, depletion etc., are found at the nanoparticle 
media interface responsible for interaction with biomolecules
93
. 
 
Figure 1.8. Depiction of nano-bio interface, reproduced from Nel, A. E. et al93. 
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1.6.1. Nanoparticle-biological membrane interaction 
Increasing bacterial resistance towards traditional/conventional antibiotics is a major 
global health concern in current era
95-96
. Some bacterial strains have the potential to 
produce slime, which facilitates the adhesion and formation of biofilms on any artificial 
surfaces or implantable devices. The formation of biofilms enhances the possibility of 
bacterial survival by preventing antibiotic action
95-96
. Additionally, the interaction of 
nanoparticle to bacteria is a research focus of nanoecotoxicity; bacteria play major role for 
maintaining normal ecosystem
97
. Moreover, bacteria are generally used as representative 
model for single cell organisms. However, the nanoparticle interaction with bacteria helps, 
in broad view, us to understand the adhesion of nanoparticle on a cell membrane, and its 
uptake. Although, the toxicity of nanoparticles towards microbes is a well established 
research area
98-99
. However, to explore whether the toxicity caused upon interaction with 
membrane or internalization or both is essential to understand the mechanism of 
nanotoxicity. Different non-specific interactions like electrostatic, dipole-dipole, H-bond, 
hydrophobic, and van der Waals interactions are responsible for adhesion of bacteria on 
any material surfaces, triggering bacterial biofilm formation
95
. Hence, before screening 
any nanoparticle mediated approach as possible antibiotics, the material must have anti-
microbial property to reduce the microbial adhesion. The NPs with photocatalytic 
properties have the potential to reduce biofilm formation
95
. Inside microbial medium, the 
interactions between accessible functional groups of nanoparticle and biomolecules like 
lipopolysaccharide (LPS), phospholipid, protein, and lipoteichoic acid (LTA) present over 
the bacterial envelop contribute in interaction pattern at the interface. The functional 
groups of biomolecules enhance adhesion of bacteria to different surfaces, and help their 
proliferation
97
. Hence, the accessible functional groups present at bacterial envelop and 
nanoparticle surfaces, along with the physico-chemical property of nanoparticle, 
determine the fate of bacteria as well as the nanoparticle (whether nanoparticle will be 
compatible or toxic to bacteria) in biological milieu.  
1.6.2. Cellular internalization of nanoparticles 
Nanoscale materials are being formulated for different biological applications. For 
successful biomedical applications, sometimes nanoparticles are often functionalized with 
different ligands, coated with different biopolymers to target a specific cell
100
. Upon 
conjugation/encapsulation with drug molecules, cell internalizes the nanoparticle through 
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different pathways (Figure 1.9), and releases the drug molecule successfully. However, the 
efficacy of nanoparticle-based approaches depends on physico-chemical parameters of the 
nanoparticle like shape and size, surface potential, surface functionalities etc. In addition, 
different physico-chemical properties of the membrane such as (i) stretching and elasticity 
of membrane, (ii) thermal fluctuation of cell membrane, and (iii) hydrophobic exclusion of 
polar surfaces by membrane, resist the nanoparticle against the permeabilization
93, 101
. 
Interestingly, the nanoparticles upon interaction produces sufficient energy at the interface 
to overcome these forces
93
. 
 
Figure 1.9. Nanoparticles internalization pathways, reproduced from Zhang, S. et al100. 
1.6.3. Nanoparticle-nucleic acid interaction 
Exploring the interaction between the nanoparticle and biomolecule is an active research 
area, in current era. Nanoparticles, having high surface free energy, show high affinity to 
interact with biomolecules, especially biopolymers resulting in various applications like 
development of novel biosensor for clinical diagnosis, imaging, drug delivery, and 
pathogenic bacteria detection
102
. Recently, various metal and metal oxide nanoparticles 
like Au and Ag are identified to interact strongly with nucleic acid like DNA
102
. Hongjie 
An et al have elaborated about the possible covalent interaction between the nanoparticles 
and DNA with the help of different functional groups like –SH, -OH, -NH2, and –
COOH
103
. However, non-specific binding of nanoparticles to DNA can also be possible 
through non-covalent interactions
103
. The non-specific binding, leading into DNA-
nanoparticle conjugation, make the nanoparticles as a better DNA carriers in case of 
targeted delivery, which can replace the commonly used liposomes having various 
drawbacks
103
. Additionally, in delivery of plasmid DNA, antisense oligonucleotides, small 
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interfering RNA (siRNA), nanoparticles have also replaced the commonly used viral 
vectors possessing unpredictable immune response
103
.  
1.6.4. Nanoparticle-protein interaction 
Generally, with decrease in size of material, the free energy content of material/molecule 
increases
104
. When nanoparticle is dispersed in biological fluid, it interacts with 
biomolecules to lower the surface free energy content. Thus, nanoparticle interaction with 
biomolecules helps in proper dispersion of nanoparticles. In chemist’s word, when 
nanoparticle is placed in biological fluids, nanoparticle interface form attractive 
interactions with different moieties present in the fluid, resulting into release of free 
energy content of the nanoparticle. Thus, attractive interaction with moieties present in 
biological fluid helps in dispersion of nanoparticle in monomeric form, i.e. the interaction 
acts against agglomeration of nanoparticles. The concept applies for the case of protein 
biomacromolecules, which interacting with nanoparticles in biological fluids and forms 
‘nanoparticle-protein corona’. According to the proposal given by Monopoli et al, 
biological ‘corona’ obtained upon interaction of nanoparticles with biomacromolecules is 
one of the major elements of biological identity for the nanoparticle in biological 
milieu
104
. Additionally, nanoparticle properties like size, shape, solubility, surface charge 
and surface functionalities play vital roles in defining the strength and kind of interactions 
with biological moieties, thus the biological response and distribution
105-109
. Among all the 
biological moieties adsorb on nanoparticle interface, influence of protein-nanoparticle 
complexes to living system is now an emerging area of research
110-112
. When dispersed 
inside the biological medium, the nanoparticle obeys the universal rule of the material 
science, i.e. the material always covers itself by biomolecules present in biological milieu 
upon interaction
113
. Hence, the nanoparticles inside the biological medium are also 
covered with proteins forming nanoparticle-protein corona. Studies have shown that 
plasma proteome consists of approximately 3700 proteins, and minimum of 50 proteins 
have been observed to bind with different nanoparticle interfaces
114-117
. Opsonins, 
components of nanoparticle corona, act as a “molecular signature” which is recognized by 
immune cells and determines fate of the particle, like kind of cell reaction, route of 
internalization, rate of clearance, volume of distribution, and organ disposition
110-111, 118
. 
For example in one study, single walled carbon nanotubes and silica nanoparticles coated 
with albumin were observed to induce anti-inflammatory responses in macrophages. 
However, in another experiment, a modified nanoparticle interface, using non-ionic 
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surfactant (Pluronic F 127) to reduce adsorption of albumin, resulted in relatively lower 
anti-inflammatory response 
112, 119
. All these properties of nanoparticles like rate and root 
of clearance from body, organ deposition, and volume of distribution are dependable on 
nanoparticle-protein corona
110, 118
. Studies have shown that all the biological responses to 
nanoparticles are because of surface area rather than mass
120-122
. When particles become 
smaller, the surface area of particles shrinks much more slowly than their volume, 
resulting in larger surface-to-volume ratio. Due to larger surface-to-volume ratio, 
relatively higher protein population fraction binds to the nanoparticle surfaces
114
. 
Furthermore, the biological response and bio-distribution of the particles are influenced by 
the nanoparticle-protein complexes. The nanoparticle-protein complexes are possibly 
responsible for the side effects
123-124
, since on interaction with nanoparticle, certain 
proteins have shown sign of conformational rearrangement leading to loss of normal 
physiological functions
125
. The protein abnormality on interaction with nanoparticle 
interface induces unpredicted biological reactions including cytotoxicity
126
. Thus, the 
biological property of nanoparticle basically differs according to the physico-chemical 
nature of the nanoparticle interface that defines biological interaction partners of the 
nanoparticle (Corona), which ultimately defines fate of the nanoparticle in biological 
system. 
1.6.4.1. Protein conformational rearrangement upon interaction with NP interfaces 
Proteins are polymers of 20 naturally occurring amino acids. The linear sequence of these 
amino acids fold spontaneously forming tertiary structures (3D) in physiological media 
and these tertiary structures are relatively stable and functional in nature. When protein 
binds to the planar surface, overall structure of protein changed because of the additional 
interactions at interface. On the other hand, fine nanoparticle with relatively high 
curvature helps proteins to retain their tertiary structure on interaction. Nonetheless, 
studies on nanoparticle-protein interaction suggested that perturbation of the structure vary 
in extent depending upon the physico-chemical properties of nanoparticles
53
. When 
lysozyme and β-lactoglobulin are adsorbed on the silica nanoparticles, conformational 
changes of proteins occur at both secondary and tertiary levels
54, 127
. Different studies on 
nanoparticle-protein interactions have shown that the adsorption leads to decrease in α-
helical fraction, with or without increase in β-sheet fraction51, 127. Bovine serum albumin 
(BSA) has been taken as a model protein for nanoparticle protein interaction, since BSA 
undergoes conformational changes at different pH values
53
. The interaction of BSA with 
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gold nanoparticles has shown that the interaction resulted in α-helical fraction decrease, 
and a significant increase in sheets and turns
127
. Although, from various studies it has been 
concluded that protein retains its conformational stability when bind to nanoparticles, but 
in certain cases the stability decreases due to which conjugated protein become relatively 
sensitive to chemical denaturants such as urea
52
. 
1.7. Applications of nanoparticle-biomolecular interactions 
in biological sciences 
Due to huge potential in nanotechnology and having advanced physico-chemical 
properties such as high surface to volume ratio, nanoparticles have drawn the attention of 
various scientific communities for over a century. Hence, the particles are widely used in 
biomedical science and engineering. Few of the remarkable applications in biomedical 
engineering are nanoparticle as targeted drug delivery vehicles, diagnostic imaging, 
biosensors, anticancer agents, antimicrobial agents etc
8, 27
. However, among different 
nanoparticles, metal and metal oxide nanoparticles having photocatalytic activity have 
shown enormous applications in different fields of biomedical science. Easy synthesis and 
modification of these nanoparticles with various functional groups allow them to 
conjugate easily with different ligands, antibodies, and drugs of interest, hence opens 
different application windows in biomedical sciences and engiennering
27
. For example 
different metal and metal oxide nanoparticles like zinc oxide (ZnO), silver (Ag), silver 
oxide (AgO), titanium dioxide (TiO2), gold (Au), silicon (SiO2), calcium oxide (CaO), and 
magnesium oxide (MgO) having high photocatalytic activity possess high antimicrobial 
and cytotoxic activity, hence the biological applications
128
. The effectiveness of these 
nanoparticles depends on surface functionalities, defects, and size of the particle. 
1.7.1. Nanoparticles as novel antibiotics 
The emergence of different antibiotic resistant bacterial strains becomes a serious threat to 
public health. Hence, various research groups are trying to replace the conventional 
antimicrobial agents to check the bacterial infection. It is reported that, most of the 
bacterial infections (approximately 70 %) are resistant to different commonly used 
antibiotics
128-129
. Hence, research groups are trying to develop novel antibiotics which can 
replace the traditional antibiotics. Due to small size and high surface to volume ratio, 
nanoparticles are assumed to be possible antimicrobials against various resistant strains. 
Metal and metal oxide nanoparticles like zinc oxide (ZnO), iron oxide, silver (Ag), silver 
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oxide (Ag2O), titanium dioxide (TiO2), copper oxide (CuO) exhibit strong antimicrobial 
activities
128
. However, the mechanism of antimicrobial activities of these nanoparticles 
varies from particle to particle. From different studies, various research groups have 
proposed possible mechanisms like membrane damage, release of metal ions, ROS 
production etc. for antimicrobial activity
128-129
. 
1.7.2. Nanoparticle-mediated approach for cancer diagnosis and therapy 
The exploration of nanotechnology has opened several possibilities in biomedical sciences 
like drug delivery. Accordingly, various nanotechnology formulations are being developed 
to obtain safer therapeutics for different clinical applications, for example nanoparticle-
based approach in cancer treatment
10
. Now a days, although cancer is a major reason for 
death of millions people, still not an effective treatment is available for eradication of the 
disease. The commonly used methods adopted for cancer treatment are surgery, 
chemotherapy, radiation-therapy, immunotheraphy etc
10
. However, all these processes 
have advantages and disadvantages, and for better efficiency a combination of these 
processes are needed. It is important here to discuss that most human cancer are solid 
tumors and current strategy for treatment of cancer include chemotherapy to shrink the 
developed tumor before its removal by surgery. Despite of many efforts to treat cancer, the 
toxic side effects remain major issues in current era. Hence, various drug delivery carriers 
are being used to improve the efficacy of cancer therapy. Among these carriers, small size 
nanoparticles with biodegradable and biocompatible properties have received enormous 
attention of scientists working in cancer therapy research. The basic characteristics of 
anticancer strategies to be effective for cancer treatment are first it should actively reach 
the target site upon administration, without loss of content. Secondly, at the target site it 
should have the potential to kill the tumor cells without killing the normal cells. Thirdly, it 
should be released safely in controlled manner
10
. 
The rationale behind considering the nanoparticles to treat cancer is that reduction 
of the materials to nanoscale lead to development of advanced physico-chemical 
properties
130
. A number of research groups have reported that very low concentration of 
different metal and metal oxide nanoparticles have the potential to kill cancer cells
131-133
. 
Additionally, the anticancer efficiency of the metal and metal oxide nanoparticles can be 
increased by functionalizing them with specific antibodies and other ligands against 
cancer cells
130
. Different nanoparticles having anticancer activities are silver, zinc oxide, 
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iron oxide, titanium dioxide, cerium oxide, copper oxide, silica nanoparticles etc
134-135
. In 
addition to drug carrier, nanoparticle-mediated approaches have been adopted for cancer 
biomarker imaging and early detection
130
. It is reported that ZnONP capped with 
polymethyl methacrylate can be used for detection of low abundant biomarkers
130, 136
. 
Additionally, ZnO nanorods are being used as cancer biomarkers for detection of 
telomerase activity even at low concentration
137
. Along with ZnONP, iron oxide 
nanoparticles can be used as contrast agents for detection of cancer. Additionally, iron 
oxide nanoparticles having oleic acid coating modified with pluronic and tetronic block 
copolymers with iron oxide core are used for in-vivo tumour imaging
130
. 
1.7.3. Nanoparticle acting as a protein folding chaperone 
Various studies have reported that in some cases, perturbation of protein structure happens 
to some extent upon adsorption on the nanoparticles. Surprisingly, some studies have 
proved that some nanoparticles might act as a chaperone to help in protein folding
53
. In the 
native structure of a protein, the hydrophobic cores are buried inside, and hydrophilic 
residues are present over the surface that interacts with the aqueous environment and 
keeps hydrophobic core hidden from aqueous media. However, unfolding of protein 
causes exposure of hydrophobic surfaces leading to protein aggregation. In such cases, 
different chaperons like GroEL/GroES binds selectively to the unfolded protein through 
different non-covalent interactions, and stabilizes the protein from aggregation, hence 
helps in proper folding
53, 138-139
. It is also reported that during the refolding process, the 
aggregation of intermediate protein folds are prevented by surfactants and 
cyclodextrins
140-141
. Rozema, D. et al have reported that the refolding of protein is 
enhanced in presence of low molecular weight surfactants along with cyclodextrins, acting 
as a stripping agent
142
. However, it becomes difficult to remove surfactant completely 
after treatment. Although, water soluble polymers like poly-(ethylene-oxide) and 
polyamino acids are also used for preventing protein aggregation 
143-144
, however the 
efficacy of these chemicals are found low. 
Hence, currently researchers are focusing on nanoparticles to avoid the limitations 
of using these traditional chemical chaperones. Researchers have found that two types of 
nanoparticles can help in refolding of proteins
53
. Among them, one is nanogel, acting as a 
molecular chaperon, which is fabricated by pullulan self-aggregation with cholesterol 
group (CHP)
53
. When the β-cyclodextrin was added to the complex, the release of trapped 
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carbonic anhydrase B (CAB) was observed and its refolding was observed upon CHP-
nanogel dissociation
53
. Figure 1.10 shows the detail mechanism of refolding of CAB on 
the assistance of artificial molecular chaperons. Here, during the refolding process CHP 
trapped the unfolded proteins of intermediates to prevent aggregation. The process is very 
similar to the process as adopted by GroEL/GroES, and β-cyclodextrin act as an ATP 
molecule that helps in release of folded protein from complex
53
. In addition, another study 
Nomura Y. et al have also reported the chaperon like activity of nano-gel mediated protein 
refolding
145
. 
 
Figure 1.10. Schematic representation of artificial molecular chaperones, reproduced from Fei, L. 
et al53. 
1.7.3.1. Nanoparticle interface that enhances amyloid fibrillation kinetics 
As shown in figure 1.11, it is suggested that nanoparticles have the potential to increase 
the possibility of amyloidosis and other protein misfolding diseases
146
. Accordingly, the 
research done by various groups about catalytic property of nanoparticles in protein 
fibrillation proved that some nanoparticles have the potential to accelerate the process of 
protein fibrillation. Proteins are generally considered as potentially important molecules 
from biological point of view. The binding of proteins either in native or denatured state 
depends on the surface charge of protein, hydrophobicity, intrinsic stability and the 
characteristic of interacting particles. Hence, nanoparticles interact with proteins resulting 
in different pathological consequences. Additionally, surface charge and high surface area 
to volume ratio of nanoparticles greatly influence the interaction with protein molecules. 
However, size of nanoparticle also affects the interaction of nanoparticles with protein. It 
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is well known that protein fibrillation kinetics which is a nucleation-dependent mechanism 
is triggered by various external factors
147
. External factors, like presence of nanoparticle, 
polymeric charged surfaces, salts etc., act as a moderator for protein fibrillation. The 
process of amyloid fibrilliation is assisted by some nanoparticles
148-149
. Like the findings 
of Wu, W. H. et al, where he found that TiO2NP have the potential to assemble Aβ into 
amyloid fibrils in vitro, by accelerating nucleation process
150
. Additionally, Linse, S. et al 
in their study suggested that the association of protein at nanoparticle surface led into 
protein conformational rearrangement
151
, in addition to many fold increased local 
concentration. The conformational rearrangement and increased local concentration act as 
seed for amyloid fibrillation, hence enhance the rate of amyloid fibrillation
146, 151
. The 
work also indicated that mature fibrils, formed upon protein-nanoparticle interaction, had 
no affinity for the studied nanoparticle
151
. 
 
Figure 1.11. Amyloid protein fibrillation in presence of nanoparticles. (A) Shows nanoparticles 
(blue) and amyloid proteins (green) in its monomeric state. (B) The amyloid proteins are 
associated on nanoparticle surfaces generating small oligomers which are considered as precursors 
of fibrils. Reproduced from Colvin, V. l. et al146. 
1.7.3.2. Nanoparticle interface that reduces amyloid fibrillation kinetics 
Generally proteins in the folded state possess hydrophobic residues inside and polar 
groups on the surface. The hydrophobic effects or π-π stacking interactions or both 
between non-polar residues present in hydrophobic core help to maintain its tertiary 
structure
152
. For unfolded protein, chaperones like hsp 26/70/94, GroEL/GroES assist the 
unfolded conformation to attain a physiologically active tertiary conformation
152
. Protein 
folding process follow two steps, as described by Rozema and Gellman, (1) the capture 
step- the unfolded conformation bind with a host molecule, which assist the conformation 
Chapter 1                                                                                                            Introduction 
29 
against misfolding, and (2) release step- in this step host molecules take the help of 
competitive guests to get removed from the refolded protein
152-153
. Generally 
GroEL/GroES are considered to be hosts, which have hydrophobic inner compartment 
where unfolded protein goes and bind (capture step). Other molecules which are used for 
the purpose are linear dextrins, hydrophobic carbohydrate nanogels, liposomes, and 
stimuli responsive polymers, all are hydrophobic in nature
153-154
. Examples of 
hydrophilic/amphiphillic additives used for refolding of protein are polyamines, amino 
acids and polyethylene glycol etc
152
. Hydrophobic compounds bind to hydrophobic 
domains of protein, whereas hydrophilic compounds bind with exposed charged residues 
of unfolded protein
155
. 
 
Figure 1.12. The unfolding of protein and exposure of hydrophobic core followed by either 
aggregation of protein or refolding of protein depending upon the presence of amphiphilic 
nanoparticles, reproduced from De, M. et al152. 
The refolding capacity of nanoparticles was studied by De, M. et al as shown in 
figure 1.12. In the study, they have chosen protein having positive residues on the surface. 
These positive charges prevent protein aggregation. They unfolded the protein by thermal 
denaturation so that the hydrophobic inner core becomes exposed. In this state the protein 
aggregates by intermolecular association of hydrophobic domains on refolding. During 
this unfolded stage they introduced malonic acid functionalized gold nanoparticles 
(AuDA), which on interaction with denatured protein formed a nanoparticles-protein 
complex. This is due to electrostatic interaction of nanoparticles with positive residues of 
protein. Zeta potential measurement studies demonstrated that high negative charge of 
these nanoparticles protein complex prevent protein aggregation, thus promoting correct 
Chapter 1                                                                                                            Introduction 
30 
folding
152
. Shemetov, A. A. et al (2012) studied the inhibition of Aβ-fibril formation using 
biocompatible nanogels. The nanogel was prepared from polysaccharide of pullulan 
backbone and hydrophobic cholesterol moieties. The gel used as an artificial chaperone to 
inhibit the Aβ-fibrils156. 
1.7.4.  Detection of protein aggregation using nanoparticles 
Protein aggregation is the primary cause for many degenerative and incurable diseases like 
Alzheimer’s disease, cystic fibrosis, and prion diseases etc. In addition, it is important to 
study protein aggregation for development and storing of protein based 
biopharmaceuticals
157
. Hence, different analytical tools such as: UV-Visible spectroscopy, 
dynamic light scattering (DLS), ultracentrifugation, and size-exclusion chromatography 
(SEC) are some well known methods to study protein aggregation
157
. However, many of 
these processes are not sensitive to low concentrations of proteins as well as the methods 
are time consuming. Additionally, microtiter assays like thioflavin T (ThT) is commonly 
used to study protein aggregation. However, the assay have also limitations for low 
concentration, aggregate size etc
157
. Hence, research groups are trying to develop simple, 
novel, and cost effective methods for detection of protein aggregation. In this context, 
Pihlasalo et al formulated a novel protein aggregation assay based on nanoparticles. In this 
assay they have utilized time-resolved luminescence energy transfer (TR-LRET) to detect 
protein aggregation at picomolar concentration range
157
 (Figure 1.13).  
 
Figure 1.13. LRET assay based protein aggregation analysis with the help of europium(III) doped 
polystyrene nanoparticles. Low LRET signal is detected in case of non-aggregated protein, since 
these kinds of proteins are adsorbed on the nanoparticle that prevents the adsorption of labelled 
protein (left). However, the aggregated proteins are not efficiently adsorbed on the particles that 
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lead to adsorption of labelled protein, hence high LRET signal (right). Reproduced from Pihlasalo, 
S. et al157.  
When the LRET-acceptor labeled proteins are absorbed on the europium(III)-
doped polystyrene particles, the signal of TR-LRET is monitored. The energy from the 
europium(III)-doped polystyrene particles is transferred to the -globulin labeled with 
Alexa Fluor 680, and the emission is detected at 730 nm in time-resolved luminescence 
mode using a microtiter plate, luminometer. There is a change in signal when the 
aggregated protein attempts to displace the labeled protein. Since the concentration of the 
protein remains constant, the change in signal measures the rate of aggregation. However, 
the non-aggregated proteins are covered on the surface of the particles, so that the 
absorption of labeled protein is prevented. Hence, the process of protein aggregation 
detection becomes fast and inexpensive. 
1.7.5.  Advantages of nanoparticles based therapeutics over conventional 
therapies for amyloidoses 
A brief mechanistic discussion about protein misfolding and amyloid formation concluded 
that formulation of possible therapeutic strategies intend to rescue the native protein 
conformation or stabilize the intermediate or misfolded protein conformations. Based on 
these concepts, although many chemical compounds and their derivatives were found to 
be having potential to inhibit the protein aggregation, however no successful therapeutic 
approach has been formulated for human being to treat protein misfolding diseases. 
Furthermore, many are in trails like Doblin-based Elan Pharmaceuticals, AN-1792 against 
Alzheimer’s disease. Moreover, all amyloid-β-centric approaches have failed in phase-III 
clinical trials
158
. Many of them like tramiprosate, tarenflurbil and semagacestat have been 
discontinued
158
. Hence, scientists are looking forward for alternative strategies to cure 
protein misfolding diseases. Since the problems, entirely or partly, pose a significant 
social burden due to the increasing numbers of affected people and severity of the disease, 
the necessity for improved health care, diagnostics and treatment is immediate need of the 
society. However, nanotechnology based treatments involving the design and application 
of nanoscale medicines and drug delivery systems have been employed to optimize the 
therapeutics. It includes metal nanoparticles, solid lipid nanoparticles, polymeric 
nanoparticles, microemulsion, nanoemulsion, nanostructured lipid carriers and liquid 
crystals. One specific example of nanotechnology in advanced experimental treatment of 
Parkinson’s disease (PD) is the brain-targeted delivery of dopamine159. The in vitro 
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cytotoxicity of dopamine-loaded chitosan nanoparticle was found to be less than the free 
dopamine
160
. Nanodelivery of dopaminergic agonists like bromocriptine
161
, levodopa
162
, 
and ropinirole
163
 is being pursued because of their potential to improve brain uptake, and 
reduce its associated side effects. Hence, the nanosystems prove to be more effective as 
drug delivery agents specifically targeted to the CNS, because of good bioavailability and 
therapeutic efficacies. Ikeda and co-workers have shown that biocompatible nanogels of 
20-30 nm diameter can prevent aggregation of proteins and inhibit amyloid fiber 
formation
164
. Hence, nanoparticles can be adopted as a novel therapeutic approach to treat 
protein misfolding diseases. 
1.8. Objectives 
Objectives of the thesis are to study the effects of different photocatalytic nanoparticle 
interfaces on biological membranes and biomacromoleculs like: 
(a) (i) Effect of interfacial potential on antimicrobial propensity of ZnONPs 
(ii) Effect of surface functionality on antimicrobial propensity of IONPs 
(b) Effect of ZnONP surface defects on cytotoxic and antimicrobial propensities 
(c) Effect of interfacial assembly of antimicrobial peptide on conformational and 
functional dynamics of the peptide 
(d) Effect of interfacial interaction with globular protein on conformational dynamics 
of the protein (lysozyme) 
First objective of the thesis will shed light on underlying mechanism of antimicrobial 
activity of photocatalytic nanoparticles, emphasizing on the role of interfacial potential 
and functional groups at the nano-bio interfaces. Whereas, the second objective explored 
the effects of nanoparticle surface defects and crystallinity on cytotoxic and antimicrobial 
activities of the particle. Third and fourth objectives of the thesis evaluated the role of 
protein interfacial assembly or interaction onto nanoparticle in defining the conformational 
and functional dynamics of the protein. Interfacial assembly of protein onto nanoparticle is 
a resultant of the physico-chemical properties of the particle/protein, hence the behavior of 
interface against protein varies accordingly. The findings may be adopted in designing 
nanoparticle mediated approaches to enhance the functionality of peptides as well as to 
evaluate the role of conformational rearrangement upon interaction in amyloidosis 
diseases. 
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Chapter 2 
Materials and Methods 
2.1. Materials 
2.1.1. Chemicals 
Zinc acetate dihydrate, urea, glutaraldehyde, sodium hydroxide were purchased from 
Merck, India, whereas ferrous chloride tetrahydrate, ferric chloride hexahydrate, silver 
nitrate, lysozyme, nisin, silver nanoparticle were purchased from Sigma Aldrich, USA. 
Nutrient broth, nutrient agar, tannic acid, DMEM medium were purchased from Himedia, 
India. 2', 7'-Dichlorodihydrofluorescein diacetate (DCHF-DA) used for oxidative stress 
measurement was purchased from Cayman chemicals USA. 
2.1.2. Bacterial Strains 
Different bacterial strains used for antimicrobial studies, like Bacillus subtilis (MTCC 
736), Bacillus thuringiensis (MTCC 8998), Staphylococcus aureus (MTCC 737), 
Escherichia coli (MTCC 443), Shigella flexneri (MTCC 1457), Proteus vulgaris (MTCC 
426), were purchased from Institute of Microbial Technology (IMTECH), Chandigarh, 
India. 
2.1.3. Cell culture 
Human Embryonic Kidney (HEK 293) and fibrosarcoma (HT1080) cell lines were 
purchased from National Centre for Cell Sciences (NCCS), Pune. Cell lines were cultured 
in DMEM media supplemented with 10% fetal bovine serum (FBS) and penstrep (1% 
(v/v)). 
2.2. Synthesis of nanoparticles 
2.2.1. Synthesis and surface modification of zinc oxide nanoparticle 
The zinc oxide nanoparticles (ZnONPs) of different morphology were prepared by 
chemical precipitation method using zinc acetate dihydrate and urea. Briefly, zinc acetate 
dihydrate (0.1 M) and urea (0.1 M) solutions were prepared and mixed in a beaker at the 
volumetric ratio of 1:4. The mixture was stirred at room temperature and heated at 115 
o
C 
in a muffle furnace for 1.5 hrs. The white precipitate formed as a result of reaction 
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between zinc acetate and urea was collected by centrifuging at 6,000 rpm for 10 min and 
washed three times to remove absorbed chemicals and ions using deionised water. The 
pellet was dried at 100 
o
C and different fraction of the obtained powder were calcinated in 
silica crucible at different temperatures like 300, 500, 700 
o
C for two hrs.  
The ZnONP synthesized was found to have positive surface potential (p-ZnONP). 
To obtain negative surface potential ZnONP, surface modification of ZnONP (calcinated 
at 300 
o
C) prepared earlier was done using sodium citrate. Briefly, 20 grams of ZnONP 
was suspended in 1% sodium citrate, 10 mM HEPES buffer, pH 7.4, and vigorously 
vortexed for 5 mins followed by sonication for 10 mins. The above solution was 
centrifuged at 6000 rpm for 30 mins, and the pellet was collected and washed twice in 
deionised water. Thereafter, the pellet was dried in hot air oven to get the negative surface 
potential ZnONP (n-ZnONP)
165
.  
The XRD patterns of both p-ZnONP and n-ZnONP were recorded on an Ultima IV 
model Rigaku X-ray diffractometer (Tokyo, Japan) using CU-Kα radiation at a scan rate 
of 20 
o
/mins with a step size of 0.05 degree over 2 range of 25o to 70o. The X′-pert high 
score software having search and match facility was employed to study the different 
phases present in the samples. The morphological features like shape and size of 
synthesized NPs were studied using FE-SEM (Nova Nano SEM 450, FEI company), 
whereas the surface plasmon resonance properties of both types of NPs were analyzed 
using UV-Vis spectrophotometer (Cary 100, Agilent Technology, Singapore) in 
absorbance mode. The FTIR spectra of both types of NPs were recorded on an alpha 
platinum attenuated total reflection fourier transform infrared (ATR)-FTIR 
spectrophotometer (Bruker, Germany). The spectra were obtained in ATR mode with 128 
scans and 8 cm
−1
 resolution in a range of 2500–500 cm−1 on diamond crystal, and the 
surface potential was studied using a zeta analyzer (Malvern Zetasizer Nano ZS90, 
Netherland). 
2.2.2. Synthesis and surface modification of iron oxide nanoparticle 
The iron oxide nanoparticle (IONP) was synthesized from ferrous chloride tetrahydrate 
(FeCl2.4H2O) and ferric chloride hexahydrate (FeCl3.6H2O) by co-precipitation method, 
following the protocol described by Bellova et al
89
 with some modifications. Required 
amounts of 0.1 M FeCl2.4H2O and 0.2 M FeCl3.6H2O were added to 100 mL of deionised 
water, and stirred using a magnetic stirrer until a homogeneous solution was formed. The 
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solution was sealed and heated at 60 
o
C for 15-20 mins in a water bath followed by the 
addition of 14 mL of 25% sodium hydroxide (NaOH). The black precipitate formed upon 
completion of the reaction was centrifuged at 7000 rpm for 15 mins, and washed three 
times with deionised water, followed by drying at 60 
o
C to get the powder form of IONP. 
For surface modification of IONP, the protocol adopted by  Samani S. M. et al.
166
 was 
followed. In Brief, 20 mg of chitosan was dissolved in 100 mL of deionized water 
containing 1 M of acetic acid, and vortexed for 5 mins. 70 mg of synthesized IONP was 
dissolved in the above prepared chitosan solution, and kept overnight (~18 hrs) on a 
magnetic stirrer at room temperature (25 
o
C). During the process, chitosan molecules 
absorbed upon the IONP surface resulting into color change from black to brown. After 
the change in color, suspension was centrifuged at 7000 rpm for 30 mins, and pellet was 
collected. The pellet was further washed two times with deionised water to remove 
unabsorbed chitosan molecules and traces of acetic acid, and dried to powder at 70 
o
C to 
obtain surface modified IONP. The two IONPs obtained were named as n-IONP and p-
IONP for iron oxide nanoparticle as synthesized and chitosan modified iron oxide 
nanoparticle respectively. 
The XRD patterns of both iron oxide and chitosan coated iron oxide NPs were 
recorded on a X-ray diffractometer (Ultima IV model Rigaku, Tokyo, Japan) using CU-
Kα radiation at a voltage of 30 KV and a current of 40 mA with a scan rate of 20 o/min 
and step size of 0.05 
o
 over 2 range of 25o to 70o. The different phases present in the 
synthesized sample were evaluated using X′-pert high score software having search and 
match facility. The field emission scanning electron microscopy (FE-SEM, Nova Nano 
SEM 450, FEI Company, Netherland) was employed to analyze the morphological 
features of synthesized IONPs at an accelerating voltage of 10 KV upon gold coating for 3 
mins. The UV-Visble spectrophotometer (Cary 100, Agilent Technology, Singapore), was 
employed to study the surface plasmon resonance properties of both n-IONP and p-IONP 
at desired dilutions using deionised water. Fourier transform infrared (FTIR) spectra of 
both types of the IONPs along with chitosan were recorded on a alpha platinum attenuated 
total reflectance (ATR)-FTIR spectrophotometer (Bruker, Germany) in ATR mode with 
128 scans and 8 cm
−1
 resolution in a range of 2000–500 cm−1 on diamond crystal, whereas 
the surface potential of both IONPs was measured using zeta analyzer (Malvern Zetasizer 
Nano ZS90, Netherland). Moreover, the concentrations of Fe
3+
 present in our synthesized 
IONP samples were determined using atomic absorption spectrophotometer (Perkin Elmer 
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AA200, Singapore). Specific cathode lamps were employed and the instrument tuned to 
corresponding wavelengths. Air-acetylene flame was used for atomization of IONP 
suspension. Initially, the flame absorptions were calibrated by using respective standard 
solutions in the range of 1-2 mg/L. Following the calibration, concentration of the 
synthesized IONP samples were found 18.1 ppm of Fe. On applying the empirical formula 
of magnetite (Fe3O4) present in the nanoparticles, since our synthesized iron oxide is 
magnetite as reported by XRD results, the equivalent concentration of iron oxide in 
suspension were estimated to be 101 µM. The different concentrations in reactions were 
obtained by dilution with respective buffers or broth. 
2.2.3. Synthesis of silver nanoparticls using bacteria from coal mine- A 
green synthesis approach 
2.2.3.1. Isolation of bacterial samples 
For isolation of bacterial strains, 100 mg coal powder was measured and dissolved in 1mL 
of autoclaved distilled water, followed by 10000 dilutions using autoclaved distilled water. 
20 µL of the solution was spread on agar plate, and kept for overnight incubation at 37 
o
C. 
The slant cultures of bacterial strains were prepared for further use by taking single 
colonies from the plates. Many strains were isolated and randomly chosen three among 
them for our further experimental works. 
2.2.3.2. Determination of AgNO3 minimum inhibitory concentrations against 
extracted bacteria 
Minimum inhibitory concentration (MIC) was determined to check resistance of extracted 
bacteria against silver metal ions in comparison to normal chemical conditions. The 
mother cultures of the bacteria were prepared by inoculating a loop full of bacteria into 5 
mL nutrient broth, and incubated overnight at 150 rpm and 37 
o
C. Different reaction 
mixtures were prepared in 96 well plate taking different concentrations (0, 0.019, 0.15, 
and 1.25 mM) of AgNO3 and 20 L of bacterial culture, and the volume was adjusted to 
final volume of 300 L using nutrient broth. The growth of bacteria was observed by 
taking O.D. at 600 nm using micro-plate reader (Synergy H1 hybrid reader, Biotek, USA) 
at 37 
o
C at regular time interval. Colony forming unit (CFU) measurements were 
performed to estimate the number of viable bacteria cells present in different reaction 
mixtures. The samples were taken from early stationary phase of the growth curve from 
respective bacteria culture in presence of 0, 0.019, 0.15, and 1.25 mM AgNO3. The 
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samples were spread on nutrient agar plate after 10000 times dilutions. The plates were 
kept overnight in incubator at 37 
o
C for their proper growth in colony, and the colonies 
were counted and expressed as percentage of viable cells. The percentage of viable cells 
was measured by comparing the number of colonies obtained in bacterial growth found in 
absence of AgNO3. Additionally, three bacteria were characterized using the standard 
protocol of Gram staining to know whether the bacteria are Gram-positive or Gram-
negative. From the above study, first two tested bacteria found resistant to AgNO3 and the 
third one sensitive to AgNO3. So, two resistant bacteria were taken for synthesis of 
AgNPs. 
2.2.3.3. Synthesis of silver nanoparticles 
For synthesis of AgNPs, 5 mL of mother cultures of two bacteria ware prepared in nutrient 
broth, and kept overnight at 37 
o
C and 150 rpm. 1 mL of the culture was added to 100 mL 
of nutrient broth and left for growth at 37 
o
C and 150 rpm agitation. Appropriate amount 
of AgNO3 was added at the mid log phase of growth so as to obtain the MIC value (0.15 
mM) of AgNO3 in growth medium. The reaction mixtures were incubated further for 24 
hrs at 37 
o
C with agitation at 150 rpm for nanoparticles synthesis. The bacterial culture 
containing the nanoparticles was sonicated followed by centrifugation at 6000 rpm for 15 
mins, and the supernatant was collected for characterization of AgNPs. The nanoparticle 
samples obtained from the two bacteria were named as AgNP1 and AgNP2 respectively. 
2.2.3.4. Characterization of silver nanoparticles 
The synthesis of silver nanoparticles (bioreduction of silver ions to silver nanoparticles) 
was confirmed using UV-Visible spectroscopy (Cary 100, Agilent Technology, 
Singapore) within the range of 350-600 nm. Dynamic light scattering is a technique to 
determine the size distribution of particles in aqueous solution. Here, we have used Zeta 
analyzer (Malvern Zetasizer Nano ZS90, Netherland) to measure the distribution of 
nanoparticles in the aqueous solution synthesized using the bacteria. To check the stability 
of nanoparticles, the zeta potential of the above two nanoparticle samples were also 
measured using zeta sizer. The morphology of bacteria after treatment of AgNO3 at MIC 
was studied using Field Emission Scanning Electron Microscopy (FE-SEM, Nova Nano 
SEM 450, FEI, Netherland). The samples were prepared following the protocol adopted 
by Arakha et al.
167
. In brief, the AgNO3 treated bacterial samples were collected from the 
stationary phase of growth kinetics and centrifuged at 5000 rpm for 5 mins. Pellets were 
collected and washed twice using PBS buffer and resuspened in PBS buffer again. One 
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drop of the resuspened bacteria sample was put on glass slide and kept for dying at 37 
o
C 
in incubator. The dried bacterial samples were flooded with glutaraldehyde (2.5%) and 
kept for overnight (~18 hrs) incubation at room temperature. After incubation, 1% of 
tannic acid was flooded over the slides, and the slides were kept for 5mins at room 
temperature. The slides were again washed with distilled water and dehydrated with 
ethanol series (30, 50, 70, 90, and 100%), and kept for drying. The samples were scanned 
for bacterial as well as nanoparticle morphology using FE-SEM after gold coating of the 
samples for 3 mins. The elemental composition of synthesized nanoparticle sample was 
determined using energy dispersive X-ray spectroscopy attached with the FE-SEM. The 
samples were characterized by ATR-FTIR spectroscopy (2 model, Bruker, Germany) to 
observe the bond level vibrations of different bonds present in the synthesized samples. 
For this, samples were sonicated and analyzed putting on the diamond platform of ATR-
FTIR with 128 scans at 8 cm
-1
 resolution in a range of 2000-500 cm
-1
. 
2.3. Effect of interfacial potential on antimicrobial 
propensity of ZnONPs 
2.3.1. ZnONP-bacteria interfacial potential measurement 
The mother cultures of all bacteria were prepared by inoculating a single bacterial colony 
into nutrient broth followed by incubation at 37 
o
C with constant shaking at 150 rpm. For 
surface potential measurement at zeta analyzer, bacterial cells were harvested by 
centrifugation at 5000 rpm for 10 mins at 4 
o
C from the overnight culture, followed by two 
times washing using 1X PBS buffer, and resuspended in PBS buffer prior to the 
measurement. 
For surface charge neutralization study, 100 µL of bacteria culture in Muller 
Hinton Broth (MHB), grown overnight at 37 
o
C and 150 rpm, were inoculated into 5 mL 
of fresh MHB. The culture was allowed to grow at 37 
o
C until the bacterial concentration 
reached ∼3 × 108 colony forming units/mL (O.D.600 ~ 0.1). The culture was diluted using 
fresh MHB to 3 × 10
5
 CFU/mL. ZnONPs were suspended in 10 mM HEPES buffer (pH 
7.4 containing 150 mM NaCl) with stock concentration of 5 mg/mL, and sonicated for 
proper dispersion. Dilutions of ZnONPs were prepared to final concentrations of 160, 250, 
500, 1000, and 2500 µg/mL, using HEPES buffer. For neutralization reactions, 100 µL of 
the diluted ZnONPs concentrations were added to 900 µL of bacterial culture, and 
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incubated for approximately 2-3 hrs (higher incubation time for B. subtilis) at 37 
o
C with 
shaking, prior to zeta potential measurements. Positive control was 900 L bacterial 
cultures diluted with 100 L of the medium. For zeta potential measurements and ROS 
study, B. subtilis and E. coli cell cultures were taken only, as representatives for Gram-
positive and Gram-negative bacteria. 
2.3.2. Bacterial cell viability in presence of ZnONPs 
The strain specific antibacterial activity of p-ZnONP was studied against the bacterium. 
All growth kinetic studies were performed by measuring O.D. at 600 nm using a UV-
Visible spectrophotometer (Perkin Elmer, Lambda 35, Singapore) with temperature 
controller peltier system (PTP 1+1 peltier system, Perkin Elmer, Singapore) at 37 
o
C in 
static condition. In an aseptic condition, 100 L of respective bacteria culture was diluted 
to 3 mL using nutrient broth, followed by growth till mid log phase. Thereafter, an 
appropriate amount of p-ZnONP suspension (prepared in sterilized nutrient broth) was 
added to get the final p-ZnONP concentrations of 16, 25, 50, 100 and 250 µg/mL 
(additional 500 µg/mL data point was taken for Bacillus thuringiensis) in culture, by 
keeping total volume constant. Culture without p-ZnONP was taken as positive control. In 
each case, p-ZnONP was added to the reaction mixture at mid log phase of growth 
kinetics, since at this phase the organisms are most potent/viable. Hence, the requirement 
of p-ZnONP to inhibit the growth is relatively high, that lead to precise determination of 
the MIC of p-ZnONP
168
. In addition to above study, similar growth kinetics of bacteria 
was performed for n-ZnONP. 
The number of viable cells, after p-ZnONP treatment at mid log phase of their 
kinetics, were determined by CFU study. For the study, upon completion of the growth 
kinetics (from stationary phase) 10 µL of the bacterial samples were taken and spread on 
the nutrient agar plates after 10000 fold dilution. The plates were incubated overnight at 
37
 o
C. Colony forming units were quantified and compared with control to check the 
viability of bacterial cells upon treatment with varying concentrations of p-ZnONP.  
2.3.3. ROS detection 
The production of ROS in the bacterial cultures treated with different concentrations of the 
ZnONPs was evaluated using 2', 7'-dichlorodihydrofluorescein diacetate, DCFH-DA. E. 
coli and B. subtilis cultures were incubated at 37 
o
C with 200 µM of DCFH-DA, and 
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fluorescence emission was observed at 523 nm with excitation at 503 nm using micro-
plate reader (Synergy H1 hybride reader, Biotek, USA). The stock concentration of 
DCFH-DA was calculated using 59,500 M
-1
cm-
1 
molar extinction coefficient at 500 nm.
 
At the mid log phase of bacterial growth, the ZnONP suspensions were added to the final 
concentration of 16 and 250 µg/mL. To determine the ROS variation, the emission 
intensity of the treated cultures was compared with both, positive (without ZnONP 
treatment) and negative (culture media without DCFH-DA only) controls. 
2.3.4. Bacterial morphology on ZnONP treatment 
Initially, the morphology of bacteria upon p-ZnONP treatment was visualized using phase 
contrast microscopy (Olympus CKX41, JAPAN) with U-CMAD3 digital live camera and 
Q-capture pro7 software, taking samples directly upon the slide from stationary phase of 
growth kinetics. To gain more insights into the morphological features, the samples using 
SEM and FE-SEM were scanned. For the imaging, samples were prepared using the 
protocol given by De, J. et al, with some modifications
169
. In brief, from the stationary 
phase of growth kinetics, 1 mL of bacterial cultures were taken, and centrifuged at 5000 
rpm for 5 mins at 4 
o
C. The pellet was collected, washed twice, and resuspended in 1X 
phosphate buffer saline (PBS). One drop of the resuspended culture was put on glass 
slides, and bacterial cells were fixed by incubating overnight in 2.5% glutaraldehyde 
(prepared in 1X PBS). The fixed slides were suspended in 1% tannic acid for few mins, 
and washed with distilled water followed by dehydration using increasing concentration of 
ethanol (30, 50, 70, 90, and 100%). The fixed, washed, and dehydrated bacterial cells were 
coated with platinum and gold for SEM (Jeol-JSM-6480 LV SEM, Japan) and FE-SEM 
(Nova NanoSEM 450/FEI), scanning, respectively.  
2.4. Effect of surface functionality on antimicrobial 
propensity of IONPs 
2.4.1. Growth kinetic analysis 
Initially, effects of interaction pattern at IONP-bacteria interface was studied by following 
growth kinetics of B. subtilis and E. coli in absence and presence of different n-IONP and 
p-IONP concentrations. The mother cultures of test organisms were prepared in nutrient 
broth taking loop full of bacteria from the specified slant culture, and cultured overnight at 
37 
o
C and 150 rpm agitation. Different concentrations of both, n-IONP and p-IONP, taken 
were 2.5, 5, 10, 25, and 50 µM. The IONP stock solution was prepared by dispersing 
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IONP in sterilized nutrient broth and sonicated for 10 mins followed by UV radiation 
sterilization before use. The reaction mixtures without NPs were taken as controls. Briefly, 
20 µL of bacterial mother cultures were added to the different reaction mixtures prepared 
in 96-well plate, and the reaction volumes were adjusted by adding nutrient broth to a final 
volume of 300 µL with nanoparticle. The growth kinetic studies were performed by 
measuring optical density (O.D.) at 600 nm using plate reader (Synergy H1 hybrid reader, 
Biotek, USA) at regular time interval. At approximately mid log phase of bacterial growth, 
respective concentrations of NPs were added to the respective reaction mixtures. Upon 
addition of the NP, data collection for growth curve was immediately started with dead 
time of 10 mins. 
2.4.2. CFU measurement 
The number of viable cells was quantified by measuring colony forming units (CFUs) for 
both types of bacteria upon treatment with different n- and p-IONP concentrations. For 
CFU measurement, 10 µL of sample from the stationary phase of growth kinetics were 
taken from different reaction mixtures having different n-IONP and p-IONP 
concentrations (2.5, 10, and 50 µM), and spread on the nutrient agar plates after 10000
 
times dilution in autoclaved distilled water. The plates were incubated overnight at 37 
o
C. 
The number of viable cells after treatment with different IONPs were quantified and 
compared with positive control (culture without NP) to evaluate the antimicrobial 
propensity of IONPs. 
2.4.3. ROS detection 
The production of ROS, predominantly responsible for the toxicity of NPs, was evaluated 
using 2', 7'-dichlorodihydrofluorescein diacetate (DCFH-DA). Generally, DCFH-DA, a 
peroxynitrite indicator, having the potential to detect both nitric oxide and hydrogen 
peroxide (considered as ROS) inside as well as outside of the cells
170
. The bacterial cells 
were treated with DCFH-DA (200 µM), and fluorescence emission at 523 nm was 
measured using synergy H1 hybrid reader (Biotek, USA) with an excitation at 503 nm. 
Different n-IONP and p-IONP concentrations (0, 2.5, and 50 µM) were added to 
respective wells at log phase of the growth kinetics. ROS variation was determined 
comparing the fluorescent intensities of different wells with that of positive control 
(without NPs treatment). For error bar these experiments were done in triplicate.  
2.4.4. LIVE/DEAD BacLight fluorescence microscopy assay 
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The fluorescence microscopy assay is one of the important methods to visualize the effect 
of interaction pattern on antimicrobial propensity of the NPs in the bulk culture. The 
fluorescence microscopy (Olympus IX71, Germany) with 20X objective lens was 
employed for imaging bacteria cells (control) and NPs (50 µM) treated bacterial cells to 
distinguish viable cells from dead cells with the help of LIVE/DEAD BacLight Bacterial 
Viability Kit (L7007, Molecular probes, invitrogen). In brief, 30 mL of each culture, B. 
subtilis and E. coli, were prepared in separate flasks by inoculating 29 mL of nutrient 
broth with 1 mL of overnight cultures. At mid log phase of bacterial growth, the NP 
solutions were added to the final concentration of 50 µM NPs, and allowed to grow till 
late log phase. From these cultures, 25 mL of each bacterial solution were centrifuged at 
7000 rpm for 15 mins. The supernatant were discarded, and the pellets were suspended in 
2 mL of HEPES buffer (10 mM, pH 7.4, containing 150 mM NaCl). 1 mL of the bacterial 
cell suspensions were added to 20 mL of HEPES buffer in two separate tubes. Both 
samples were incubated at room temperature for one hour (with mixing every 15 mins). 
The suspensions were centrifuged at 7000 rpm for 15 mins, pellets were collected and 
suspended in 20 mL of HEPES buffer, and centrifuged at 7000 rpm for 15 mins. Finally, 
the pellets were resuspended in 10 mL of HEPES buffer in separate tubes, and optical 
density was measured at 670 nm. 3 µL of dye mixture (equal volume of component A and 
component B of the kit) was added to each 1 mL of the prepared bacterial samples, and 
incubated in dark for 15 mins after proper mixing of bacterial suspensions. Fluorescence 
images were taken by trapping 5 µL of stained bacterial samples between a slide and cover 
slip. 
2.5. Effect of ZnONP surface defects on cytotoxic and 
antimicrobial propensities 
2.5.1. Cell culture and ZnONP stock solution preparation 
Fibrosarcoma (HT1080) cell lines were purchased from National Centre for Cell Sciences 
(NCCS), Pune. Cell lines were cultured in DMEM media supplemented with 10% fetal 
bovine serum (FBS) and penstrep (1%, v/v). Stock solutions of ZnONPs were prepared in 
autoclaved PBS buffer. Trypsinization was done to harvest the cells and the number of 
cells was counted using hemocytometer. 
2.5.2. Cytotoxicity of ZnONPs 
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The cytotoxicity of ZnONPs synthesized at different calcinations temperatures was 
evaluated following the protocol adopted by Arakha M. et al
23
 against fibrosarcoma cell 
line (HT1080) using Alamar blue dye reduction assay. Briefly, 5000 cells of HT1080 
cells/well were seeded in 96-well plate with proper medium (DMEM, Himedia, India), 
with 10 % fetal bovine serum (FBS). Following 24 hrs of incubation in a CO2 incubator, 
the culture media were replaced with fresh DMEM media containing different ZnONPs at 
different concentrations (0, 2.5, 5, 10, 25, and 50 µg/mL). The cells were further incubated 
for another 24 hrs in CO2 incubator. Alamar blue dye (10% v/v), Invitrogen, USA) was 
added to different wells and fluorescence intensity was detected at 590 nm (emission 
wavelengths), with an excitation at 544 nm. Percentage of viable cells for ZnONPs treated 
and untreated (control) samples were calculated from the ratio of fluorescence intensity of 
treated and untreated cells.  
2.5.3. ZnONPs induced ROS generation 
Intracellular ROS levels generated due to treatment of different ZnONPs were evaluated 
using 2,7-dichlorodihydrofluorescein diacetate oxidation (DCFH-DA, Invitrogen) using 
multimode fluorescence microplate reader (Synergy H1 hybrid, Biotek, USA), following 
the protocol adopted by Kang, M. A. et al.
171
. In brief, HT1080 cell was seeded in a 
black/clear bottom 96-well plate at a density of 5000 cells/well, followed by incubation in 
a CO2 incubator for 24 hrs. Following the incubation, cells were washed using PBS buffer 
and treated with 25 M DCFH-DA dye for 1 hr. Cells were then re-washed with PBS, and 
treated with different ZnONPs (50 g/mL). The generated ROS level was detected 
measuring the fluorescence intensity at 523 nm with an excitation at 502 nm. Level of 
ROS variation was determined by comparing the obtained fluorescence intensity of treated 
samples with control. Triplicate experiments were performed to determine the standard 
error of mean. 
2.5.4. Comet assay 
The possibility of DNA damage upon ZnONP treatment was analyzed using comet assay. 
For the same, approximately 2*10
5
 cells were seeded in a six well tissue culture plate and 
treated with different types of ZnONPs (fabricated at 300, 500, and 700 
o
C calcination), 
and prepared for comet assay following the protocol adopted by Olive, P. L. et al.
172
.  
2.5.5. Cell cycle analysis 
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Cell cycle analysis was carried out upon ZnONP treatments by staining the obtained DNA 
with ethidium bromide followed by flow cytometric measurement. For the same, 
approximately 2*10
5
 cells were seeded in a six well tissue culture plate. Following 24 hrs 
incubation, the cells were treated with ZnONP of different concentrations (5, 25, and 50 
μg/mL), and incubated for further 24 hrs followed by removing the medium and stored 
until further analysis. The obtained ZnONP treated cells and control cells were washed 
using 1X PBS and trypsinized followed by harvesting in stored medium, and centrifuged 
at 1000 rpm for 15 mins. The obtained pellet was re-washed using PBS and fixed in ice-
cold ethanol (70%) and stored in -20 
o
C. For flow cytometric analysis, the stored cells 
were washed using PBS and stained with ethidium bromide, and analyzed using flow 
cytometry (BD Bioscience, USA). 
2.5.6. ZnONPs induced autophagy 
The induction of autophagy was monitored using acridine orange assay. For this, the cells 
(2*10
5
) were seeded in a six well plate, and treated with different 50 μg/mL ZnONPs, 
followed by incubation in a CO2 incubator for additional 24 hrs. Following the incubation, 
1 μg/mL acridine orange (Invitrogen, A3568) was added to the cells and incubated for 15 
mins. The cells were then washed using PBS to remove the excess acridine orange and 
fresh media was added. The induction of autophagy upon the treatment of ZnONP was 
monitored using fluorescence microscope (Olympus IX71). 
2.5.7. ZnONPs induced apoptosis 
Apoptosis, which is also known as programmed cell death, plays key role both in 
development of multi cellular organisms maintaining tissue homeostasis and in many 
diseases like neurodegeneration, cancer etc. However, initiation of apoptosis progression 
is due to the caspases mediated activation of a proteolytic cascade
173
. It has been reported 
that chromatin condensation and fragmentation are two hallmarks of apoptosis
173
. Hence, 
theses two phenomena were studied in the cell upon ZnONP treatment. For this, upon 24 
hrs ZnONP treatment, the HT1080 cells (2*10
5
) were stained with 4,6-diamido-2-
phenylindole dihydrochloride (DAPI) to observe the condensed chromatin. The 
fluorescence images were taken using an Epi-fluorescence microscope (Olympus IX71, 
Germany). The condensed nuclei obtained as a result of ZnONP treatment were counted 
among the total nuclei present in the field, and plotted graphically to demonstrate the 
percentage of apoptotic nuclei compared to normal nuclei. The induction of apoptosis by 
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ZnONPs was further confirmed by DNA fragmentation assay following the protocol 
adopted by Suman, S. et al
174
. Briefly, the obtained DNA precipitate was solubilized at 60 
oC in 20 μL of 2 % sodium dodecyl sulfate (SDS) in TE buffer (10 mM Tris-HCl and 1 
mM EDTA, pH 8.0), followed by adding 10 μL of loading dye (0.25 % bromophenol blue, 
0.025 % xylene cyanol, and 30 % glycerol in water) to 40 μL of processed samples. 
Finally, the samples were loaded on 2 % agarose gel followed by electrophoresis for 45 
mins at 70 V in presence of 0.5 μg/mL ethidium bromide. Upon completion of the 
electrophoresis, DNA was visualized in a UV trans-illuminator. 
2.5.8. Morphological changes 
The morphological variation of HT1080 cell upon ZnONPs treatment was observed by 
FE-SEM analysis, and the samples were prepared using the protocol followed by Wang J. 
et al.
175
 with some modifications. HT1080 cells were grown on the slides used for FE-
SEM analysis to a semi confluent state, treated with different ZnONPs (50 g/mL), and 
incubated in CO2 incubator for 24 hrs. Most of the media were removed, and the cells 
were washed with PBS buffer and fixed using 2% paraformaldehyde for 5 hrs at 4 
o
C. 
Cells were re-washed four times with PBS buffer followed by deionised water. Post 
fixation of samples was done in 1 % OsO4 solution for 1 hr at 4 
o
C, followed by 1 hr 
tannic acid treatment. Finally, the cells were dehydrated using an ethanol series of 10, 20, 
40, 50, 70, 90, and 100 %, and dried at room temperature. 
2.6. Effect of interfacial assembly of antimicrobial peptide 
on conformational and functional dynamics of the peptide 
2.6.1. Preparation of AgNP-nisin conjugates 
Initially, nisin stock solution of 450 µg/mL was prepared in phosphate buffer (pH 7.4) and 
stored at -20 
o
C for further use. For preparation of AgNP-nisin conjugates, AgNP solution 
(20 µg/mL) was taken in three micro-centrifuge tubes, and varying volumes of nisin stock 
were added to respective centrifuge tubes to obtain a AgNP-nisin ratio of 1:0.25 (18 
g/mL AgNP : 4.5 g/mL nisin), 1:0.5 (18 g/mL AgNP : 9 g/mL nisin), and 1:1 (18 
g/mL AgNP : 18 g/mL nisin) w/w, respectively. The volume of all tubes was adjusted 
to 1 mL using phosphate buffer, pH 7.4. All samples were incubated overnight on rocker. 
Following the incubation, AgNP-nisin conjugates were separated by centrifuging the 
respective reaction mixtures at 14,000 rpm for 30 mins followed by washing twice with 
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phosphate buffer. The unbound nisin and silver nanoparticles were remained in 
supernatant, whereas the pellets representing the AgNP-nisin conjugates were separated. 
The pellets were resuspended in 50 µL phosphate buffer, and kept at 4 
o
C for further use. 
The resuspended precipitates were quantified for nisin using bicinchoninic acid (BCA) 
assay
176
. The found nisin concentrations were 5, 8 and 17 M in 1:0.25, 1:0.5 and 1:1 
AgNP:nisin ratio conjugates, respectively. From the resuspended volumes of respective 
ratios, a certain volume of the conjugates were taken for reaction with nisin concentration 
equivalent to 85, 170 and 340 nM (340 nM=1.2 g/mL), respectively. 1.2 g/mL (2.8 nM, 
approx.) of AgNP in the resuspended conjugates were observed using atomic absorption 
spectroscope (Perkin Elmer AA200, Singapore). Thus, the control for every antimicrobial 
measurements done were untreated, 1.2 µg/mL of nisin, and 1.2 µg/mL AgNP treated 
cells, respectively.  
2.6.2. Biophysical characterization of AgNP-nisin conjugates 
Initially, the impact of nisin on SPR spectra of AgNP was monitored just after 2 hrs of 
incubation with nisin using a UV-Visible spectrophotometer (Cary 100, Agilent 
Technology, Singapore). The conjugation of AgNP with nisin was further confirmed by 
zeta potential analysis. For the measurement, the AgNP-nisin conjugates were prepared in 
deionised water to avoid the interference of ions present in phosphate buffer. However, the 
conformational dynamics of nisin upon AgNP conjugation was analysed using ATR-FTIR 
(Bruker, Germany) spectroscope with 128 scans and 2 cm
-1
 resolution in the range of 
2000–500 cm-1 on diamond crystal. To further strengthen IR data, CD-spectroscope (Jasco 
J-720 spectropolarimeter) was used to analyze the change in secondary structure upon 
conjugation in the range of 190-260 nm. Additionally, the impact of nisin on the 
morphology of AgNP was further explored using TEM (Tecnai F30, FEI, The Netherland) 
and FE-SEM (Nova Nano SEM 450, FEI, The Netherland). 
To further strengthen the stability of complex with time, the molecular dynamics 
simulation of the AgNP core, nisin, and complex were performed by GROMACS 5.0.4,
177
 
using the GROMOS96 54A7 force field parameter set. An experimentally derived NMR 
structure of nisin deposited against the PDB entry 1WCO
178
 was used for the simulations. 
The bonded and non-bonded parameters for the modified amino acid residues, 
didehydroalanine (Dha) and (2E)-2-Aminobut-2-enoic acid (Dbu) present in the peptide 
were obtained from the Automated topology Database (ATB)
179
. Parameters for D-alanine 
(Dal) and D-alpha-aminobutyric acid (Dbb) are available in the 54A7 force field set. The 
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coordinates and parameters for AgNP core were used as given in Kyrychenko et al
180
. The 
simulation was first set up for the modified nisin alone to observe structural changes, if 
any. First, the peptide was minimised and equilibrated for 10 ns, and then an independent 
production run for 50 ns was run. RMSD analysis was performed to observe structural 
change during the production run of 50 ns. Similarly, the AgNP core has been subjected to 
energy minimisation, equilibrated for 5 ns, and finally exposed to a 50 ns production run. 
This has been performed in order to ensure that the core does not collapse during the 
binding simulations. The compactness of the simulated AgNP has been validated by 
calculating the radius of gyration at the end of the simulation. AgNP and nisin conjugated 
at an average distance of 7 Å. The complex has been placed in a box with an edge distance 
of 1 nm. Solvation of the system has been implemented using the simple point charge 
(SPC) water model. After neutralizing, the system has been minimised using the steepest 
descent gradient followed by a 10 ns equilibration run at constant volume and 298 K 
temperature, employing the Berendsen method
181
. A 50 ns production run has been done 
to find the interaction between the nanoparticle core and nisin. With a time step of 2 fs, in 
all the simulations, the bond lengths have been kept constant using the LINCS 
algorithm
182
. Long range electrostatic interactions have been carried out using particle 
mesh Ewald (PME) summation
183
. Periodic boundary conditions have been applied. All 
the graphical visualizations have been done using VMD
184
. 
2.6.3. Antimicrobial activity of AgNP-nisin conjugates 
The effect of AgNP-nisin conjugates on viability of bacterial cells was investigated using 
growth kinetic studies against Bacillus subtilis, Staphylococcus aureus, Proteus vulgaris, 
and Escherichia coli. The different reaction mixtures were prepared in 96-well plate 
taking 20 µL mother cultures of different bacteria, and the volume was adjusted using 
autoclaved nutrient broth to a final volume of 300 µL with respective concentrations of the 
AgNP-nisin conjugates. The growth kinetics of different bacteria was monitored recording 
the optical density (O.D.) at 600 nm with the help of a multi mode plate reader (Synergy 
H1 hybride reader, Biotek, USA) at a regular time interval of 5 minutes. 20 µL of AgNP-
nisin conjugate suspension was added to respective well at mid log phase of growth 
kinetics, and data collection was started immediately with a dead time of 10 mins. In 
addition to growth kinetic studies, the number of viable cells in control, nisin, AgNP, and 
AgNP-nisin conjugates treated bacteria were measured following the protocol adopted by 
Arakha M. et al
167
.  
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2.6.4. Interfacial and intracellular ROS detection 
The generation of ROS due to the interaction of AgNP-nisin conjugates with bacterial 
membranes was evaluated using the DCFH-DA dye
23
. Different reaction mixtures were 
prepared in 96-well plate taking 20 μL of mother culture of bacteria, and nutrient broth 
was added to adjust the final volume of 300 μL with AgNP-nisin conjugates. After adding 
the dye with final concentration of 200 µM in reaction mixture, the fluorescence intensity 
at 523 nm was measured using the plate reader at an excitation wavelength of 502 nm. 20 
μL of different AgNP-nisin conjugates were added to respective wells in the log phase of 
growth kinetics and fluorescence measurement was continued with a dead time of 5 mins. 
2.6.5. Membrane destabilization and internalization of AgNP-nisin 
conjugates 
The LIVE/DEAD BacLight fluorescence microscopy assay was performed to distinguish 
the live cells from the dead cells, upon treatment with AgNP-nisin conjugates using 
fluorescence microscope (Olympus IX71, Germany) with 20X objective lens, following 
the protocol adopted by Arakha M. et al
23, 167
. Additionally, the morphological changes of 
bacteria upon the conjugate treatment was studied using Scanning Electron Microscope 
(Jeol JSM6480, Japan), following the protocol adopted by Arakha M. et al.
167
.  
For labelling of the AgNP-nisin conjugates with fluorescein, the conjugates were 
prepared and suspended in deionised water. Upon washing the conjugate, the pellet was 
resuspended in 50 µL of fluorescein stock (1 mM stock in DMSO), and incubated in dark 
for 2 hrs at room temperature for labelling of fluorescein to the conjugate. The labelled 
AgNP-nisin conjugates were centrifuged at 14,000 rpm for 30 mins, and washed twice 
with deionised water to remove the residual free dye. Finally, the obtained pellet was 
resuspended in deionised water for further use. For confocal microscopic study, the 
studied bacteria were cultured in nutrient broth until mid-log phase of growth curve. At 
the mid log phase, the labelled AgNP-nisin conjugates were added to the bacterial culture 
and incubated overnight at 37 
o
C. The bacterial samples were analysed using the confocal 
microscope (Leica, TCS-SP8). 
2.7. Effect of interfacial assembly of globular protein on 
conformational dynamics of the protein 
2.7.1. Preparation of ZnONP solution 
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For all experimental purpose, colloidal ZnONP solution was prepared by dissolving 1 
mg/mL of synthesized and characterized ZnONP powder (300 
o
C) in respective buffer 
followed by sonication at full amplitude for 5 minutes. The sonicated solution was filtered 
using 220 nm membrane filtered paper and analyzed using Atomic absorption 
spectroscope (AAS) for concentration determination. The concentration of colloidal 
ZnONP was found to be 3 mM using. The solution was stored in 4 
o
C for further use. 
Since ZnONP have the potential to aggregate in colloidal solution, hence to avoid 
aggregation, the colloidal solution of ZnONP was sonicated each time before use. 
2.7.2. Preparation of lysozyme:ZnONP conjugates 
The lysozyme-ZnONP conjugates (1:5, 1:10, 1:20,1:50, and 1:100 M/M) were prepared in 
two buffers (phosphate buffer pH 7.4 and glycine NaOH buffer pH 9) by dissolving 
different concentrations of ZnONP to 10 μM lysozyme solution followed by incubation of 
reaction mixture on rocker for overnight at room temperature. 
2.7.3. Circular Dichroism (CD) Spectropolarimetry 
The structural change of lysozyme upon interaction of ZnONP was evaluated using 
Circular Dichroism (CD) Spectropolarimetry (Jasco J-720 spectropolarimeter) with an 
average of three scans from 200 to 260 nm. The contribution of respective buffer was 
subtracted from the protein spectra to obtain the final spectra. 
2.7.4. Intrinsic tryptophan fluorescence spectroscopy 
Steady-state intrinsic tryptophan fluorescence spectra of the native and samples treated 
with varying concentrations of ZnONPs (overnight incubation) at pH 7.4 and pH 9 were 
recorded in LS 55 luminescence spectrofluorometer (LS55, Perkin- Elmer, USA). The 
excitation wavelength of 280 nm was used at a scan speed of 100 nm/min, and the 
emission spectra were recorded between 300 and 400 nm with excitation and emission slit 
of 3 nm each. Baseline correction was done with buffer without protein for all samples. 
2.7.5. ANS fluorescence studies of lysozyme 
The steady-state fluorescence measurements were performed on LS 55 luminescence 
spectrofluorometer. Both excitation and emission slits were set at 3 nm. For ANS binding 
experiment, protein samples (incubated overnight with and without ZnONPs) at pH 7.4 
and pH 9 were incubated with optimized concentration of ANS (100 μM) for 30 min at 25 
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o
C in dark. The excitation wavelength for ANS fluorescence was set at 350 nm and the 
emission spectra were recorded from 400 to 600 nm.  
2.7.6. Lysozyme tryptophan fluorescence quenching study using 
acrylamide 
Fluorescence quenching of lysozyme was studied using different concentration of 
acrylamide (0-400 mM) in presence and absence of ZnONPs. Intrinsic tryptophan 
emission spectra were measured in the range of 300-400 nm after adding acrylamide, 
followed by incubation for 30 mins at 25 
o
C. Intrinsic tryptophan fluorescence intensities 
were measured in the emission wavelength range of 300-400 nm upon an excitation 
wavelength of 280 nm. 
2.7.7. Thioflavin T assay of lysozyme fibrillation kinetics 
Thioflavin T (ThT) stock solution was prepared in deionised water and filtered using 220 
nm membrane filter paper and the concentration of the stock was determined using the 
molar extinction coefficient (εM = 36,000 M
-1
cm
-1
) at 412 nm. Different conjugates of 
lysozyme:ZnONP (1:5, 1:10, 1:20,1:50, and 1:100 M/M) were prepared at both pH (pH 
7.4 and 9) keeping the concentration of lysozyme (10 µM) constant followed by overnight 
incubation on rocker at room temperature. The lysozyme and lysozyme:ZnONP 
conjugates were added with 100 µM SDS and 20 µM ThT. The fibrillation kinetics was 
observed by measuring fluorescence intensity at 490 nm upon excitation at 440 nm using a 
multi mode plate reader (Synergy H1 hybride reader, Biotek, USA). 
2.7.8. Transmission Electron Microscopy study 
To analyze the morphological features of the lysozyme amyloids, samples were taken 
from the stationary phase of fibrillation kinetics of lysozyme in absence and presence of 
ZnONP and prepared following the procedure adopted by Jha S. et al
185-186
. Briefly, 10 μl 
of the samples (control and 1:100, lysozyme:ZnONP conjugate) were put on carbon 
coated cupper grids (Ted Pella) and incubated at room temperature for 20 mins followed 
by negative staining with 2% osmium tetraoxide (OsO4) for 2 mins. Electron microscopy 
images were recorded using FEI Tecnai transmission electron microscope (Tecnai F30, 
FEI, Netherland). 
2.7.9. Circular Dichroism (CD) Spectropolarimetry 
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The structural change of lysozyme upon interaction of ZnONP in presence of 100 µM 
SDS was evaluated using Circular Dichroism (CD) Spectropolarimetry (Jasco J-720 
spectropolarimeter) with an average three scans from 200 to 260 nm. The contribution of 
respective buffer was subtracted from the protein spectra to obtain the final spectra. 
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Chapter 3 
Results and discussions 
3.1. Synthesis and characterization of nanoparticles 
3.1.1. Zinc Oxide nanoparticle 
Synthesis of nanoparticles is a promising area of research in nanobiotechnology that aims 
to control the size, shape, and composition of nanoparticles, since each of these factors 
plays critical role in determining different applications
187
. Among different nanoparticles, 
zinc oxide nanoparticles (ZnONPs) have received enormous attention due to their wide 
band gap energy, high transmittance, and good electrical conductivity etc
18
. Hence 
ZnONPs are widely used in different fields like biosensors, gas sensors, solar cells, 
biological imaging, drug releasing, waste water treatment etc
18-19
. Although, various 
methods like sol gel, microemulsion techniques, pyrolysis, laser ablation, thermal 
evaporation, hydrothermal synthesis, microwave methods etc. have already been well 
established for synthesis of ZnONP. However due to their relatively higher surface free 
energy content, nanoparticles aggregate easily
18
. Hence, this study optimized a synthesis 
method to get control of surface potential, size and shape of nanoparticle with varying 
calcination temperatures, such as 300, 500 and 700 
o
C calcinations. 
Initially, the formation of ZnO nanocrystals were confirmed from the analysis of 
X-ray diffraction (XRD) spectra of ZnONPs. The XRD spectra (Figure 3.1a) revealed that 
the ZnONP samples, prepared at different calcination temperatures were crystalline in 
nature with peaks at different diffraction 2 angle values of 31, 34, 36, 47, 56, 62, 66, 67, 
and 68
o
 corresponding to different indices (100), (002), (101), (102), (110), (103), (200), 
(112) and (201), respectively. The indices are well indexed to the hexagonal structure of 
bulk ZnO lattice parameters
16, 188-189
. Additionally, the analysis of XRD spectra of 
ZnONPs using X’-pert high score software with search and match facility demonstrated 
that the synthesized ZnONPs have hexagonal Zn-O packing (JCPDS reference code–80-
0074). The average particle size of different ZnONPs obtained at different calcination 
temperatures were determined using Scherrer’s equation  
Particle size = K*/ cos (),        Eq (1) 
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Where is the wavelength of X-ray (1.540*10-10 m), K= 0.9 (shape factor),  is the full 
width at half of maximum (FWHM) in radians, and  is the Braggs angle. From the 
Scherrer’s equation, the average particle size of ZnONPs was 30, 35, and 45 nm for 300, 
500, and 700 
o
C calcination temperatures, respectively. In addition, it was observed in the 
XRD spectra that upon increasing the calcination temperature, sharpness of the peaks 
increases while the FWHM decreases (Figure 3.1b). The FWHM value for crystals 
obtained at 700 
o
C was 0.220, which is significantly very low compared to crystals 
obtained at 300 
o
C (0.435). The lower FWHM values and increase in intensity of peaks 
implied that the synthesized ZnO powder become more crystalline with increase in the 
calcination temperature (Figure 3.1b).  
 
Figure 3.1. (a) XRD spectra of ZnONPs, (b) peak FWHM values (degree) and crystal size with 
respect to caclination temperatures of ZnONPs, (c) UV-Visible absorption spectra of ZnONPs, 
representative FE-SEM images for (d) 300 oC, (e) 500 oC, (f) 700 oC, and TEM images for (g) 300 
oC, (h) 500 oC, (i) 700 oC calcinated ZnONPs, respectively.  
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Figure 3.1c represented the UV-Visible absorption spectra with absorption peaks at 
368, 370, and 378 nm for ZnONPs calcinated at 300, 500, and 700 
o
C, respectively. The 
peaks are attributed to the SPR properties of respective ZnONPs. The shifting of 
absorption peak towards higher wavelength with increasing calcination temperature was 
due to increasing surface defects occurred at higher calcinations temperature, leading into 
decreased energy band gap. The energy band gap (Ebg) of synthesized ZnONPs was 
determined using the equation, Ebg=1240/ (eV)
16
, where Ebg and  represent for energy 
band gap in eV and wavelength in nanometer, respectively. The energy band gap of 
ZnONPs was found to be 3.36, 3.35 and 3.28 eV respectively, which clearly demonstrated 
the decrease in energy band gap with increase in calcination temperature. The XRD and 
UV-Visible spectra analysis, together, concluded that the calcination temperature 
significantly affect the crystallinity of ZnONPs, as ZnONPs crystallinity increased with 
increasing calcination temperature.  
The bond level vibrations of different bonds present in ZnONPs were analyzed 
using ATR-FTIR spectroscope (Figure A1, Appendix). Strong absorption peaks at 1529 
and 2337 cm
−1
 for each ZnONPs were due to bending vibrations of N-H and the 
asymmetric stretching vibration of C=O bonds, respectively. Additionally, peaks at 1680 
cm
−1
 was due to C=O bond vibration. However, peaks below 800 cm
−1
 were due to metal-
oxygen (Zn-O) bond vibration
190
, which were found at 546 and 632 cm
−1
 confirming the 
presence of Zn–Oxygen bonds in the prepared sample. Moreover, peak at 3193 cm−1 was 
due to C-H vibrations, and at 3617, 3735 and 3850 cm
−1 
were attributed to the presence of 
elongation vibration of O-H bonds present in the ZnONPs
191
. 
The morphological features of the ZnONPs synthesized at different calcination 
temperatures were explored using Field Emission Scanning Electron Microscopy (FE-
SEM), and Transmission Electron Microscopy (TEM). As shown in figures 3.1(d-f), 
nanoparticles possess various shapes in samples calcinated at 300 
o
C with most of them 
spherical in shape having diameters in the range of 10-30 nm. However, an increase in 
calcination temperature from 300 to 500 
o
C significantly increased the particle size 
without change in shape. Interestingly, with further increase in calcination temperature to 
700 
o
C, besides the increase in size of the particle, the shape of particle became irregular. 
The morphologies of synthesized ZnONPs were further investigated using TEM. Figure 
3.1(g-i) represented the images of ZnONPs synthesized at different calcination 
temperatures of 300, 500, and 700 
o
C, respectively using TEM. Most of the particles in 
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300 
o
C samples were approximately spherical in shape with average size ranging from 10-
30 nm, whereas the size of nanoparticles increased to 20-50 nm for 500 
o
C sample. 
Interestingly, the particles in 700 
o
C
 
sample were irregular in shape with relatively larger 
size. The shape of particle calcinated at 700 
o
C indicated that at highest calcination 
temperature the particles self-assembled to form rod-like structures. The morphology as 
analyzed from FE-SEM and TEM micrographs indicated that the growth of ZnONP was in 
both lateral and longitudinal direction at the highest calcinations temperature. The finding 
was also observed when the nanocrystal frabrication pH is changed, in the work of 
Baruah, S. et al
192
. Additionally, the studied SAED patterns of the particles obtained at 
different calcination temperatures indicated that the particles became more crystalline with 
rise in the temperature (Figure A2, Appendix). 
EDX analysis was carried out to illustrate the elemental composition of the 
synthesized ZnONPs. As shown in figure A3 (Appendix), prominent peaks for carbon, 
oxygen, zinc and copper were found in the EDX spectra. However, the peaks for carbon 
and copper were due to the carbon grid used for analysis, whereas prominent peaks of zinc 
and oxygen confirmed the composition of crystalline powder as ZnONP. The atomic 
percentage of zinc and oxygen present in the synthesized samples are listed in table A1 
(Appendix). Here, it is noteworthy that the atom percentage of oxygen decreased with 
increasing temperature. Hence, the finding indicated that the oxygen vacancy created due 
to high calcination temperature, which is resulting into narrowing of energy band gap
193
. 
The increase in oxygen vacancies helped in delocalization of the impurity states, and the 
delocalized impurity states overlap with the edge of the valence band resulting in 
narrowing of the energy band gap
194-195
. Hence, the ZnONP obtained at 700 
o
C calcination 
temperature showed highest oxygen vacancy demonstrating narrower energy band gap, 
which further supported the findings from UV-Visible spectroscopic data. In addition, 
Zhang, X. et al have also reported that ZnO nanorods possess higher photocatalytic 
activity due to presence of abundant oxygen vacancies or defects
16
. 
The zeta potential values of the synthesized ZnONPs were found to be +24.8, 
+18.4, and -4.19, respectively. Irrespective of charge, sign the magnitude of zeta potential 
decreased from 300 
o
C to 700 
o
C, which possibly played role in lateral and longitudinal 
assembly of the particle, producing larger size NP with increase in calcination 
temperature. 
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3.1.1.1. Surface modification of ZnONP 
To elucidate the role of nanoparticle interface and/or interfacial potential affecting the 
antimicrobial propensity of ZnONP, The surface of ZnONP from positive to negative 
surface potential so as to obtain two ZnO nanoparticles of opposite surface potential was 
modulated using sodium citrate. For this, ZnONP synthesized at calcination temperature 
of 300 
o
C was chosen, since the temperature produced small size and spherical shaped 
ZnONP with insignificant surface defects. The synthesized and surface modulated 
ZnONPs were named as p-ZnONP and n-ZnONP for positive surface potential and 
negative surface potential ZnONPs respectively. The XRD data (Figure 3.2a) of p-ZnONP 
and n-ZnONP revealed that both the samples prepared are crystalline in nature with peaks 
at different 2θ, i.e. the Bragg’s angle values 31, 34, 36, 47, 56, 62, 66, 67 and 68o 
corresponding to different indices (100), (002), (101), (102), (110), (103), (200), (112) and 
(201), respectively. The indices are well indexed to the hexagonal wurtzite structure of 
bulk ZnO lattice parameters. Additionally, the analysis of XRD spectra of p-ZnONP and 
n-ZnONP using X′ pert high score software with search and match facility demonstrated 
that both types of the nanoparticles have hexagonal ZnO crystals (JCPDS reference code–
80-0074 and 79-0208 for p-ZnONP and n-ZnONP, respectively). Interestingly, it is 
observed in the XRD spectra that the diffraction peaks of n-ZnONP are slightly shifted 
towards the lower Bragg angle compared to p-ZnONP (inset of Figure 3.2a). The shifting 
of peaks revealed the lattice expansion upon sodium citrate coating leading into increased 
interlayer spacing of n-ZnONP along the c-axis
196
. The average particle size for p-ZnONP 
and n-ZnONP is determined using Scherrer's equation and found to be 30 and 39 nm for p-
ZnONP and n-ZnONP, respectively. The theoretical specific surface area (SA) of 
synthesized nanoparticles are also determined using the equation SA = 6/(D*ρ), as 
suggested by Hjiri, M. et al, where D and ρ represents the particle size and theoretical 
density (5.606 g/cm
3
), respectively
196
. Using the equation, the theoretical specific surface 
area of p-ZnONP and n-ZnONP are found to be 35.67 and 27.44 m
2
/g, inferring specific 
surface area decreases upon surface coating. 
The compositions of p-ZnONP and n-ZnONP were, further, analyzed using ATR-
FTIR spectroscope, shown in figure 3.2b. Strong absorption peaks at 1531 and 2341 cm
−1
, 
for both types of nanoparticles were due to bending vibrations of N-H and the asymmetric 
stretching vibration of C=O bonds, respectively. The absorption peaks observed at 1680 
cm
−1
 was due to vibration of C=O bond present in the residual acetate/carbonate or citrate 
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formed in the process. The absorption peaks below 800 cm
−1
 provided important 
information about internal metal-oxygen bond vibration
190
. The spectra of materials 
showed absorption peak near 542 and 566 cm
−1
 for n-ZnONP and p-ZnONP respectively, 
corresponding to Zn-O bond stretching vibration present in nanocrystal lattice (Figure 
3.2b inset). The shift in peak from 566 to 542 cm
−1
 for Zn-O-Zn bond vibration on surface 
modulation interpreted that p-ZnONP required higher frequency vibration to vibrate Zn-O-
Zn bond compared to the bond present in n-ZnONP; frequency of vibration is inversely 
proportional to square root of the mass of the vibrating molecule, Hooke's Law. Thus, the 
presence of citrate as coating on the surface of ZnONP was resulting into lower 
wavenumber vibration for Zn-O-Zn bond present in n-ZnONP compared to p-ZnONP. 
Additionally, the modification was further confirmed at bond level using ATR-FTIR 
spectroscopy, where peak intensities corresponding to C=O vibrations, i.e. 2341 and 1680 
cm
−1
 were found to be enhanced for n-ZnONP compared to p-ZnONP. 
 
Figure 3.2. Characterization of p and n-ZnONPs. (a) XRD, (b) ATR-FTIR absorption spectra, (c) 
UV-Vis absorption spectra of p-ZnONP and n-ZnONP, (d) FE-SEM image of p-ZnONP (d-i) and 
n-ZnONP (d-ii), (e) Zeta potential analysis of p-ZnONP and n-ZnONP showing value of +12.9 
mV(e-i) & -12.9 mV (e-ii). 
Surface plasmon resonance (SPR) property is a characteristic property of 
nanoparticles, especially photocatalytic metal nanoparticles with short band gap energy, an 
energy gap between top vibrational level of valence band and bottom vibrational level of 
conduction band. Figure 3.2(c) showed the UV-Visible absorption spectra of p-ZnONP 
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and n-ZnONP with absorption peaks at 362 and 369 nm respectively, which are attributed 
to SPR property of ZnONPs
16, 197-199
. The absorption peak at 362 nm obtained for p-
ZnONP was very close to the absorption peak of 364 nm obtained by Tankhiwale, R. et 
al
197
 and 361 nm by Vigneshwaran, N. et al
198
. From the figure, it was evident that upon 
coating by sodium citrate the absorption peak for ZnONP shifted from 362 nm to 369 nm, 
i.e. red shift, confirming the surface modification of ZnONP. The shifting of absorption 
peak towards higher wavelength is due to decrease in band gap of nanoparticle, which is 
due to increase in particle size. The band gap energy (Ebg) of synthesized ZnONPs was 
determined using the equation, Ebg = 1240/λ (eV) 
16
, where Ebg and λ represent for band 
gap energy in eV and wavelength in nanometer, respectively. The band gap energy of p-
ZnONP and n-ZnONP were 3.4 and 3.3 eV respectively, which were very close to the 
theoretical values of ZnONP, as supported by different literatures
16, 99, 200
. 
Field Emission Scanning Electron Microscopy (FE-SEM) images of both positive 
and negative potential ZnONPs suggested that the particles are spherical in shape with 
diameter range in 25–35 nm (Figure 3.2d-i) and 35–45 nm (Figure 3.2d-ii), respectively. 
The significant increase in average size of negative potential ZnONP further confirmed the 
coating. Zeta potential measurement showed that the synthesized p-ZnONP has surface 
potential of +12.9 mV, while surface modification with citrate reversed the surface 
potential to −12.9 mV for n-ZnONP (Figure 3.2e-i&-ii). 
3.1.2. Iron oxide nanoparticle and its surface modification 
It has been reported that among different types of NPs, magnetic nanoparticles due to their 
biocompatibility, chemical stability, and magnetic behavior are widely used in biomedical 
sciences
25
. Magnetic nanoparticles are also being used for delivery of drugs to targeted 
tissues by application of external magnetic field, which in turn increases stability of the 
drugs against enzymatic or metabolic degradation
25-26, 201
. Due to outstanding magnetic, 
physico-chemical, thermal, and mechanical properties, magnetic nanoparticles can also be 
used in other fields, like analytical chemistry, pathogen detection, antigen diagnosis, tissue 
repair, hyperthermia etc
26, 202
. Most of transition metal nanoparticles like ions like iron, 
cobalt, nickel, and their compounds belong to magnetic nanoparticles
203
. Iron oxides 
coming under magnetic nanoparticles are magnetite (Fe3O4), maghemite (γ -Fe2O3), 
hematite (α -Fe2O3), and goethite (FeO(OH))
203
. Numerous methods have been formulated 
for synthesis of iron oxide nanoparticle (IONP), still synthesis of IONPs having small and 
uniform size distribution with good stability to avoid agglomeration is a matter of 
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intensive research in current era. Furthermore, evaluation of the role of functional groups 
on the nanoparticle interface is a key challenge for safe use of IONP. Hence, in this sub-
ojective iron oxide nanoparticle (p-IONP) was synthesized by chemical precipitation 
method, and modulated the surface functional groups using biocompatible chitosan 
molecule (n-IONP). 
The synthesized IONPs were studied using X-ray diffraction spectroscopy. Figure 
3.3(a) showed the XRD patterns for both n-IONP and p-IONP. The major diffraction peak 
at 35° (311) in addition to minor peaks at 30° (220), 43° (400), 53° (422), 57° (511), and 
62° (440) confirmed the spinel structure of iron oxide (magnetite-Fe3O4 and maghemite- γ 
-Fe2O3)
95
, revealing that the synthesized IONP did not not contain any other forms of iron 
oxide such as hematite (α-Fe2O3), goethite (FeO(OH)), or any iron hydroxides in 
detectable range
95
. Shan Z. et al. have suggested that the lattice parameter (α) for 
magnetite and maghemite are 8.3960 Å and 8.3515 Å, respectively
204
. For the synthesized 
IONPS, lattice parameter for n-IONP was 8.3840 Å, which was very close to lattice 
parameter of magnetite, revealing that the synthesized n-IONP contains predominantly 
magnetite (Fe3O4) population. For further confirmation, the 2θ value of the (311) peak was 
considered. As reported in various literatures, the standard values of this peak (311) for 
magnetite and maghemite are at 35.423° and 35.631°, respectively
95, 204
. The diffraction 
angle for the synthesized nanoparticle is 35.47°, which is more close to magnetite index 
than maghemite index. It indicated presence of predominantly magnetite (Fe3O4) lattice 
with traces of maghemite lattice. From the observations, it is concluded that the 
synthesized n-IONP has major fraction of magnetite (Fe3O4) in the nanocrystal. The 
surface modification with chitosan molecule does not affect the crystal structure of IONP, 
since the major peaks at 2θ, 30° (220), 35° (311), 43° (400), 57° (511), and 62° (440), 
correspond to 8.3840 Å lattice, only. The 2θ value for the peak (311) is 35.46, which is 
basic characteristic feature of magnetic nanocrystals, as described above
95, 204
. 
Additionally, the analysis of n-IONP and p-IONP XRD patterns using X’ pert high score 
software with search and match option revealed that the both types of nanoparticle have 
Fe3O4 crystals (JCPDS reference code–75-0033). The particle size of n-IONP and p-IONP 
was determined using Scherrer equation, and found to be 10.36 +/− 5.1 nm and 11.37 +/− 
5.6 nm, respectively. The size obtained was an average of data obtained from peaks 
present for n-IONP and p-IONP diffractions, respectively. The XRD spectra obtained in 
the study are compatible with XRD spectra of different literatures
25, 205-207
. 
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Figure 3.3(b) showed FTIR spectra of n-IONP and p-IONP suspended in deionised 
water. The data were collected in attenuated mode FTIR using diamond crystal. The 
presence of the metal oxide nano-crystals was confirmed from the peaks at 564  and 
555 cm−1, which were due to metal oxygen bond vibrations present in n-IONP and p-IONP 
nano-crystals, respectively
190
. It was very interesting to observe that there was a peak shift 
from 564 cm−1 to 555 cm−1 upon chitosan coating of n-IONP, demonstrating that p-IONP 
needed lower frequency to vibrate Fe-O bond than n-IONP. Following Hook’s Law, the 
lower frequency of vibration indicated that Fe-O bonds present in p-IONP are less stable 
than the bond present in n-IONP
167
, hence more prone to produce electron-hole pair. The 
absorption peak at 1664 cm−1 (for n-IONP and p-IONP), 1702 cm−1 (for chitosan), and 
1524 cm−1 (for all) were due to C = O and N-H vibrations, respectively. In the chitosan 
spectra, the absorption peak at 1051 cm−1 was due to vibration of C-O-C bonds208, which 
shifted to 1032 cm−1 for chitosan coated IONP (p-IONP). However, shifting of peak from 
1051 cm−1 to 1032 cm−1 with lesser intensity peak at 1032 cm−1 was attributed to 
decreased population of the bond on washing of residual chitosan molecules from bulk. 
The increased intensities of N-H vibrations for p-IONP confirmed the surface coating of 
chitosan over negatively charged IONP, indicating strong interactions between the amino 
group on chitosan molecules and IONP. Thus, the data supported both XRD and UV-
Visible data for successful coating of IONPs with chitosan molecule. 
 
Figure 3.3. (a) XRD spectra (b) ATR-FTIR absorption spectra, and (c) UV-Visible absorption 
spectra of n-IONP, and p-IONP, (d) Zeta potential analysis of n-IONP (d–I), and p-IONP (d–II). 
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UV-Visible spectra of both n-IONP and p-IONP were shown in figure 3.3(c). Due 
to surface plasmon resonance property, n-IONP showed characteristic absorption peak at 
359 nm, whereas p-IONP showed peak at 367 nm which is in accordance with the reported 
results by ur Rahman O. et al.
209
. The red shift in surface plasmon resonance by 8 nm for 
p-IONP confirmed chitosan coating on n-IONP. In addition, the shift indicates decrease in 
energy band gap of nanoparticle, i.e. photocatalytic propensity enhanced, strengthening 
the conclusion of relatively weak Fe-O bond in chitosan coated IONP as drawn from FTIR 
spectra. The band gap energy for both IONPs was determined using the equation 
Ebg = 1240/λ eV
16
, where Ebg stands for band gap energy in eV, and λ is the wavelength in 
nanometre. Using this equation, the band gap energy for both n-IONP and p-IONP were 
found to be 3.4 and 3.3 eV, respectively. 
The zeta potential measurements for n-IONP (Figure 3.3d-I) and p-IONP (Figure 
3.3d-II) suspension in deionised water showed surface potential of −32.2 mV and 
+36.3 mV, respectively. p-IONP possesses relatively higher zeta potential magnitude than 
n-IONP, inferring that chitosan coated IONP is relatively more stable. In addition, reversal 
of surface potential further supported the XRD analysis and surface plasmon resonance 
property for chitosan coated IONP. Chitosan is already known for very high adhesive 
tendency for negatively charged surfaces
210
. 
 
Figure 3.4. FE-SEM image of n-IONP (a) and p-IONP (b). 
The images obtained using FE-SEM, figure 3.4, indicated that both types of IONPs 
are nearly spherical in shape with size ranging from 8–20 nm, which is very close to the 
estimated particle size by XRD analysis, i.e. ~11 +/− 5 nm. Both, FE-SEM analysis and 
XRD analysis, suggested that size of the nanoparticles does not change significantly upon 
chitosan coating. Yu S. et al. have reported a similar observation, 8 nm IONP retained its 
size on coating with poly-(methacrylic acid)
211
. Additionally, slight difference in particle 
Chapter 3                                                                                         Results and Discussion 
62 
size for n-IONP and p-IONP may be dedicated to instrumental artefact or sampling 
artefact or both. 
3.1.3. Synthesis of silver nanoparticle using bacteria from coal mine- A 
green synthesis approach 
Among different metal and metal oxide nanoparticles, silver nanoparticles (AgNPs) have 
drawn the attention of various research groups for various possible biological applications, 
such as nanomedicine, drug delivery, nanodevice fabrication, biosensing, catalysis, and 
imaging. Hence, different research groups are trying to synthesize AgNPs by various 
processes. However, green synthesis approach for AgNP synthesis is considered as non-
toxic, eco-friendly and cost effective approach than other physical and chemical 
approaches. A number of biological resources available in nature including plants, plant 
products, algae, bacteria, and fungi can be used for synthesis of nanoparticles. Among the 
microorganisms, bacteria have received the most attention in the area of biosynthesis of 
nanoparticles. Here, coal mine has been chosen as a place to isolate metal resistance 
bacteria. Due to local high temperature and low pH, coal mine soil is treated as physico-
chemically stressful habitat for soil microorganisms
212
, still thermophilic and pH resistant 
bacteria are found in the coal mine. Additionally, coal mine soil also harbours heavy metal 
resistant bacteria
213
. Thus, coal mine was found as a suitable place to isolate bacteria, 
which can withstand high concentration of silver metal ions and adverse physico-chemical 
conditions like change in pH and temperature during the synthesis of nano/microparticles 
at industrial scale. Bacterial strains isolated from coal mine, evaluation of their metal 
tolerance capacity against AgNO3, were used for successful reduction of silver ion into 
silver nano- and micro-particles. 
Minimum inhibitory concentration (MIC) was determined to check resistance of 
extracted bacteria against silver metal ions in comparison with normal chemical conditions 
(Figure 3.5). Figure 3.5 showed the viability of three bacteria treated with different 
concentrations of AgNO3. From the result, it is confirmed that 0.15 mM AgNO3 is the 
MIC for first two bacteria, whereas bacteria 3 has MIC at less than 0.019 mM. The 
bacterial growth was only ~ 50 % of the growth happening in absence of the metal ions for 
first two bacteria, whereas approximately 10 % cells were found viable in presence of 0.15 
mM AgNO3 for the third bacteria. Hence, MIC concentration, 0.15 mM AgNO3, has been 
chosen for synthesis of silver nanoparticles using the two metal ion resistant bacteria. 
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Bacteria 1 showed relatively higher viability at 0.15 mM AgNO3 than bacteria 2, hence we 
expected relatively higher amount of reduced silver element in bacteria 1 extract. 
Interestingly, unlike the bacteria 3 (Gram negative), the other two AgNO3 resistant 
bacteria were found to be Gram-positive bacteria (Figure 3.6). The sensitivity of third 
bacterium towards AgNO3 can be explained taking the surface potential of both bacteria 
and Ag(I) ion into consideration. Having higher surface potential than Gram-positive 
bacteria, Gram-negative bacterium interacts relatively strongly with positively charged 
Ag(I) ion, hence the bacterial death occurs to a larger extent in comparison to Gram-
positive bacteria. 
 
Figure 3.5: MIC of AgNO3 against (a) bacteria 1, (b) bacteria 2 and (c) bacteria 3. 
 
Figure 3.6. Characterization of bacterial strains by Gram staining and found to be (a) bacteria 1-
Gram-positive, (b) bacteria 2-Gram-positive and (c) bacteria 3-Gram negative bacteria. 
Although, various studies have already been done to synthesize silver 
nanoparticles using different bacteria, but in most of the studies Ag(I) ions
214-215
 are 
reduced to elemental silver (Ag(0)) nanocrystals using bacterial biomass, i.e. bacterial 
cytoplasm. However, the objective intends to synthesize the nanoparticles from live 
bacteria, even if the yield is relatively low, the yield would be enhanced by adopting the 
approach in bio-fermenter. Hence, from AgNO3 screened bacterial populations, first two 
Gram-positive bacteria were chosen for green synthesis of silver nanoparticle. Further, 
0.15 mM AgNO3 (MIC conc.) was added at mid log phase of the growth curve, i.e. the 
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phase where bacteria are more potent to adopt the change in physico-chemical conditions. 
Hence, the bacteria synthesized elemental metal nanoparticles upon internalizing and 
reducing the metal ions in duration of their further growth. Thus, the nanoparticles are 
formed during the growth of bacteria without significant change in bacterial viability. The 
process further, named as “continuous production of silver nanoparticles”. Ramanathan, R. 
et al
216
 have also synthesized pure copper nanoparticles using the bacteria Morganella 
morganii, which is a silver resistant strain. However in the work, metal ion was added for 
reduction into elemental copper nanocrystals after the growth of the bacteria, i.e. the 
bacterial biomass is used to reduce the Cu(II) ion into elemental Cu (0). Unlike 
Ramanathan’s work, the metal ion (MIC concentration) was added at the mid log phase of 
the bacterial growth, and observed the formation of micro- / nano-particles by live 
bacteria. Hence, the protocol can be directly adopted for continuous production of silver 
nanoparticle using the extracted/metal resistant bacteria. 
The figure 3.7(a) showed the UV-Visible spectra of silver nanoparticles 
synthesized using two bacteria. For both the samples, absorption peak at 425 nm 
confirmed the presence of silver nanoparticle, and the result is in accordance with the 
published results
217-218
. The strong interaction between light of particular wavelength 
(photons) and metal nanoparticles results enhanced collective oscillation of 
valence/conduction electrons of the silver element present at the surface of particle, which 
in turn results in unusually strong absorption and scattering properties of the metal 
nanoparticle. The SPR property provides a greater deal of information about the physical 
state of silver nanoparticle
219
. The broader peaks at 425 nm confirms polydispersity of the 
nanoparticle that means presence of some microparticles in the fabricated sample. 
Additionally, the intensity at 425 nm indicated the quantity of the particles; smaller the 
intensity, lower is the concentration. 
The figure 3.7 (b) showed the bond level characterization of AgNP, fabricated 
using the isolated bacteria. The peaks below 800 c.m.
-1
 in the IR spectra indicated the 
presence of metal-metal or metal-oxygen bond in samples
167
. Hence, the absorption peaks 
at 575 and 598 c.m.
-1
 represented the Ag-O/Ag-Ag bond vibrations, confirming the 
presence of AgNPs in the synthesized samples. The strong absorption peaks at 1657and 
1646 c.m.
-1
 for AgNP1 and AgNP2 respectively, are due to the C=O vibrations (amide I). 
On the other hand, absorbance peaks at 1530 and 1538 c.m.
-1
 for AgNP1 and AgNP2, 
respectively, are due to the N-H vibrations (amide II). The amide I and amide II bond 
Chapter 3                                                                                         Results and Discussion 
65 
vibrations confirmed the presence of proteins in AgNP samples. The proteins are assumed 
to be responsible either for reduction of AgNO3 to silver nanoparticles or for capping of 
AgNP or both. In addition to that, the protein(s) from bacteria 1 responsible for either of 
the factors is predominantly a-helix in secondary structure contents, since 1657 c.m.
-1 
is 
characteristic IR absorbance peak for a-helix. However, the proteins from bacteria 2 are 
having predominantly -sheet in its secondary structure contents. 
The EDX spectra (Figure 3.7c) showed the presence of Ag signals at bacterial 
surface, confirming the synthesis and secretion of silver nanoparticles. Additionally, the 
strong Si signal in the spectra was due to the glass slide, which was used as a platform for 
bacterial-nanoparticle sample preparation for FE-SEM analysis. The Au signal is due to 
the gold coating done prior to imaging. The presence of other signals in the spectra was 
due to the chemicals used either for preparing the sample for analysis or were integral part 
of the bacteria. However, the less intense signal of Ag supported our previous findings 
that synthesized sample contains relatively low amount of silver nanoparticles at the 
surface of the bacteria. 
 
Figure 3.7. (a) UV–Visible absorption spectra of AgNPs synthesized, (b) FTIR spectra showing 
the bond level vibrations present, (c) EDX spectra showing the presence of elemental silver on 
bacterial surface, and DLS analysis of silver nanoparticle samples for (d) AgNP1 and (e) AgNP2. 
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To determine size of particles present in the sample, zeta sizer was used. Figure 
3.7(d) and 3.7(e) showed the DLS analysis of silver nanoparticles obtained using two 
different bacteria. As shown in the figure, average particle size was found to be 624 and 
856 nm for AgNP1 and AgNP2, respectively. Hence, the results indicated that some 
microparticles are also present in addition to the nanoparticles in our synthesized 
nanoparticle suspension. The observation, further, supported the SPR spectra collected 
using UV-Visible spectroscope, i.e. broadening of peaks at 425 nm for both the samples 
indicating the presence of larger size nanoparticles (here, it is mentioned as sub-
microparticles). 
 
Figure 3.8. FE-SEM micrographs of (a) bacteria 1 with AgNP1, (b) bacteria 2 with AgNP2 grown 
in presence of 0.15 mM AgNO3. 
The figure 3.8 showed the FE-SEM images of two bacteria grown in presence of 
0.15 mM AgNO3. Both the bacteria were found to be rod shaped with presence of some 
particles on the surface of bacteria. Most of the particles are spherical in shape with 
diameter in nano-meter range, i.e. 20-40 nm. Hence, the images obtained using FE-SEM 
indicated the synthesis of silver nanoparticle using the extracted bacteria. 
The comparison of FE-SEM results with DLS data provides the information about 
variation of particle size. Generally, FE-SEM gives particular field image of the 
nanoparticles, however DLS measures the hydrodynamic size of all the particles in 
aqueous solution, and gives the average of the particles present in solution, i.e. average 
size of the predominant particle population. Additionally, the variation can be explained 
taking the physico-chemical parameters of nanoparticles. Nanoparticles being very small 
in size possess very high free energy content. Thus, when dispersed in biological solution, 
the nanoparticle interacts with different biomolecules to release its free energy content. In 
presence of salts or absence of coulombs repulsive interaction, the particles self-assemble 
to form larger structure, losing the free energy content. The interaction between 
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biomolecules and nanoparticles spontaneously form nano-bio interfaces. For example, in 
this objective, the attachment of nanoparticles on the bacteria is an example of nano-bio 
complex. On the other hand, assembly of nanoparticles with each other creating larger 
particles, here termed as sub-microparticles, as detected by DLS measurements. 
Additionally, the zeta potential value of two nanoparticles samples (AgNP1 and AgNP2) 
was found to be -16.9 and -13.0 mV respectively. These values of zeta potential 
demonstrate the incipient instability of nanoparticle solutions. Hence, the synthesized 
nanoparticles have the tendency to aggregate forming sub-microparticles. 
The term ‘green synthesis’ signifies the synthesis of nanoparticles using biological 
entities such as: microorganisms, plants, and plant products. When micro-organisms 
mediated synthesis is discussed, it is generally bacteria, fungi, virus etc. However, we can 
not use all microorganisms for synthesis of metal nanoparticles, and the study is a clear 
example of it. Initially, the work chose three bacteria for the biofabrication. One out of 
three bacteria, unlike other two, was sensitive to silver ion. Hence, it could not be used to 
produce silver nanoparticles. The MIC results followed by nanoparticle characterization 
results for metal resistant bacteria strongly supported that the bacteria with silver 
resistance have the potential to reduce the silver ion into silver nanoparticles. It is well 
reported that the enzymes responsible for reduction of Ag(+) into Ag(0) belong to 
NADPH dependent enzyme, nitrate reductase
220
. Additionally, many studies have also 
shown that some of the bacterial proteins are also responsible for biosynthesis of silver 
nanoparticles
214-215
. However, our study (the findings from ATR-FTIR results) supports 
the later findings, i.e. bacterial proteins are responsible for biosynthesis of silver 
nanoparticles at either or both the stages. One stage involves the reduction of metal ion 
into elemental metal, and another stage involves capping of the elemental metal assembly 
at nanocrystal size
214-216
. Additionally, the microparticles formation totally depends upon 
the physico-chemical property of nanoparticles as discussed in DLS analysis section. 
Here, fabrication of silver nanoparticle is an intracellular process and the bacterial 
proteins play major roles in either reduction of silver ions to elemental silver nanoparticle 
or capping of AgNP or both. Upon completion of the fabrication, the nanoparticle is 
secreted by exocytosis. Being small in size these nanoparticles possess relatively high free 
energy content, hence unstable in biological milieu. As a result, the secreted nanoparticles 
are attached to the bacterial surface (as shown in FE-SEM image) or attached to each other 
forming larger particles (sub-microparticles as confirmed by DLS measurement). 
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However, the size could be controlled at nano-meter size by optimizing the pH, 
temperature, and stages of metal ion feed to the culture
8
. 
3.2. Effect of interfacial potential on antimicrobial 
propensity of ZnONPs 
To understand the role of interfacial potential on antimicrobial propensity, the 
antimicrobial propensity of ZnONPs having positive and negative surface potentials 
against three randomly chosen Gram-positive and Gram-negative bacteria was studied. In 
order to bring significant changes in microbial viability, the interface needs to develop 
such a potential that results in either physical rupture of the membrane (membrane 
depolarization) or enhanced ROS production (at the interface or inside the bacteria or 
both). Although, the antibacterial activity of ZnONP against different bacterial strains is 
well established 
221-223
. However, the role of interaction profile at the interface in 
determining antimicrobial propensity of ZnONP had not been reported before. 
3.2.1. ZnONP-bacteria interfacial potential 
To study the effect of interfacial potential on antimicrobial propensity of ZnONPs, 
different bacteria with varying surface potential were used for the objective. Figure 3.9 
showed the zeta potential values of both Gram-positive and Gram-negative bacteria used 
in the study. Negative zeta potential values were obtained for all tested organisms. 
However, Gram negative bacteria exhibited higher negative potential than Gram-positive 
bacteria, due to the presence of additional layer of negatively charged lipopolysaccharide 
(LPS) compared to Gram-positive bacteria. 
 
Figure 3.9: Zeta potentials of Gram-positive and Gram-negative bacteria 
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The growth kinetic studies were carried out in absence and presence of p-ZnONP 
and n-ZnONP in order to observe the minimum inhibitory concentration (MIC), as shown 
in figure 3.10. From the figure, it is evident that lower concentrations of p-ZnONP (i.e 16, 
25 and 50 g/mL) show insignificant effect on growth kinetics of the Gram positive 
bacteria (Figure 3.10a–c). However, 100 g/mL and higher concentrations of p-ZnONP in 
culture exerted significant growth inhibition for Bacillus subtilis and Staphylococcus 
aureus, while Bacillus thuringiensis showed relatively higher resistance against positively 
charged p-ZnONP. The bacteria only showed significant growth inhibition above 500 
g/mL of p-ZnONP. Although, 250 g/mL of p-ZnONP delayed the growth of B. 
thuringiensis. However, upon adoption to the stress condition, the bacteria resumed the 
growth after a short dormant phase. Hence, the complete inhibition of B.thuringiensis 
growth kinetic happened above 500 g/mL of p-ZnONP. Additionally, the figure 3.10d–f 
represented the effect of varying concentrations of p-ZnONP on the growth kinetics of 
Gram-negative bacteria. The growth curves for Escherichia coli and Proteus vulgaris only 
showed the inhibition above 50 g/mL of p- ZnONP. However, in case of Shigella 
flexneri, inhibition of bacterial growth starts from 25 g/mL of p-ZnONP. 
 
Figure 3.10. Growth kinetics of bacteria (a) B. subtilis, (b) S. aureus, (c) B. thuringiensis, (d) E. 
coli, (e) S. flexneri, and (f). P. vulgaris in presence of different concentrations of p-ZnONPs. 
Different concentrations of p-ZnONP taken were 16, 25, 50, 100, 250, and 500 (only for B. 
thuringiensis) μg/mL, and injected at the mid log phase of growth kinetics, as shown by arrow. 
Figure 3.11a showed the growth kinetics of B. subtilis in presence of n-ZnONP. 
From the figure, it is evident that the bacteria showed normal growth in presence of n-
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ZnONP concentrations below 200 g/mL, but the inhibition of bacterial growth occurred 
at 250 g/mL. The value is more than two folds higher than the concentration of p-ZnONP 
(100 g/mL) needed to completely suppress the growth of bacteria. Figure 3.11b–d 
showed the growth kinetics of Gram-negative bacteria in presence of n-ZnONP. Like 
Gram positive bacteria, the growth of E. coli and P. vulgaris are also unaffected in the 
studied range of n-ZnONP concentrations. However, 250 g/mL of n-ZnONP completely 
inhibited S. flexneri growth. Nevertheless, the inhibition concentration is much higher than 
those observed for p-ZnONP against the bacterium.  
 
Figure 3.11. Growth kinetics of bacteria in the presence of different concentrations of n-ZnONP. 
In each case, black line shows the growth kinetics of untreated bacteria. Both Gram positive (a) B. 
subtilis and Gram negative (b) E. coli, (c) S. flexneri, (d) P. vulgaris bacteria were treated up to 
250 g/mL of n-ZnONP, injected at the mid log phase of growth kinetics, as shown by arrow. 
Moreover, LIVE/DEAD BacLight Bacterial Viability fluorescence Kit was used to 
distinguish the non-viable cells from viable cells, which resulted from disintegration of the 
membrane upon the nanoparticle treatment. According to the principle and as shown in the 
figure 3.12,viable bacterial cells having intact cell membrane are stained green by 
membrane permeable DNA binding Syto9 fluorescent dye, whereas nanoparticle treated 
bacterial cells with deformed cell membrane are stained red by relatively stronger 
membrane impermeable DNA binding propidium Iodide fluorescent dye
224
. As shown in 
figure 3.12a-i & 3.12bi, untreated B. subtilis and E. coli cells exhibited green fluorescence 
indicating presence of 100% viable bacterial cells, whereas the p-ZnONP treated bacterial 
Chapter 3                                                                                         Results and Discussion 
71 
samples showed a mixture of red and green fluorescence confirming a mixture of viable 
and non-viable cells (Figure 3.12a-ii & 3.12b-ii). In presence of 250 g/mL of p-ZnONP, 
the fraction of bacterial cells exhibiting red fluorescence is upto 90%, indicating loss of 
the membrane integrity and cell viability (Figure 3.12a-iii & 3.12b-iii).  
The cell viability of both Gram-positive and Gram-negative bacteria in presence of 
different concentrations of p-ZnONP was further supported by the colony forming unit 
(CFU) study, as shown in figure 3.13. The CFU results were in accordance with growth 
kinetic study of both Gram-positive and Gram-negative bacteria, as well as the BacLight 
fluorescence microscopic study. The MIC of p-ZnONP for both types of bacteria was 
evaluated from CFU measurement, shown in table 3.1. The reduction in number of viable 
cells with increasing concentrations of ZnONP, further, confirmed the antibacterial 
activity of ZnONP against the selected bacteria. 
Table 3.1: Minimum inhibitory concentration (MIC) of p-ZnONP against different Gram-positive 
and Gram-negative bacteria. 
Bacteria name Gram-positive/MIC Gram-negative/MIC 
Bacillus subtilis 105. 17 ± 15.81  
Staphylococcus aureus 118. 66 ± 21.66  
Bacillus thuringiensis 120.27 ± 20.26  
Escherichia coli  47.25 ± 9.29 
Shigella flexneri  25.58 ± 5. 24 
Proteus vulgaris  83.97 ± 6.7 
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Figure 3.12. Fluorescence microscopic images of the green and red fluorescence B. subtilis and E. 
coli in absence and presence of p-ZnONP; B. subtilis (a-i), B. subtilis in presence of 100 μg/mL p-
ZnONP (a-ii), and 250 μg/mL p-ZnONP (a-iii), E. coli (b-i), E. coli in presence of 50 μg/mL p-
ZnONP (b-ii), and 250 μg/mL p-ZnONP (b-iii). The scale bars represent for 20 μm. 
 
Figure 3.13. Colony forming units (CFU) were quantified for both Gram positive and Gram 
negative bacteria, and expressed as percentage of viable cells. 
3.2.2. Surface potential neutralization of B. subtilis and E. coli by 
ZnONPs 
 
Figure 3.14. Percentage cell viability and cell zeta potential of B. subtilis (a) and E. coli (b) cells 
when treated with increasing concentrations of p-ZnONP like 16, 25, 50, 100, and 250 μg/mL. 
Solid black lines represent the relative percentage of viable bacterial cells, whereas dashed red 
lines correspond to zeta potential values at different concentrations of p-ZnONP. Triplicate 
experiments were done for each reaction, and error bar represents the standard error of mean. 
Zeta potential measurements were carried out to examine the effects of ZnONPs on the 
membrane surface potential. As shown in figure 3.14, B. subtilis and E. coli cells display 
zeta potential of -18.5 mV and -23.6 mV, respectively. However, the potential moved to 
neutral upon addition of increasing concentrations of p-ZnONP. On the other hand, 
addition of increasing concentrations of n-ZnONP showed insignificant change in 
interfacial potential for both the bacteria. The observation indicated insignificant potential 
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neutralization upon n-ZnONP addition. Although, the interfacial potentials at highest 
studied concentrations of p-ZnONP for both the bacteria are same, but change in 
magnitude of interfacial potentials are capable of destabilizing the respective bacterial 
membrane via enhanced ROS production and/or surface tension. Both the factors are 
explored in next section using the fluorescent dye, 2’, 7’-Dichlorodihydrofluorescein 
diacetate (DCFH-DA) and using the SEM/FE-SEM for high resolution images for any 
possible membrane deformities. 
3.2.3. Enhanced ROS production in presence of ZnONP-bacteria 
interface 
The surface potential neutralization of bacteria triggers the production of ROS, which is 
considered responsible for lipid, protein and DNA damage, resulting into non-viable 
bacterial population
225-226
. Change in ROS production upon addition of ZnONP has been 
evaluated using the fluorescence dye, DCFH-DA. DCFH-DA is known as peroxynitrite 
indicator, which detects both hydrogen peroxide and nitric oxide, and considered as ROS 
indicator
170
. The dye upon oxidation has excitation and emission maxima at 503 and 523 
nm, respectively. Thus, in order to study the ROS production, the culture was inoculated 
with DCFH-DA dye which gets oxidized with production of ROS, and gave the emission 
at 523 nm on excitation with 503 nm, as shown in figure 3.15.  
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Figure 3.15. ZnONPs induced ROS detection in B. subtilis cells (a and c) and E. coli cells (b and 
d) were treated with 16 μg/mL (red curve) and 250 μg/mL (blue curve) of positive potential (panel 
a and b) and negatively potential (panel c and d) ZnONPs, and ROS were detected by measuring 
fluorescence emission intensity at 523 nm. In each case, except control, NPs were added in the log 
phase of bacterial growth. The fluorescence emission intensities are compared with positive 
control (without injection of NPs, black curve) in each case. Each curve represents the average of 
three independent measurements with corresponding standard error of mean. 
The figure indicates that ROS is produced also in absence of ZnONPs treatment, 
i.e. in control culture, since the dye is showing increasing quantum yield with bacterial 
growth (black line, control +). Nevertheless, the produced ROS in non-stress condition is 
counteracted by ROS scavenging enzymes present in bacteria. However, in presence of 
250 g/mL of nanoparticle, the ROS production is relatively very high, increased by 100–
200%, exceeding the capacity of ROS scavengers and resulting in reduced populations of 
viable bacterial cells (Figure 3.15). On comparing figure 3.15a & 3.15c with figure 3.15b 
& 3.15d respectively, it is evident that production of ROS is relatively higher in presence 
of p-ZnONP than n-ZnONP for the species, B. subtilis and E. coli. Additionally, E. coli 
culture showed higher ROS production on p-ZnONP treatment in comparison to B. subtilis 
culture, which can be rationalized with the difference in magnitude of change in interfacial 
potential for both the bacterium (Figure 3.14a & 3.14b). Thus, the data, besides supporting 
observations from the kinetic studies, CFU, BacLight fluorescence measurements, and 
potential neutralization studies, indicated that the production of ROS on interaction of 
ZnONP with bacterial membrane mainly result in non-viability of bacterial populations. 
3.2.4. Surface morphology of bacteria upon ZnONP treatment 
To observe the membrane deformities upon the ZnONPs treatment, the phase-contrast, 
SEM and FE-SEM were used. The images, obtained using the phase contrast microscopy, 
showed the clumping or aggregation of cells (Appendix, Figure A5 and A6). For further 
details, the ZnONPs treated and untreated bacterial cells were scanned using SEM. The 
images indicated more clumping and membrane rupture in treated cells than the untreated 
cells (Appendix, Figure A7 and A8). Additionally, images obtained using FE-SEM helped 
in detail investigation of topological changes in bacterial membrane (Figure 3.16). Upon 
interaction with p-ZnONP, the bacterial membrane surface potential is neutralized, 
resulting into increase in surface tension. Above certain p-ZnONP concentration, the 
interactions result in surface tension change, which possibly leads into the membrane 
Chapter 3                                                                                         Results and Discussion 
75 
depolarization. As a result, bacterial membrane showed abnormal textures like membrane 
rupture, membrane blebs, in images obtained using FE-SEM (Figure 3.16b). The ruptured 
cells no longer remain discrete, often found in aggregates or clumps (Figure 3.16b). 
 
Figure 3.16. Visualization of ZnONP treated E. coli cell by FE-SEM, (a) control (without the 
treatment), (b) showing membrane blebs, membrane damage, and membrane clumping in ZnONP 
treated cells. 
3.2.5. Discussion 
Although various biological studies have been done to demonstrate the antimicrobial 
activity of different nanoparticles against different Gram-positive and Gram-negative 
bacteria. The mechanism underlying the antimicrobial activity is a matter of intensive 
research for safe use of nanoparticles as modern antibiotics. As reported by different 
literatures, various proposed mechanisms of antimicrobial activity of nanoparticles include 
the generation of ROS (like hydroxyl radicals, superoxide anions, hydrogen peroxide), 
release of Zn
2+
 ions, cell wall damage, penetration of the cell envelop etc.
223, 227-228
. The 
objective aimed to explore the mechanism in a new dimension by elucidating the 
biophysical events happening at the interface of nanoparticle and bacteria, leading into 
various changes resulting into bacterial non-viability. Here, ZnONP is taken due to its 
strong antimicrobial activity as reported by different literatures and wide applications in 
biological sciences
223
. The data altogether from the objective indicated that a sequence of 
events happen at the interface, like (i) resulting interfacial potential lead to attachment of 
nanoparticle on bacterial membrane, (ii) simultaneous neutralization of bacterial surface 
potential resulting into electron-hole pair generation in proximity, which (iii) enhances the 
production of ROS resulting into cell non-viability.  
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Due to additional layer of negatively charged lipopolysaccharides, Gram-negative 
bacteria are more negatively charged than Gram-positive bacteria
229
, which were also 
confirmed from the zeta potential measurements for the bacteria (Figure 3.9). To this end, 
two types of ZnONPs having opposite potentials (+12.9 mV and -12.9 mV) were 
synthesized, and bacterial growth kinetic studies have been performed in presence of the 
NPs. The MIC of p-ZnONP for both Gram-positive and Gram-negative bacteria varied in 
range of 50–100 g/mL, which was further supported by CFU measurement studies. Since 
bacterial surface possess negative potential and citrate modified ZnONP is also having 
negatively surface potential, there would be a relatively repulsive interaction between the 
surfaces. The growth kinetic study of B. subtilis, which is a Gram-positive bacterium with 
relatively less negative surface potential among the studied bacteria, showed inhibition at 
250 g/mL of n-ZnONP, only. However, the value is two and half fold higher than that 
found for p-ZnONP against same bacteria, i.e. 100 g/mL. To investigate more about the 
interfacial potential between NPs and bacteria surfaces, three Gram-negative bacteria were 
taken for their relatively higher negative surface potential than Gram positive bacteria. For 
all the bacteria, higher MIC was observed for n-ZnONP (Figure 3.11b–d) compared to the 
value found for p-ZnONP (Figure 3.10d–f). The observations clearly indicated that the 
interaction between the nanoparticle and bacterial membrane surfaces results in the 
interfacial potential that triggers possible ROS mediated reactions leading into bacterial 
non-viability. 
The term surface neutralization is largely attributed, in biological system, to 
balance the surface potential that exist between accessible negatively charged, polar and 
non-polar functional groups on bacterial surface and the interacting entities present on p-
ZnONPsurface
229
. Since E. coli is a Gram-negative bacterium, possesses a more negative 
surface potential than B. subtilis, which is a Gram-positive bacterium (Figure 3.9). 
Increasing concentrations of p-ZnONP take the interfacial potential at the p-ZnONP-
bacteria interface to neutral, suggesting the neutralization of surfaces by the respective 
surface functional groups present on the interacting partner. As a result of the 
neutralization, the energy released is possibly either utilized in production of ROS or 
membrane surface tension or both, as indicated in the work of Espita P.J.P. et al.
230
. The 
work suggested that generation of ROS on the surface of ZnONP plays role in the 
antimicrobial activity by ZnONP following the possible reaction steps given below
230
. 
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Since ZnONP is a photocatalytic material having a band gap of 3.3 eV
16
. Hence, 
energy released higher than the band gap energy, can trigger the movement of electrons 
from the valence band (vb) to the conduction band (cb) resulting in a positive area in the 
valence band (electron hole, h
+
) and free electrons (e
-
) in the conduction band
231
. When 
ZnONP is in suspension, the created electron-holes react with H2O molecules and separate 
the H2O molecules into 
•
OH and H
+
. Simultaneously, dissolved O2 molecules in the 
medium are transferred into O2
•-
 (superoxide anion radicals) and react with H
+
 ions to 
generate HO2
•+
 followed by collision with an electron to produce H2O2 molecules
230-232
. 
The reaction occurs at the interface and produces reactive oxygen species, among which 
hydroxyl radicals and superoxide anion radicals are negatively charged. The negatively 
charged free radicals can not penetrate the cell membrane, since the bacterial cell 
membrane is negatively charged
233
. However, modification of the membrane physico-
chemistry cannot be ruled out while the generation of ROS is happening in the proximity. 
Since H2O2 is uncharged reactive oxygen species, the molecule can penetrate inside the 
bacteria and cause the cell non-viability
233
. The amount of ROS generated is directly 
proportional to the concentration of p-ZnONP in suspension. The increase in concentration 
of p-ZnONP increases the number of possible interactions leading into ROS production, 
and hence antibacterial activity increases
230
.  
The DCFH-DA dye is a cell permeant dye, and indicator of reactive oxygen 
species. The initial ROS formation, i.e. before injection of NP, is due to metabolic 
activities (Figure 3.15), that is approximately same for all the bacteria. Above MIC, the 
fluorescence intensity upon the nanoparticle addition increased many folds (Figure 3.15a, 
b), supporting the work of Espitia P.J.P. et al. It is very interesting to observe that at 250 
g/mL of p-ZnONP, the emission intensity in E. coli culture is higher than the intensity 
observed in B. subtilis culture, inferring production of more ROS leading to more cell 
death. The observation is similar to growth kinetics and CFU results for both the bacteria. 
In case of n-ZnONP, the increased emission intensity of the dye is insignificant compared 
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to control cultures. The observations rationalize the interaction between the negative 
surface potentials result in interface that can not produce or enhance reactive oxygen 
species generation, hence insignificant cell death. 
Effect of the interactions on bacterial cell viability is further explored using the 
BacLight assay, which distinguishes viable or non-viable cells based on the membrane 
integrity. The kit uses mixture of two fluorescent dyes, Syto9 and propidium Iodide (PI) 
dyes, which stains green (Syto9) to viable cells with intact membrane and stains red (PI) 
to non-viable cells with ruptured membrane. The images obtained using the BacLight kit 
indicate loss of membrane integrity or alteration in membrane permeability on p-ZnONP 
treatment
224
. Hence, the resulting interfacial potential on interaction of the nanoparticle 
with bacterial membrane also result in membrane rupture either because of ROS or 
increased surface tension of bacterial membrane or both. The latter case is further 
investigated using FE-SEM through morphological changes in the bacterial membrane. 
The high resolution images obtained using FE-SEM, indicate occurring of membrane 
blebs along with the membrane damage/rupture. Upon addition and incubation of p-
ZnONP with bacterial cells, neutralization of surface potential was observed; as a result of 
interaction at the interface leading into increased surface tension. The increased surface 
tension is capable of affecting the bacterial membrane to a greater extent. As a result of 
increased ROS and surface tension, bacterial membrane showed some abnormal textures 
like rupture, blebs etc. The neutralized cell membrane and ruptured cells no longer remain 
discrete and result in aggregates/clumps
234
. 
In conclusion, two types of ZnONPs having opposite surface potentials of same 
magnitude were synthesized. Based on the data, insights into the biophysical events 
happening at the interface of ZnONP-bacteria were gained. Firstly, the interaction at the 
ZnONP-bacteria interface was explored to understand mechanism behind the attachment 
of NPs to bacterial surface. Secondly, the resultant interfacial potential, measured using 
zeta potential measurement study, and the standard antibacterial activity assay helped us to 
establish a correlation between the interfacial potential and antimicrobial propensity of the 
NPs. Together, the bio-nano interfacial potential result in a surface tension generating high 
lateral stress in the membrane leading to irreversible membrane damage via membrane 
blebs or rupture, as clearly visible in images obtained using fluorescence microscope, 
SEM, and FE-SEM. At the end, the molecular events leading to the antimicrobial activity 
of ZnONP was explored by evaluating ROS production from the interaction at different 
Chapter 3                                                                                         Results and Discussion 
79 
concentrations of ZnONPs. Taking altogether, the biophysical and antimicrobial data 
obtained from the study, it was concluded that the interfacial potential at the ZnONP-
bacteria interface is largely responsible for the antimicrobial propensity of ZnONPs. 
3.3. Effect of surface functionality on antimicrobial 
propensity of IONPs 
Nanoparticles, when suspended in biological culture medium, encounter with various 
biological interfaces resulting from the presence of cellular moieties like DNA, proteins, 
lipids, flavonoids, polysaccharides etc. Fate of the suspended NP depends upon different 
physico-chemical properties of nanoparticle and interactions present at the nano-bio 
interface
93
. Understanding the interactions at nano-bio interface, help in adopting 
approaches for safe use of NPs in biomedical, clinical and pharmaceutical industries. The 
understanding can help in moderating surface cytotoxic and/or antimicrobial propensities 
of nanoparticles. Inside biological medium, the interactions between accessible functional 
groups of NP and biomolecules like lipopolysaccharide (LPS), phospholipid, protein, and 
lipoteichoic acid (LTA) present over the bacterial envelop or eukaryotic membrane 
contribute in the interaction pattern at the interface. The same functional groups of 
biomolecules enhance adhesion of bacteria to different surfaces, and help their 
proliferation
97
. Hence, the accessible functional groups present at bacterial envelop and 
NP surfaces, along with the physico-chemical property of NP, determine the fate of 
bacteria as well as NP (whether NP will be compatible or toxic to bacteria). It has been 
reported that among different types of NPs, magnetic NPs due to their biocompatibility, 
chemical stability, and magnetic behavior are widely used in biomedical sciences 
25
. 
Magnetic NPs are being used for delivery of drugs to targeted tissues by the application of 
external magnetic field, which in turn increases the stability of drugs against enzymatic or 
metabolic degradation
25
. Due to outstanding magnetic, physico-chemical, thermal, and 
mechanical properties, magnetic NPs can also be used in other fields, like analytical 
chemistry, pathogen detection, antigen diagnosis, tissue repair, and hyperthermia
23
. Thus, 
this objective aims to evaluate the antimicrobial propensity of IONP with a special 
emphasis on the role of functional groups at the nano-bio interface determining the 
antimicrobial propensity of IONP. 
To explore the effects of functional groups present at nano-bio interface affecting 
the antimicrobial activity, IONP with magnetite like atomic arrangement and negative 
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surface potential (n-IONP) was synthesized by co-precipitation method. Positively 
charged chitosan molecule coating was done to reverse the surface potential of n-IONP, 
i.e. positive surface potential IONP (p-IONP). The comparative data from fourier 
transform infrared spectroscope, XRD and zeta sizer indicated the successful coating of 
IONP surface with chitosan molecule. Additionally, the nanocrystals obtained were found 
to have spherical size with 10–20 nm diameters. The antimicrobial activity of both types 
of IONPs was evaluated adopting different antimicrobial and biophysical studies as 
described below. 
3.3.1. Effect of the interfaces upon bacterial cell viability 
The growth kinetic studies of B.subtilis and E. coli in presence of different concentrations 
of n-IONP and p-IONP are shown in figure 3.17. Figure 3.17a and 3.17c display the 
growth curve of B. subtilis and E. coli, respectively, in presence of different 
concentrations of n-IONP. As shown in the figures, insignificant growth inhibition 
compared to control were observed for the studied concentrations of n- IONP, whereas the 
inhibition is relatively very significant for B. subtilis (Figure 3.17b) and E. coli (Figure 
3.17d) in presence of relative p-IONP concentrations.  
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Figure 3.17. Growth kinetics of B. subtilis (a and b) and E. coli (c and d) in absence and presence 
of different concentrations of n-IONP, (a) B. subtilis and (c) E. coli, & p-IONP, (b) B. subtilis and 
(d) E. coli. Different concentrations of the NPs taken were 2.5, 5, 10, 25, and 50 μM, and injected 
at the log phase of growth kinetics (shown by arrow). Triplicate experiments were done for each 
reaction, and the error bar represents the standard error of mean 
However, CFU measurements indicated the antimicrobial activity of n-IONP at 
higher concentrations (Figure 3.18). The viability of both bacterial cells reduced by 
approximately 30% in presence of 50 μM n-IONP. However, the coated IONP has 
significant effect on bacterial viability, viability reduced by 70% in presence of 50 μM p-
IONP. The data indicated strong antimicrobial propensity of p-IONP against studied 
bacterial strains. Additionally, the data support the growth kinetic studies observed in 
presence of n-IONP and p-IONP.  
 
Figure 3.18. Quantification of bacterial cell viability at different concentrations of n-IONP (a) and 
p-IONP (b). Colony forming units (CFU) were quantified for both B. subtilis and E. coli cells, and 
represented as percentage of viable cells in comparison to colony obtained from untreated culture. 
Figure 3.19 showed the kinetics of DCFH-DA oxidation upon the bacterial cell 
treatment with the NPs. The NPs were added in log phase of bacterial growth. ROS is also 
produced in culture media in the absence of NP treatment, inferring the production of ROS 
is natural. Bacteria produce ROS in non-stress condition. The produced ROS in non-stress 
conditions is counteracted by ROS scavenging enzymes present in bacteria like superoxide 
dismutase in E. coli. However, presence of both n-IONP (Figure 3.19a & 3.19c) and p-
IONP (Figure 3.19b & 3.19d) resulted in significant increase in the fluorescence intensity, 
with relatively higher change in p-IONP presence than n-IONP. The change in the 
fluorescence intensity is directly correlated with the higher amount of ROS production for 
both, B. subtilis (Figure 3.19a & 3.19b) and E. coli (Figure 3.19c & 3.19d) cells. The ROS 
observation and the growth kinetics study, together, indicated that the ROS production is a 
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reason for antimicrobial activity by both the IONPs. Additionally, it is observed that the 
amount of ROS produced (as measured from the fluorescence intensity) is higher for p-
IONP than n-IONP. The observation rationalized that p-IONP has higher antimicrobial 
activity than n-IONP.  
 
Figure 3.19. n-IONP and p-IONP induced ROS production in bacterial culturess. Panels a and c 
represent change in fluorescence intensity with DCFH-DA oxidation in presence of n-IONP in B. 
subtilis and E. coli cultures, respectively. Whereas, b and d panels represent DCFH-DA oxidation 
kinetics in presence of p-IONP treated B. subtilis and E. coli, respectively. Each curve represents 
the average of three independent measurements with corresponding standard error of mean. 
The antibacterial activity of both NPs resulting from the interaction pattern is 
further explored using LIVE/DEAD BacLight fluorescence Kit. It differentiate viable cells 
from non-viable cells by staining green and red to viable and non-viable cells, 
respectively
224
. As shown in figure 3.20, untreated (control) bacterial cells showed green 
fluorescence inferring presence of 100% viable cells. The n-IONP (50 μM) treated 
samples showed insignificant fraction (~10%) of non-viable bacterial cells, indicating 
insignificant antimicrobial activity of n-IONP against B. subtilis and E. coli, at studied 
concentration. On other hand, p-IONP (50 μM) treated bacterial culture showed 90% of 
non-viable bacterial cells, which confirmed the significant change in antimicrobial activity 
of IONP upon chitosan coating. 
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Figure 3.20. Fluorescence microscopic images of B. subtilis and E. coli in absence and presence of 
n-IONP and p-IONP. Intact B. subtilis (a-i), B. subtilis in presence of 50 μM n-IONP (a-ii), and B. 
subtilis in presence of 50 μM p-IONP (a-iii), intact E. coli (b-i), E. coli in presence of 50 μM n-
IONP (b-ii), and E. coli in presence of 50 μM p-IONP (b-iii). The scale bars represent for 20-μ m. 
3.3.2. Discussion 
Studies have been done to demonstrate the antimicrobial activity of IONP
235-237
, still the 
mechanism behind antimicrobial activity is a matter of intensive research, in present. 
Chatterjee, S. et al
236
 have demonstrated that IONP has antimicrobial activity against E. 
coli, and the activity increases with increase in concentration of IONP. Borcherding, J. et 
al
238
, on the other hand, have shown that IONP have no antimicrobial activity. Here, we 
have extended the studies taking the help of different antimicrobial and biophysical studies 
to draw a concluding remark against these contrasting statements, and to explore the 
mechanism behind the antimicrobial activity of IONPs.  
Initially, IONP with negative surface potential (n-IONP) having small size and 
good stability was synthesized. Surface of the NP was further modified with chitosan to 
modulate the surface potential and functional groups. Positively charged chitosan 
molecules are strongly bonded to magnetic n-IONP via electrostatic and/or H-bonding as 
predominant interactive forces
210
. The chitosan coated IONP has positive surface potential 
majorly due to the free hydroxyl group (-OH) of chitosan, which interact with the aqueous 
solution through hydrogen bonds resulting into a stable well dispersed colloidal 
suspension. Additionally, the coulomb repulsion between the IONPs having 
positive/negative surface potential also plays a role in well dispersivity of the particle
208
.  
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To explore the effect of interaction pattern at the interface on antimicrobial activity 
of IONPs, growth kinetic, LIVE/DEAD BacLight Bacterial Viability assay, and CFU 
measurement studies were done taking both negative and positive surface potential IONPs. 
The outcome indicated that p-IONP has higher antimicrobial activity than n-IONP. Due to 
presence of negative potentials on both n-IONP and bacterial surfaces, the interaction 
between n-IONP and bacteria would not be strong due to dominant electrostatic repulsion 
at the interface which is the primary cause of non-attachment of the NP on bacterial cell. 
However at higher concentration, > 50 μM, n-IONP have antimicrobial activity to some 
extent, as suggested by growth kinetic, LIVE/DEAD BacLight assay, and CFU 
measurement studies. The finding can be rationalized to the molecular crowding upon 
increase in the NP concentration, which resulted into net attractive interaction between 
nano-bacteria interface. Above certain concentrations of NP, despite the negative surface 
potentials, the particle will be preferentially excluded along with the larger particles or 
interfaces of same or opposite potentials, like bacterial membrane here. The exclusion, 
hence, resulted into the net attractive interactions. The net attractive interaction enhances 
relative ROS production at the interface, as shown in figure 3.19. Hence, higher 
concentrations of n-IONP in the culture media are capable of enhancing ROS production, 
a principal reason for the antimicrobial propensity of metal oxide nanoparticles. The 
findings supported the work of Borcherding, J. et al
238
 provided the concentration of n-
IONP is above the critical concentration.  
Considering the role of interfacial potentials on interaction, IONP with positive 
surface potential will have better surface for bacterial attachment with stronger 
interactions at interface than n-IONP. The stronger interactions will result in relatively 
enhanced ROS production. Hence, to strengthen the hypothesis, surface potential of n-
IONP was reversed by coating with positively charged chitosan molecule. Chitosan of 
different molecular weights, above 25% (w/v), shows significant antimicrobial propensity 
against both Gram-positive and Gram-negative bacteria, as reported by Zheng, L.-Y. et al. 
239
. In order to nullify the chitosan mediated antibacterial activity, only 0.02% (w/v) 
chitosan concentration was used for surface modification of n-IONP. Chitosan at 0.02% 
(w/v) does not show any antimicrobial activity against studied bacteria. Like predicted, p-
IONP inhibited the bacterial cell growth relatively at very low concentration than n-IONP, 
suggesting that p-IONP have higher antimicrobial propensity. Comparison of the 
fluorescence intensities in figure 3.19 indicates that the interaction at nano-bacteria 
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interface is relatively stronger for p-IONP than n-IONP. Stronger the interaction, higher is 
the change in free energy content, resulting into more ROS production. In case of IONP, 
ROS production follows the Fenton reaction as mentioned below in Eq 7 and Eq 8. From 
the metabolic activity, hydrogen peroxide (H2O2), which is a toxic oxidant causing DNA 
and protein damage, is produced in cultures of all aerobic organisms 
240-241
. E. coli 
produces H2O2 at the rate 10-15 μM/s during the growth in oxygen rich glucose medium 
241
, as also observed in untreated bacterial culture, figure 3.19. However, the produced 
H2O2 is counter-balanced by various scavenging enzymes present in cells like superoxide 
dismutase for E. coli. In this objective, ROS production in culture was measured using a 
fluorescent dye, DCFH-DA. Upon IONPs dispersion inside the culture media, different 
oxido-reduction reactions are followed involving both the species present in magnetite, 
Fe
3+
 and Fe
2+
 resulting into generation of different and more potent reactive oxygen 
species
241-242
. The reactions are known as Fenton reaction or Haber-Weiss cycle, as 
following. 
Fe(III) + H2O2 = Fe(II) + OH
-
 + OH
o      
Eq (7) 
Fe(II) + H2O2 = Fe(III) + HO2
o
 + H
+
      Eq (8) 
OH
o
 and HO2
o
 formed in the process are free radicals. Iron in magnetite (Fe3O4) NP 
through a series of reactions is fully oxidized to maghemite (γ-Fe2O3) causing oxidative 
stress to bacterial cells, hence bacterial cell death. In contrast, fully oxidized maghemite is 
relatively stable in culture medium without any further possibility of electronic or ionic 
transition. Hence, maghemite formed as end product possesses insignificant in vitro 
cytotoxic propensity
242
. Nevertheless, the amount of free radicals formed in the oxido-
reduction process is sufficient to put stress on the viable bacterial cells, causing non-viable 
cells. The amount of ROS produced at the nano-bacteria interface depolarizes the bacterial 
membranes, causing membrane damage as suggested by BacLight assay (Figure 3.20) and 
in our work with ZnONP
167
. However, the membrane depolarization of B. subtilis (Figure 
3.21) was studied using Scanning Electron Microscopy and the interaction between p-
IONP and bacteria was confirmed using energydispersive X-ray spectroscopy (EDX). 
Unlike control (Figure 3.21a, inset), the EDX spectra of p- IONP treated bacterial surface 
shows the traces of Fe, confirming the interaction of p-IONP with bacteria catalysing the 
membrane depolarization (Figure 3.21b, inset). Moreover, the bacterial membrane 
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depolarization upon p-IONP treatment as suggested by BacLight assay, was further 
confirmed and illustrated in SEM micrograph (Figure 3.21).  
Figure 3.22 showed the proposed schematic model elucidating the detail 
mechanism described here to understand the p-IONP antimicrobial activity. Although n-
IONP has relatively less antibacterial activity, the growth kinetic study, LIVE/DEAD 
BacLight assay, and ROS detection studies indicated that the surface modification of n-
IONP with chitosan makes it more toxic to bacterial cells due to relatively stronger 
attractive interaction at the interface. Additionally, the cytotoxicity assay using Alamar 
Blue dye following the procedure adopted by Jha, S. et al
185
 demonstrated the 
cytocompatibilty nature of the nanoparticles, IONP and chitosan coated IONP. 
 
Figure 3.21. SEM micrographs showing membrane deformation/damage of B. subtilis upon p-
IONP treatment. (a) SEM representative image of control (without p-IONP treatment), and figure 
inset shows the EDX spectra of B. subtilis surface. (b) SEM representative image of B. subtilis cells 
upon p-IONP treatment, and figure inset shows the EDX spectra of B. subtilis surface after p-IONP 
treatment. 
The work indicates that the interfacial potential is not only the determining factor 
for the bactericidal effects of nanoparticle. In addition to interfacial potential, the 
interacting functional groups at the interface also contribute in the effect through 
regulating level of ROS production. Hence, adopting the optimized approach, the 
antibacterial propensity of IONP interface can be modulated using chitosan coating 
without changing cytocompatibility nature of the nanoparticle. The findings conclude that 
n-IONP has antimicrobial activity at relatively very high concentrations. The activity, 
Chapter 3                                                                                         Results and Discussion 
87 
however, can be moderated by accordingly changing the surface potential and accessible 
surface functional groups. The changes cause interaction pattern change at the nano-bio 
interface, hence play crucial role in determining the antimicrobial propensity of IONPs. 
The enhanced production of ROS because of the interaction potential at the interface is the 
principal cause for antimicrobial propensity of the NPs. As a conclusion, the interaction 
pattern at the nano-bio interface plays vital role in determining the antimicrobial activity 
of metal oxide nanoparticles. 
 
Figure 3.22. Proposed schematic model elucidating the detail mechanism of IONPs against 
bacterial cells. 
3.4. Effect of ZnONP surface defects on cytotoxic and 
antimicrobial propensities 
Due to wide band gap (3.37 eV) and large excitation binding energy (60 meV at room 
temperature), ZnO nanomaterial has been adopted as a promising material for different 
biomedical applications
16
. However, cell permeabilization because of small size and high 
specific surface area is the matter of concern, when the particle is considered for 
biological applications
16, 243
. Various studies have demonstrated that ZnONPs have the 
potential to reach different organs during numerous biological applications, and cause 
hazardous effects to lungs, kidney, liver, stomach, pancrease, testis, spleen, heart, thymus, 
blood, and brain
243
. Additionally, in vitro cytotoxicity has also been observed during 
culture of many cells, like epidermal cells, human lung, epithelial cells etc
243
. 
Furthermore, the studies have demonstrated that inhaled ZnONPs translocate to central 
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nervous system resulting in inflammatory response, hence possibly causes the brain 
edema
16
. In general, the studies indicated that ZnONP is one among the most toxic NPs
16, 
244
 to eukaryotic cells. Nevertheless, ZnONP is being regarded as possible treatments for 
different types of cancer and autoimmune diseases
243, 245
. 
From the extensive in vitro and in vivo studies, it has been reported that oxidative 
stress is one of the mechanisms to elucidate the toxic effects of metal oxide NPs
16
. The 
oxidative stress is caused from an imbalance between the antioxidant defence system 
versus different reactive oxygen species (ROS) generated in a cell
16
. In addition, it has 
been identified that ROS act as a signaling molecules for various pathways which result in 
both, the cell survival and death
16
. Hence, the ROS production in higher amount, mainly 
in radical forms, such as superoxide (
•
O
−
2), hydroxyl radical (
•
OH) , and hydrogen 
peroxide (H2O2) etc., causes cell death by damaging cellular biomolecules
16, 167
. 
Photocatalytic NPs with low energy band gap, like AgNP, ZnONP, IONP, TiO2NP, on 
interaction with the interacting biomolecular surfaces produces the ROS, causing the 
oxidative stress
23, 167, 246
. Hence, modulating the NPs band gap can change the 
photocatalytic activity, and the ROS-mediated cytotoxicity. 
Being a photocatalytic NP, several efforts have been made to enhance the 
photocatalytic activity of ZnONPs
16
. The photocatalytic activity of NP is affected by 
different factors, such as composition of NP, phase structure, particle size, surface 
functional groups, crystallinity, surface defects etc
16
. In this context, Zhang, X. et al have 
elucidated that the photocatalytic activity of ZnONP primarily depends upon the surface 
defects of the particle generated due to different calcination temperatures, keeping 
crystallinity constant
16
. In support to the study, work explored the role of change in 
ZnONP crystallinity on the photocatalytic activity of ZnONPs in biological milieu. To this 
end, a correlation between change in crystallinity and energy band gap of ZnONP was 
explored, since change in the band gap can significantly affect photocatalytic activity. To 
validate the hypothesis, different ZnONPs were synthesized by varying calcination 
temperature, 300, 500, and 700 
o
C, respectively that resulted in ZnONPs with varying 
surface defects, hence the band gap. However, the biophysical investigations and 
molecular studies demonstrated that the oxidative stress, generated due to the variation of 
crystallinity and energy band gap of ZnONPs, adversely affect the cytotoxic and 
antimicrobial propensities of the particle. Additionally, the treatment induced autophagy 
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mediated cell recovery from the stress, while the failure in recovery caused apoptotic cell 
death. 
3.4.1. Cytotoxic propensity of ZnONPs 
Cell viability assays are to evaluate the toxicological propensities of additives, since the 
assay provide key information about the cell death, cell survival, and their metabolic 
activities
247
. To explore variation in energy band gap and crystallinity on the particle 
cytotoxic propensity, Alamar Blue (AB) dye reduction assays were observed for varying 
ZnONP concentrations (2.5, 5, 12.5, 25, and 50 μg/mL) treated HT1080 cells. The data 
(Figure 3.23a) indicated that degree of reduction of the dye was ZnONP concentration 
dependent. The AB dye, which is a water soluble dye, is commonly used for quantification 
of viable cells upon different drug treatments
248
. Additionally, it is stable, cell permeable, 
and non-toxic to various cells, hence helpful for monitoring the continuous culture of 
cells
248
. In principle, the AB dye, a resazurin dye, invaginate into cell and the 
mitochondrial dehydrogenase enzymes convert it into its reduced form, resorufin, which 
has relatively higher quantum yield. Hence, reduction of the dye by viable cell makes it 
suitable for cell viability analysis. Interestingly, as shown in figure 3.23a, compared to 
untreated cell (control), viable cell count is unaffected for 2.5 g/mL of the particle 
fabricated at 300 
o
C caclination. However, the viability gradually reduced from 95, 77, 51, 
46 to 42 % as the ZnONP concentration in culture gradually increased from 2.5, 5, 12.5, 
25 to50 g/mL. On the other hand, the particle fabricated at 700 oC calcination reduced 
the viability from 35 % at 2.5 g/mL to 13 % at 50 g/mL. Thus, the drastic reduction in 
viable cell fraction upon the particle treatment was highest for ZnONP fabricated at 700 
o
C calcination, compared to other two variants of ZnONPs. 
Figure 3.23. (a) Percentage cell viability of HT1080 cell lines upon ZnONPs treatment, using 
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Alamar Blue dye reduction assay, (b) ZnONPs (50 μg/mL) induced ROS detection in HT1080 cell 
culture, using 2,7-Dichlorodihydrofluroscein diacetate (DCFH-DA) fluorescent dye. 
The oxidative stresses, caused by photocatalytic NP treatment, causing cell death 
have been extensively studied
23, 167
. The level of intracellular ROS generation upon the 
particle treatment was detected using the oxidative conversion of the dye DCFH-DA to a 
fluorescent compound, dichlorofluorescien (DCFH). The oxidative conversion of the dye 
was also observed for control (cell without NP treatment), which is dedicated to ROS 
generated from the unstressed cellular metabolism. Most of the eukaryotic and prokaryotic 
cells have the system to neutralize a threshold amount of ROS
167, 246
. However, enhanced 
ROS level above a threshold causes oxidative stress to cells. The oxidative stress results in 
the oxidation of various biomolecules, like carbohydrate, nucleic acid, protein, and lipid. 
Compared to control, quantum yield of the dye increased by ~ 2.5 folds, from 334 to 951 
a.u. for ZnONP fabricated at 300 
o
C, whereas for the particle fabricated at 500 and 700 
o
C, 
the yield increased by 3.2 and 3.7 folds, respectively. Hence, the oxidative conversion of 
the dye increased by 2-4 folds upon the particle treatment (Figure 3.23b). The data 
indicated that ROS production increases as the calcination temperature for ZnONPs 
fabrication increases from 300 to 700 
o
C, i.e. increase in crystallinity or decrease in energy 
band gap enhanced ROS generation in biological milieu. Hence, the particle treatment 
caused primarily ROS-mediated HT1080 cell cytotoxicity.  
The generation of ROS upon photocatalytic metal NP treatment depends on its 
photocatalytic property, which is strongly influenced by its energy band gap. Narrowing 
of the band gap can increase the photocatalytic activity, which in turn increases ROS 
generation in biological milieu. Hence, the particle with enhanced photocatalytic activity 
exhibited more cytotoxic effect. Furthermore, it is reported that photocatalytic activity can 
also be observed in visible light upon narrowing of the band gap
193
. The excitation of 
semiconductor surface electron results in the e
-
-h
+
 separation, and the holes with higher 
oxidative potential helps in formation of the reactive intermediates in proximity of the loci 
of interaction
193
. When the photocatalyst is inside the biological medium, hydroxyl radical 
(
o
OH), one of the primary oxidants in biological milieu, is formed as a result of the 
reaction between holes and OH
-
 or water
193
. Similarly, ZnONP, being a photocatalytic NP, 
produces different reactive oxygen species like hydroxyl radical (
o
OH), superoxide anion 
(O2
-
), H2O2 etc. in biological milieu
167
. The enhanced ROS generation is primary cause of 
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cellular machineries and mitochondrial machineries dysfunctions leading into cell death, 
which was further supported by the AB reduction assay. 
The ZnONP induced DNA damage was further analyzed using comet assay. 
Comet assay, a combination of DNA gel electrophoresis and fluorescence microscopic 
analysis, is generally applied to visualize the migration of DNA strands
172
. In principle, 
when there are breaks in negatively charged DNA, in electrophoresis the DNA migrate 
relatively faster towards anode due to relaxation of DNA super coils. However, larger size 
DNA fragment in case of undamaged DNA prevents its migration, hence, is considered as 
an indispensable tool to study DNA damage
172
. A comet like tail is an indication of a 
damaged DNA. Comet assay of 50 g/mL ZnONPs treated cells showed an increase in 
olive tail moment from 25 pixels to 70 pixels for the fabricated particles with increasing 
calcination temperature, from 300 
o
C to 700 
o
C, compared to control cell with olive tail 
moment of 10 pixels only (Figure 3.24). Additionally, the increasing olive tail moment 
indicated that the extent of DNA damage increases with the increase in calcination 
temperature of the fabrication. Thus, the ROS data along with the comet assay indicated 
that the increasing calcination temperature for ZnONP fabrication enhances the ROS 
production resulting in extensive DNA damage. 
Figure 3.24. Comet assay showing the damaged DNA upon different ZnONPs treatment, (a) 
control, (b) 300 oC, (c) 500 oC, and (d) 700 oC fabricated ZnONPs. (e) The image J comet assay 
plugin software was used to determine the key parameters of the obtained comet (shown in 
histogram), which demonstrate an increased DNA damage from ZnONPs untreated to treated cell. 
3.4.2. Effect of ZnONP treatment on the cell cycle 
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To further support the ROS-mediated DNA damages, cell cycle were observed using flow 
cytometry, where the early effects would be marked in cell cycle progression. As reported, 
cells having damaged DNA accumulate in gap1 (G1), DNA synthesis (S), or in 
gap2/mitosis (G2/M) phase. Whereas, accumulation of cells in subG1 phase is a clear 
indication of cells with irreversible DNA damage leading to apoptosis
247
. Hence, we 
investigated cell cycle of HT1080 cell grown in presence of different ZnONPs to detect 
different phenomena such as apoptosis, cell cycle arrest and DNA damage. The statistical 
analysis indicated that major population fraction of treated and untreated cells were in G1 
phase (Figure 3.25), i.e. growth phase, where different enzymes needed for DNA 
replication are translated
249
. Interestingly, as different variants of ZnONPs concentrations 
increased in cell culture, cell population fraction in subG1 phase increased significantly, 
from 5% in control to 25% in 50 g/mL treated cells, signifying the induction of apoptosis 
upon ZnONP treatment. Additionally, an increase in cell population in subG1 phase 
simultaneously decreased the cell fraction in G1 phase, from 55 % in control to 37 % in 
the treated cell culture (Figure 3.25). However, the cell population fractions in other 
phases were insignificantly affected upon the treatment. Hence, ZnONP primarily affects 
cells in G1 phase than the cells present in S1 and G2/M phase. 
 
Figure 3.25. ZnONP (700 oC fabricated) treated HT1080 cell showing gradual increase in subG1 
population with increasing concentrations of the particle. The statistical data are generated by C6 
accuri software, and plotted as generated. Histograms for each treatment are included in the 
Appendix. 
3.4.3. Induction of autophagy upon ZnONPs treatment 
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It is reported that chemical autophagy inducers have the potential to inhibit the growth of 
tumour cells
250
. The autophagy induction potential of fabricated ZnONPs was evaluated 
using acridine orange assay. Development of acidic vesicular organelles is a characteristic 
of autophagy. It has been reported that acridine orange being a lysotropic dye passes freely 
through the biological membrane, and accumulates in different acidic compartments such 
as lysosomes, in a pH dependent manner
251
. Acridine orange acts as a hydrophobic green 
fluorescent molecule at neutral pH, whereas in acidic conditions it becomes protonated 
and forms aggregates with red fluorescence
252
. As shown in figure 3.26, control cells 
treated with acridine orange dye showed green fluorescence with relatively small 
percentage (~ 15 %) of red fluorescence. However, ZnONP treated cells displayed 
significant increase in percentage (from 15 % to 84 %) of red fluorescence, representing 
presence of acidic vesicular organelles (AVOs). The merged images indicating orange 
cells represent viable cells with autophagosomes, while red cells represent non-viable cells 
with acidic environment. Hence, as observed from figure 3.26, the population of 
autophagosomes in different ZnONPs treated HT1080 cell indicated that the particle with 
lower energy band gap induces more cell with acidic environment/autophagosome than 
the particle with higher energy band gap. Hence, the particle fabricated with calcination 
temperature of 700 
o
C is more potent to trigger autophagy mediated cell death, in the 
studied cancer cell.  
 
Figure 3.26. ZnONPs triggered autophagy detection by Acridine Orange assay (left panel). 
Histogram shows the relative percentage of autophagosomes in control and ZnONP 
treated samples (right panel). 
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3.4.4. ZnONPs treatment causes apoptotic cell death 
In order to underline the cytotoxic mechanism of different ZnONPs, apoptosis inducing 
property of the particles against HT1080 cell was studied. During apoptosis nuclei of a 
cell become fragmented, and changes into highly condensed apoptotic bodies, which are 
quantified using DAPI staining
253-254
. In the objective, as shown in figure 3.27, the DAPI 
staining indicated that in control the nuclei of the cells were round, big, and had a distinct 
or intact nuclear membrane, with insignificant condensed nuclei population, 1 % of total 
nuclei only. However, upon ZnONPs treatment, the cell exhibited densely stained nuclei, 
indicating presence of more cells with condensed chromatin compared to control. The 
relative percentages of condensed chromatin population, as shown in figure 3.27e, were 
found 8, 19 and 29 % in the cell culture treated with the particle fabricated with 300, 500 
and 700 
o
C calcination, respectively. Hence, the relative percentage of condensed nuclei 
increased gradually with increase in calcination temperature of the particle fabrication.  
 
Figure 3.27. Chromatin condensation analysis in untreated (a) control and (b) 300 oC, (c) 500 oC 
and (d) 700 oC fabricated ZnONPs treated HT1080 cell. (e) Histogram showing the percentage of 
condensed chromatin, and (f) DNA fragmentation assay showing the fragmentation of DNA upon 
ZnONPs treatment, a hallmark feature of apoptosis. 
DNA fragmentation is another technique generally used to visualise fragmented 
DNA which arise during apoptosis as a result of endonuclease cleavage
255
. In this 
technique, the DNA from the ZnONPs treated cells were extracted and separated using 
agarose gel electrophoresis. As shown in figure 3.27f, no DNA fragmentation was 
observed for untreated cell. Whereas, ZnONP treated cells exhibited fragmented DNA at 
the base of the lanes, along with the relatively faint bands of DNA that are present in 
control. Thus, both the data indicated that the irreversible ROS-mediated DNA damage in 
HT1080 cell treated with ZnONPs resulted in apoptotic cell death. 
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3.4.5. HT1080 morphology upon ZnONPs treatment 
The alteration of cell shape/morphology is one of the most noticeable events to observe, 
upon exposure to a cytotoxic material. The change in morphological features of HT1080 
cell upon ZnONP treatment is observed using FE-SEM. As shown in figure 3.28, the 
control cells showed intact morphology. However, HT1080 cells treated with ZnONP 
exhibited distinct morphological changes as compared to control. Additionally, clustering 
of cells was observed upon ZnONP treatment, which restricted the cell spreading capacity, 
unlike control cells. The reduced spreading capacity can be rationalised to disturbances in 
the cytoskeletal assembly or functions
247
. Various groups have also found similar results 
upon different NP treatment, for example Asharani, P. V. et al have also marked similar 
results in human glioblastoma cells (U251) upon starch-coated silver nanoparticle 
treatment.
247
 Additionally, in this work blebbing of the cellular membrane (marked by 
arrow in Figure 3.28) upon ZnONP treatment was observed, which is a morphological 
indication of apoptosis. However, the ZnONP, fabricated at 700 
o
C calcination, showed 
significant membrane disruption and blebbing in HT1080 cells than other two ZnONPs. 
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Figure 3.28. FE-SEM micrographs of (a) HT1080 cells without ZnONP treatment, and the cell 
treated with ZnONPs fabricated at (b) 300 oC, (c) 500 oC and (d) 700 oC calcination. 
The plasma membrane which is a selectively permeable membrane acts as a 
boundary for cell, and maintains a suitable intracellular environment. Additionally, it 
allows permeabilization of small and nonpolar molecules like O2 and CO2, whereas polar 
molecules like ions and NPs of larger size are unable to diffuse across lipid bilayer. 
However, nanoscale molecules and supra-molecular assemblies are transported through 
the process of endocytosis, where the particles are enclosed in a membrane vesicle, and 
finally cellular uptake happens
49
. It is reported that, in case of certain NPs, the NPs are 
confined in membrane bound vesicles (endolysosomes), which restrict their path to reach 
the cytosol
49
. However, the process is not limited to all NPs. Additionally, it is also 
reported that many NPs possess the inherent property to penetrate the cell membrane
49
. In 
that case, the NPs form pores in cell membrane leading to cellular toxicity, since the pores 
imbalance the intracellular and extracellular ions, proteins, and other macromolecules 
concentration gradient, which are essential for cellular functions. Based on the surface 
charge of nanomaterials, cationic charged NPs have shown stronger interaction with 
anionic cell membrane via electrostatic interaction, and translocated easily through the cell 
membrane
49
. From the zeta potential study, it is found that cationic properties of the 
synthesized ZnONP decreases with increase in calcination temperature of the fabrication, 
where slightly negative potential for ZnONP fabricated at 700 
o
C calcinations was 
observed, i.e. -4.19 mV. However, the cytotoxic propensity revealed that the ZnONP 
fabricated at 700 
o
C calcination has highest cytotoxic propensity than the other two. In this 
context, various studies have approved the internalization of negatively charged NPs 
through the cell membrane, despite of unfavorable interaction between NP and 
membranes
49, 256
. Unlike positively charged NPs, negatively charged NPs have less 
efficiency for endocytosis, however, they bind non-specifically with some positive 
moieties on the plasma membrane with relatively less negative domain, and internalized 
through endocytosis
256
. During endocytosis, ROS produced because of the particle 
interaction with cellular moieties resulted in oxidative stress. To recover from the stress, 
cell adopted autophagy-mediated pathway, resulting in enhanced cell fraction in the 
treated samples with autophagosomes, as also observed in figure 3.26. 
The cell membrane puts certain resistive forces due to stretching and elasticity of 
the membrane, which hinder uptake of the NPs
93
. However, different specific and non-
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specific binding interactions at the nano-bio interface generate sufficient thermodynamic 
energy to overcome the resistive forces, and help in particle adhesion and engulfment
93
. 
The interfacial ROS generation also helped in destabilization of cell membrane, hence 
facilitating internalization of the NP. Interestingly, the narrowing of the band gap of 
ZnONP generated ROS more efficiently with relatively lesser amount of binding energy. 
Hence, the particle can easily destabilize the membrane and make internalization of NP 
easier. As observed in this study, the increasing calcination temperature reduced the 
energy band gap and produced rod shape ZnONP. Findings from different groups 
indicated that the rod shape NP internalized relatively efficiently than spherical shape 
NP
93, 257-258
. The data, altogether, indicated that the NP interaction with HT1080 cell led to 
interfacial and intracellular ROS generation, which resulted into irreversible DNA and 
membrane damage leading into cell cycle arrest in subG1-phase. The arrested cells adopt 
autophagy-mediated pathway to recover the damage, whereas failure of the recovery led 
the cell into apoptotic cell death (Figure 3.29). 
 
Figure 3.29. Schematic diagram illustrating the effects of ZnONP induced oxidative stress on 
HT1080 cell. Presence of the narrower energy band gap ZnONP enhances the ROS generation 
beyond a threshold ROS concentration in HT1080 cell. The increased ROS value in cell results in 
DNA damage, which the cell try to recover using autophagy. The cell with successful scavanging 
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of ROS and ROS-mediated damaged biomolecules led a normal morphology or cell cycle, whereas 
unsuccessful cells led into apoptotic cell death. 
As a summary, the study underlines a correlation between narrowing of energy 
band gap and cytotoxic propensity of ZnONPs against a HT1080 cell. The findings 
revealed that with increasing calcination temperature, the crystallinity of ZnONP was 
significantly affected that in turn narrowed energy band gap of the particle. The molecular 
findings from our study indicated that the narrowing of energy band gap increases the 
oxidative stress exerted by the ZnONPs, which in turn causes chromosomal aberrations as 
found from the comet assay and DNA fragmentation study. Hence, the chromosomal 
aberrations resulted in cell cycle arrest in subG1-phase, which the arrested cell tried to 
recover using autophagy-mediated pathway, as revealed by acridine orange assay. 
However, the cell with unsuccessful recovery led to apoptotic cell death. In the end, the 
objective concluded that the narrowing of ZnONP band gap increases the photocatalytic 
activity of the NP, which in turn increases the DNA aberrations resulting into induction of 
autophagy mediated recovery of the aberrations, failure of which led into cell death.  
3.4.6. Antimicrobial propensity of ZnONPs 
To explore the effects of surface defects on antimicrobial propensity, antimicrobial and 
biophysical studies against the bacteria Bacillus subtilis was performed. Initially, growth 
kinetic study of B. subtilis in absence and presence of different concentration of ZnONP 
(700 
o
C) was performed. From the study against HT1080 cells, it was observed that 
ZnONP (700 
o
C) has significant cytotoxic activity. Hence, initially varying concentration 
of ZnONP fabricated at 700 
o
C calcination effect on the bacterial growth kinetic was 
studied (Figure 3.30 a). As shown in the figure, highest inhibition of bacterial growth was 
observed in presence of 250 μg/mL ZnONP. Additionally, when the growth inhibition of 
B. subtilis was observed in presence of 250 µg/mL of different ZnONPs (300, 500, and 
700 
o
C) (Figure 3.30 b), highest inhibition was observed for ZnONP (fabricated at 700 
o
C 
calcinations). Hence, from the objective, it is concluded that ZnONP (700 
o
C) exhibited 
highest antimicrobial activity. To explore the mechanism behind the antimicrobial activity, 
the ROS production was measured for bacterial culture treated with 250 μg/mL of 
different ZnONPs (Figure 3.30c). As shown in the figure, highest ROS mediated DCFH-
DA oxidation was observed in case of ZnONP (700 
o
C), which supported our previous 
findings against HT1080 cell lines. Hence, the work demonstrated that, the reduction in 
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energy band gap because of surface defects increases the ROS mediated antimicrobial and 
cytotoxic activities of the particle. 
 
Figure 3.30. (a) Growth kinetics of B. subtilis in presence of different concentrations of ZnONP 
(700 oC), (b), Growth kinetics of B. subtilis at 250 μg/mL of ZnONPs (300, 500, and 700 oC), (c) 
ROS detection in presence of different ZnONP (300, 500, and 700 oC).  
To explore the mechanistic details of ZnONP antimicrobial activity on bacterial 
membrane, LIVE/DEAD BacLight bacterial viability assay was performed. As shown in 
the figure (Figure 3.31a), the control of B. subtilis cells exhibited green fluorescence due 
to the presence of syto9 in the dye, demonstrating the presence of 100% live cells. 
However, in different ZnONPs treated culture, red fluorescence was observed due to 
staining of DNA by cell impermeable propidium iodide dye, demonstrating the presence 
of non-viable cells along with viable cells. However, the percentage of non-viable cells 
increased from ZnONP fabricated at 300 
o
C calcination to ZnONP fabricated at 700 
o
C 
calcination (Figure 3.31d). The study concluded that the variation in crystallinity of 
ZnONP significantly affects the band gap energy of ZnONPs, which determine both 
cytotoxic and antimicrobial propensities of the particle. 
 
Figure 3.31. Fluorescence microscopic images of B. subtilis in absence and presence of ZnONP 
(250 µg/mL ); (a) B. subtilis, (b) B. subtilis in presence of ZnONP (300 oC), (c) B. subtilis in 
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presence of ZnONP (500 oC) and (d) B. subtilis in presence of ZnONP (700 oC). The scale bars 
represent for 20 m.  
3.5. Effect of interfacial assembly of antimicrobial peptide 
on conformational and functional dynamics of the peptide 
The emergence of resistant bacterial strains against conventional antibiotics has become a 
severe threat to public health worldwide. These antibiotic resistant bacterial strains cause 
millions of infection and thousands of death, every year. Antimicrobial peptides (AMPs) 
possessing the potential to inhibit the proliferation of conventional antibiotic resistant 
pathogens have drawn the attention of various research groups to increase their clinical 
use as an alternative to conventional antibiotics
259
. Generally, these AMPs are group of 
naturally occurring molecules playing important role as a first line of defense system to 
the host
229, 260
. Their broad activity and mode of action against different bacteria, virus, 
and fungi make them potential candidates for development of novel antibiotic strategies
229
. 
Members of this family share some common features like (i) AMPs are typically short (12 
to 100 amino acids), hence small in size, ˂ 10 kDa, (ii) cationic in charge, ranging from +2 
to +7 at pH 7, and (iii) possess amphipathic steriogeometry
261-262
. Among these properties, 
the cationic property of AMP allows them to interact electrostatically with anionic fraction 
of bacterial membrane. However, amphipathic structure guides them for insertion into the 
hydrophobic layer of cell membrane, hence the insertion onsets antimicrobial activity
229, 
262
. Among different AMPs, lantibiotic nisin is a small (3510 Da, containing 34 amino 
acids) amphiphilic peptide, produced by specific strains of Lactococcus lactis
263
. Because 
of the antimicrobial propensity and nontoxic nature against human, nisin has been adopted 
as a safe food additive by the food industry for controlling contamination by food spoilage 
microbes
264-268
. However, the efficacy of nisin in food industry is compromised due to the 
development of resistance in bacteria against nisin. Some bacteria like Staphylococcus 
aureus, Streptococcus bovis, Lactobacillus casei etc. have developed enzyme-based 
resistance due to presence of an enzyme ‘nisinase’, which clears the nisin from cytosol269-
270
. In addition, nisin at nanomolar concentrations shows insignificant activity against 
Gram negative bacteria due to presence of an additional lipopolysaccharide layer, hence 
called the membrane-based resistant strains
271
.  
The objective shows enhanced efficacy of nisin upon assembly at silver 
nanoparticle (AgNP) interface, which can be adopted as a broad range therapeutic 
formulation. Here, AgNP has been adopted as a nanoparticle interface for non-covalent 
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interaction with nisin, since AgNP is a Food and Drug Administration (FDA, US), 
Environmental Protection Agency (EPA, US), and FITI testing and research (US) 
approved nanoparticles
272
. To this end, the interfacial assembly of AgNP-nisin is 
confirmed using different biophysical techniques like zeta sizer, surface plasmon 
resonance property, circular dichroism spectropolarimetery, and infra-red spectroscopy. 
Additionally, the molecular dynamics (MD) simulation study indicated the relatively 
higher degree of freedom of C-terminus and hinge region residues than the N-terminus 
residues, for the interfacially assembled nisin. Furthermore, the biophysical investigation 
and antimicrobial studies, together, indicated that the membrane damage, interfacial and 
intracellular oxidative stress play important roles for enhanced antimicrobial propensity of 
the assembled nisin. 
3.5.1. Interfacial assembly of nisin at AgNP interface 
The AgNP-nisin conjugates at different weight/weight ratios (1:0.25, 1:0.5, 1:1) were 
obtained because of the interfacial assembly of cationic nisin onto the anionic AgNP 
interface, by establishing non-covalent interfacial interactions (predominantly electrostatic 
interaction). The nisin assembly at the AgNP interface was first confirmed from SPR 
spectra of AgNP and the conjugates, using UV-Visible spectroscope. As shown in figure 
3.32a, the peak at 397 nm attributed to the surface plasmon resonance (SPR) property of 
AgNP. However, relatively stronger SPR property of AgNP suspension in near UV region, 
which is generally dedicated to the aromatic amino acids absorption i.e. 260-280 nm, 
masked the detection of nisin by the absorption spectroscopy. Nevertheless, the peak 
intensity at 397 nm reduced by 60 % with relatively broader peak, and an additional peak 
at 490 nm appeared possibly for the conjugates. The decrease in intensity of absorption at 
397 nm rationalized to the decrease in intact/accessible AgNP surface in conjugate 
suspension. Whereas, red shift of the peak from 397 to 490 nm indicated the interfacial 
assembly of nisin at AgNP interface
167
, forming NP-peptide conjugate. The precipitation 
in the conjugate reaction mixture increased with increase in the peptide fraction in the 
mixture. Hence, the reduced peak intensity at 397/490 nm rationalised to relatively less 
amount of either AgNP or the conjugate or both exposed to UV-Visible light. The data, 
altogether, indicated that the major nanoparticle population fraction was in conjugation 
with nisin, with characteristic peak for the conjugate at 490 nm. 
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Figure 3.32. Characterization of AgNP-nisin conjugates. (a) UV-Visible spectra of AgNP, nisin, 
and different AgNP-nisin conjugates. (b) Zeta potential values of AgNP and different AgNP-nisin 
conjugates. (c) ATR-FTIR spectra of nisin and AgNP-nisin conjugates. (d) CD spectra of nisin and 
different AgNP-nisin conjugates, (e) TEM image of AgNP, and (f) TEM image of AgNP-nisin 
conjugate (1:1).  
The interfacial assembly of nisin onto AgNP interface was further confirmed from 
the zeta potential analysis for AgNP and different AgNP-nisin ratios suspensions. As 
shown in figure 3.32b, the intact AgNP surface has the zeta potential of -52.0+/- 7.4 mV 
that neutralized upon conjugation with increasing nisin concentrations in suspension. The 
increasing concentrations of nisin reduced the AgNP zeta potential to neutral, from -52.0 
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+/- 7.4 mV to -15.4 +/- 3.14 mV for the highest AgNP-nisin ratio (1:1, w/w). Hence, the 
neutralization of AgNP surface potential upon addition of increasing nisin concentrations 
indicated the interfacial assembly of nisin onto the AgNP interface (Figure 3.32b). 
Similarly, Alves, C. S. et al229 have reported that the surface potential neutralization 
plays a major role in balancing the electrostatic interaction between cationic and anionic 
molecules. Hence, the results indicated that the non-covalent interaction, predominantly 
electrostatic, at the nanoparticle interface resulted in stable AgNP-nisin conjugates. 
The conformational dynamics of nisin upon conjugation with AgNP was further 
explored using attenuated total reflection infrared (ATR-FTIR) and circular dichroism 
(CD) spectroscopies. Figure 3.32c showed the IR spectra of nisin and AgNP-nisin 
conjugates. The major peaks of nisin at 1648 cm
-1
 was due to the stretching vibrations of 
C=O (amide I), whereas 1512 and 1539 cm
-1
 were due to the bending vibrations of N-H 
(amide II), which confirmed the bond level vibrations of the peptide falling in 
predominantly random coil conformation. Like nisin, the amide I and amide II peaks for 
different ratios of AgNP-nisin conjugates were also found at same positions, confirming 
insignificant change in the conformation of nisin upon assembly at the AgNP interface. 
The hypothesis of interfacial assembly of AgNP-nisin was further strengthened by 
analysis of IR peaks below 800 cm
-1
, which indicated the presence of metal-metal/metal-
oxygen bonds
167
. From the observation of AgNP spectra, we found peaks at 516 and 545 
cm
-1
 which were observed, representing the Ag-Ag/Ag-O bond vibrations. Interestingly, 
the presence of peaks at 517 and 544 cm
-1
, in addition to amide-I and –II bonds, for 
AgNP-nisin (1:1) precipitate confirmed the presence of AgNP and peptide in the 
precipitate (Figure A12, Appendix). The retention of nisin secondary structure in 
conjugate was further confirmed by CD spectroscopy, where nisin and different AgNP-
nisin conjugates gave negative ellipticity with prominent peaks in the range of 199-201 
nm, corresponding to random coil secondary structure (Figure 3.32d). The data further 
supported the published work of Adhikari M. D. et al., which showed nisin retains the 
ellipticity at 200 nm upon conjugation with gold nanoparticle
273
. However, change in peak 
intensity for 18 mg/mL nisin and the nisin-AgNP conjugate mixture (1:1) rationalised to 
settlement of the precipitate in the time frame of data collection, resulting in lower peak 
intensity for the conjugate mixture compared to the equal concentration of intact nisin. 
The structural changes of both NP and protein upon formation of NP-protein 
conjugates have adverse effects in biological milieu. Hence, retention of structure of both 
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NP and protein is a key challenge upon the conjugation. Although, CD and IR 
spectroscopes revealed the retention of nisin conformation upon assembly onto the AgNP 
interface. It becomes essential to investigate the effect of interfacial assembly on the 
morphology of AgNP. Hence, the morphological features of both AgNP and AgNP-nisin 
conjugates were studied using transmission electron microscopy (TEM). Figure 3.32e-f is 
the representative TEM images of spherical shaped AgNP and AgNP-nisin conjugates 
(1:1), respectively. The comparative analysis of the images indicated that the interfacial 
assembly of nisin had insignificant effect on the morphology, and crystallinity (both 
possess fcc ring pattern as shown in SAED pattern, Figure A13c-d, Appendix) of the 
AgNP. Whereas, the assembly led to increase in average size of the AgNP 3-4 nm, only 
(Figure 3.32e-f). EDX data indicated the presence of additional carbon, nitrogen and 
sulphur atoms, supporting the presence of peptide onto AgNP interface (Figure S13e-f, 
Appendix). 
To further explore the conjugations at atomic level, molecular dynamics (MD) 
simulation study was done. The study confirmed that non-covalent interactions at the 
AgNP interface and nisin resulted in the interfacial assembly of the peptide. The deviation 
between native and the simulated structure has been evaluated by measuring the root mean 
square deviation (RMSD) values (Figure 3.33a)
274
. The comparative RMSD values for all 
the peptide atoms indicated insignificant change with time (50 ns), reached a stable value 
of ~0.04 nm (Figure 3.33a). Moreover, the radius of gyration (Rg, ~2.18 nm) for simulated 
AgNP core (made up of face centred cubic, fcc, arrangement of 3871 silver elements, 10 
nm diameter) showed insignificant deviation within the time frame of 50 ns (Figure 
3.33b). Thus, both the results independently confirmed stability of the components, which 
were further used in simulation for the conjugates. Here, RMSD plot showed that the 
complex is stable during simulation with least fluctuations in structure of the peptide and 
core. A stable RMSD value of 0.02 nm has been observed for the conjugate (Figure 
3.33c).  
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Figure 3.33. (a) RMSD of nisin peptide measured for 50 ns simulation, (b) Radius of gyration of 
the AgNP, (c) RMSD of nisin-AgNP conjugate measured for 50 ns simulation, and snapshots of 
AgNP-nisin conjugation at 0 ns (d) and 50 ns (e). 
Analysis of the individual residues involved in interaction at the interface is 
indicated in table A2 (Appendix). The table represented the distance (in Å) of the residues 
that interact with the AgNP core at the initial, mid, and end stages of the simulation time 
frame (50 ns). It is observed that the residue numbers 1
st
-4
th
, 22
nd
-26
th
, and 31
st
-34
th
 come 
relatively closer to the interface, i.e. loci of the conjugation. Although, the N-terminus 
residues (1
st
-4
th
 position) are placed relatively nearer to the interface than the C-terminus 
residues. The observation indicated stronger interaction between the N-terminus residues 
and interface, than between the C-terminus and interface. However, the overall 50 ns 
simulation strongly suggested that the AgNP-nisin complex remains stable. The snapshots 
of trajectories showed that the peptide does not show any repulsive behaviour from the 
core, upon placing the peptide near to the core (Figure 3.33d-e and Figure S14, Appendix). 
Moreover, the simulation was done by taking the single peptide and NP core. For higher 
peptide molecules to core ratio, as predicted from neutralization study, the crowding effect 
will further strengthen the interaction between the residues and core. Thus, the simulation 
study further supported the conclusion drawn from Zeta analyser, FTIR, and CD spectra, 
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i.e. non-covalent interactions at the interface resulted in stable interfacial assembly of nisin 
onto AgNP interface without any significant change in nisin or AgNP structure. 
3.5.2. The interfacial assembly enhances the antimicrobial propensity of 
nisin 
The antimicrobial activity of 1.2 mg/mL (~2.8 nM) AgNP, 1.2 mg/mL (~340 nM) nisin, 
and the AgNP-nisin conjugates (1:0.25, 1:0.5, and 1:1, w/w) was evaluated by following 
growth kinetics of a Gram-positive bacterium, Bacillus subtilis, and a Gram-negative 
bacterium, Escherichia coli, in presence of the additives (Figure 3.34a-b). As shown in the 
figure, for studied concentrations and conditions, AgNP and nisin showed insignificant 
effect on either of the bacterial growth kinetics. However, in presence of AgNP-nisin 
conjugates (1:0.25, 1:0.5, and 1:1, w/w), where the nisin concentration varied from 0.3-1.2 
mg/mL (i.e. 85-340 nM), and significant growth inhibitions for both the bacteria were 
observed. Among the studied ratios, inhibition was maximum for 1:1 ratio of AgNP-nisin 
conjugate. Here it is important to note that unlike other studies,
228, 275
 the additives were 
added at mid log phase of growth kinetics, since the phase is most potent/viable phase of 
the bacterial growth. Hence, in log phase requirement of any antibiotic to inhibit the 
growth of bacteria is optimum, which indicates exact antibiotic minimum inhibitory 
concentration (MIC) against the bacteria
167
. Interestingly, addition of the conjugates 
immediately ceased the log phase of E. coli, whereas growth of B. subtilis followed 
original kinetics for 30 mins before showing significant inhibition (Figure 3.34a-b). 
Nevertheless, the growth kinetics, after a dormant phase of ~4 hrs, resumed the growth for 
both the bacteria. The findings indicated that the fraction of bacterial population that either 
become tolerant to the additives or remain unexposed to the conjugates resumed the 
growth. Since the bacterial culture is highly heterogeneous system with millions of cells, 
there is very high chance that a fraction of cell population remains unexposed to 340 nM 
of interfacially assembled nisin. To further support the findings, colony forming units 
(CFU) were quantified by taking the culture from stationary phase of treated bacterial 
growth. As shown in the growth kinetics, insignificant difference in viable cell numbers 
was observed for AgNP and nisin treated bacteria (Figure 3.34c-d). However, the AgNP-
nisin conjugates had a significant effect on viable cell fraction. Compared to the untreated 
cells, viable cell fraction reduced to < 20 % for AgNP-nisin (1:1) conjugate treated 
culture; 82 and 87 % non-viable cells were found for B. subtilis and E. coli, respectively. 
Whereas, 85 and 170 nM interfacially assembled nisin to 2.8 nM AgNP interface reduced 
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the viable cell fraction by ~50 %, only (Figure 3.34c-d). Comparative analysis between 
antimicrobial propensity of the intact nisin (Figure A15, Apendix) and the nisin assembled 
at interface (Figure 3.34a) against B. subtilis indicated that the nisin antimicrobial 
propensity increased by 10 folds upon conjugation.  
 
Figure 3.34. Growth kinetics of B. subtilis (a) and E. coli (b) in presence of AgNP, nisin, and 
different AgNP-nisin conjugates. Bacterial cell viability quantified from CFU study in the 
presence of AgNP, nisin, different AgNP-nisin conjugates for B. subtilis (c) and E. coli (d) 
respectively. Triplicate experiments were done for each reaction, and the error bar represents the 
standard error of mean. 
Nisin is known to inhibit Gram-positive bacteria growth by interacting its N-
terminal AB-lanthionine ring at nanomolar concentration with peptidoglycan precursor 
lipid molecule, i.e. lipid-II, which is involved in synthesis of the cell wall
276-277
. Nisin uses 
lipid-II as an efficient receptor to initiate the permeabilization process through plasma 
membrane, leaving behind pore in membrane resulting in collapse of the bacterial ion 
gradients
276-277
. Thus, nisin is more effective against the bacteria having higher fraction of 
lipid-II than the bacteria lacking the lipid-II fraction. However, presence of additional 
layer of lipopolysaccharide in Gram-negative bacteria makes nisin relatively ineffective
271, 
278
. The growth kinetics and CFU data for the assesmbled nisin treated E. coli suggested 
that membrane-based resistance in Gram negative bacteria is eliminated upon assembly at 
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the NP interface. To further strengthen our findings, the growth kinetics of another Gram-
negative bacterium, Proteus vulgaris, against different AgNP-nisin conjugates were 
observed (Figure A16, Appendix). Like E. coli, P. vulgaris is also insensitive to nisin, 
whereas the addition of AgNP-nisin conjugates delayed the growth of the bacteria by ~4 
hrs. Additionally, it was also reported that upon repeated exposure of nisin to a certain 
Gram-positive bacteria, like Staphylococcus aureus, Streptococcus bovis, Lactobacillus 
casei, the bacteria become resistant to nisin, and the resistance is due to the expression of 
the nisin digesting enzyme, ‘nisinase’269-270. To evaluate the effectiveness of AgNP-nisin 
conjugates against nisinase-based resistant bacteria, the growth kinetics of S. aureus 
against different AgNP-nisin conjugates were observed (Figure A17, Appendix). 
Interestingly, the conjugates had relatively very devastating effect on S. aureus, compared 
to B. subtilis. Thus, the data altogether indicated that the efficacy of nisin against 
membrane-based and nisinase-based resistant bacteria increases upon interfacial assembly 
of the peptide at AgNP interface. 
3.5.3. Oxidative-stress mediated antimicrobial activity of AgNP-nisin 
conjugates 
Photocatalytic nanoparticle interfaces, like AgNP, ZnONP, on interaction with the 
biomolecular surfaces enhances the generation of reactive oxygen species (ROS)
23, 167, 246
. 
Bacteria usually have system to neutralize certain threshold amount of ROS, however 
enhanced ROS production above the threshold causes oxidative stress in bacteria
23, 167
. 
The oxidative stress in bacterial cells results in the oxidation of biomolecules, like 
proteins, lipids. Thus, the ROS mediated irreversible changes at the loci of interaction is 
most likely to contribute in membrane dynamic change, one of the main factors that 
causes photocatalytic nanoparticle mediated bacterial cell death
279
.  
Here, the oxidative stress exerted by AgNP-nisin conjugates on bacterial cells were 
studied using the ROS specific dye, 2’,7’-Dichlorodihydrofluorescein diacetate (DCFH-
DA). Generally, ROS are highly reactive free radicals in the form of small molecules or 
ions like hydrogen peroxide (H2O2), peroxide free radicals (OH
o
), or molecular oxygen 
ions (O2
-
)
246
. The quantum yield of dye at 523 nm increases by many folds in presence of 
ROS. Hence, the increasing fluorescence intensity at 523 nm with time for untreated cells 
indicated the production of ROS during the bacterial growth (Figure 3.35). AgNP induced 
the oxidative stress in both the bacteria by enhancing the production of ROS, though more 
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in B. subtilis than E. coli cell cultures. The observed differences in ROS production are 
mainly because of difference in interaction between bacteria and nanoparticle interface
167
. 
Whereas, nisin treatment was ineffective to enhance the ROS production in E. coli cells 
(Figure 3.35b), which supported the findings that 340 nM nisin does not have ROS 
mediated antimicrobial activity against the bacteria. Interestingly, the intact nisin 
enhanced the ROS production in B. subtilis culture, supporting the pervious findings that 
the antimicrobial peptide brings stress condition to Gram-positive bacteria (Figure 3.35a). 
However, 2-3 folds increase in fluorescence intensity for AgNP-nisin conjugates treated 
bacteria cell cultures were observed (Figure 3.35). Hence, the AgNP-nisin conjugates 
upon interaction with both the bacterial membrane exert the oxidative stress resulting in 
enhanced antimicrobial propensity.  
 
Figure 3.35: ROS detection in presence of AgNP, nisin, and AgNP-nisin conjugates (for 1:0.25 
and 1:1 AgNP:nisin ratios) for B. subtilis (a) and E. coli (b), respectively. For each kinetic 
experiment, except control, respective additives were added at the mid-log phase (shown by 
arrow). The error bars represent standard error of mean calculated from three independent 
kinetics. 
However, the interfacial and intracellular ROS generation depend primarily on the 
photocatalytic activity of AgNP, which arises due to localized surface plasmon resonance 
(SPR) property of silver nanoparticle
280-281
. Upon exposure to visible light or equivalent 
amount of interaction energy, AgNP absorbs the energy. As a result of energy absorption, 
the configuration of elemental AgNP changes into excited open shell configuration, i.e. 
d
9
s
1
 and/or d
9
p
1
 
280-281
 The absorption results in generation of ROS in proximity to the loci 
of interaction
281
. However, enhanced intracellular ROS production will also have the 
contribution from enhanced metabolic rate of the bacteria, which is enhanced to counter 
the stress conditions upon insertion of AgNP-nisin conjugate onto/into the membrane. 
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3.5.4. Membrane destabilization by AgNP-nisin conjugates 
The previous studies with photocatalytic metal nanoparticles, like ZnONP, have shown 
that the surface potential and accessible surface functional groups highly affect the 
bacterial membrane dynamics and the morphology
167
. The effect is mainly because of 
non-covalent interactions at the interface, resulting into enhanced level of ROS generation. 
The resultant ROS at the interface brings chemical or physical modifications in 
membrane, leading into the loss of cell viability
167
. Hence, because of the predominantly 
repulsive electrostatic interaction between the negative surface potential AgNP and 
bacterial membrane, 2.8 nM AgNP exert insignificant antimicrobial effect against both the 
bacteria. Whereas, upon reduction of the negative surface potential and functionalizing the 
interface with antimicrobial accessible functional groups (lanthionine rings/hinge region), 
the antimicrobial propensity enhanced by many folds.  
For mechanistic details of AgNP-nisin conjugate antimicrobial effect on bacterial 
membrane, the LIVE/DEAD BacLight bacterial viability assay was done. The assay uses a 
mixture of cell permeable and impermeable nucleic acids binding dyes, Syto9 and 
propidium iodide (PI) dyes, respectively. Since the kit uses mixture of two dyes and PI has 
relatively higher affinity for nucleic acids than Syto9, PI thermodynamically intercalate 
strongly with nucleic acids than Syto9, in deformed cells
282
. As shown in figure 3.36, the 
untreated B. subtilis and E. coli cells showed all green fluorescing cells, inferring presence 
of 100% viable cells. However, a statistical analysis using Image J software
283
 indicated 
56 and 58% of non-viable cells for 1:0.25 ratio, whereas 91 and 93% non-viable cells for 
1:1 ratio AgNP-nisin conjugate treated B. subtilis and E. coli cells, respectively (Figure 
3.36 and Figure A18, Appendix). The statistical findings from the assay reflected the 
statistics observed from the CFU study. Additionally, the assay also indicated the 
ineffectiveness of 1.2 mg/mL nisin or AgNP against these two studied bacteria (Figure 
A18-A19, Appendix). Hence, the data indicated that the AgNP-nisin conjugate on 
interaction with the bacterial membrane are either disrupting the membrane or making 
pore in membrane with the lifetime long enough for PI dye to diffuse and intercalate with 
nucleic acids. 
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Figure 3.36: The LIVE/DEAD Baclight fluorescence microscopic images of (a-i) B. subtilis, (a-ii) 
B. subtilis treated with AgNP-nisin (1:0.25) conjugate, (a-iii) B. subtilis treated with AgNP-nisin 
(1:1) conjugates, and (b-i) E. coli, (b-ii) E. coli treated with AgNP-nisin (1:0.25) conjugate, (b-iii) 
E. coli treated with AgNP-nisin (1:1) conjugates, differentiating the viable cells (green) from non-
viable cells (red). The scale bar represents 20 µm. 
To further strengthen our findings from the BacLight assay, the AgNP-nisin 
conjugates treated bacterial cells were visualized using SEM. As shown in figure 3.37, the 
membrane of untreated B. subtilis and E. coli showed intact bacterial membrane 
morphology. On the other hand, the interfacially assembled nisin treated bacterial cells 
showed deformed cell membrane, indicating compromised membrane. The findings from 
the BacLight assay and SEM analysis suggested that the assembled nisin has relatively 
adverse effects on bacterial cell membrane. 
Moreover, the permeabilization of AgNP-nisin conjugates was further confirmed 
by confocal microscopy (Figure 3.38). The fluorescein labelled AgNP-nisin conjugates 
was added to B. subtilis and E. coli cultures. Upon incubation, the cells were washed to 
remove residual fluorescence, and imaged using confocal microscope. In images, green 
fluorescence (fluorescien tagged AgNP-nisin conjugate) was co-localised with the 
bacterial cells, which confirmed internalization of AgNP-nisin conjugates. Since size of 
the conjugate found ~10 nm, the permeabilization process will cause cavity of respective 
size in membrane leading into membrane rupture, as observed in figure 3.37c-d. Hence, 
the assembled nisin primarily changes membrane dynamics upon interactions with 
bacterial membrane. 
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Figure 3.37: Representative SEM micrographs of (a) B. subtilis and (b) E. coli cells. The 
micrographs of AgNP-nisin conjugate (1:1) treated B. subtilis (c) and E. coli (d) showing the 
damaged/ruptured cell membrane. 
 
Figure .3.38: Panel a and b represent the confocal microscopy image of B. subtilis and E. coli, 
respectively, treated with fluorescein labelled AgNP-nisin conjugates. (a-i & b-i) phase contrast 
images of treated bacteria, (a-ii & b-ii) green fluorescence images of the treated bacteria, and (a-iii 
& b-iii) merge images of phase contrast and green fluorescence images. 
The cavity or pore formed upon internalization of molecule is generally 
replenished by cellular lipid homeostasis
284
. To replenish the cavity, formed upon 
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permeabilization of the conjugate, lipid homeostasis would be taking significant time 
leading into ions leakage above a critical limit, resulting into the rupture of membrane. 
The above rationalization came from the findings that the membrane impermeable PI dye 
stains the cells treated with the conjugates
279, 285
, whereas unable to stain cells which were 
either intact or treated with nisin or AgNP individually. Hence, insertion of the AgNP-
nisin conjugates in cell creates cavity in membrane with lifetime more than the critical 
period, consequently leading into rupture of membrane and loss of cell viability. Thus, the 
BacLight assay, confocal microscopy and SEM data suggested that permeabilization of the 
assembled nisin through the Gram-positive and Gram-negative bacterial membrane leads 
into membrane rupture.  
3.5.5. Proposed mechanism of the assembled nisin antimicrobial activity 
Silver nanoparticle on interaction with bacterial membrane triggers a series of 
thermodynamics and physico-chemical reactions, resulting in alteration of membrane 
surface tension, ROS mediated chemical modification of accessible functional groups of 
the membrane etc
93
. Hence, interactions between the assembled nisin and bacterial 
membrane play an important role in determining the antimicrobial propensity of the 
conjugates, compared to individual entity. As an individual, since AgNP has negative 
surface potential, the electrostatic repulsive interaction between AgNP and anionic 
bacterial membrane are unfavorable to bring/initiate the changes at submicromolar 
concentrations. Whereas, AgNP at higher concentrations showed antimicrobial activity 
against bacteria due to interactions with the positive potential ‘building elements’ present 
at the bacterial membrane
30
. On the other hand, nisin causes the antimicrobial effects 
either through the lipid-II dependent or independent or both pathways
286
. In lipid-II 
dependent pathway, the first two N-terminus lanthionine rings of nisin bind at nanomolar 
concentrations with lipid-II fractions of bacterial membrane, and restricts the cell wall 
homeostasis
284
. Hence, for the bacteria with higher lipid-II content, nisin has antimicrobial 
effect at nanomolar concentrations. Besides the restrictions in cell wall homeostasis, the 
binding and subsequent insertion of nisin in membrane triggers the falling-off of the lipid 
molecules from the loci of interfacial interaction. Thereafter, the last two lanthionine rings 
along with the hinge region play an important role in pentamerization and 
permeabilization of the peptide into the cell
286-287
. The reduced lipid density or enhanced 
lipid fluidity upon significant loss of the lipid molecules from cell membrane assist the 
peptide oligomerization to form pore/transient pore in membrane, leading into leakage of 
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the vital bacterial moieties causing the cell non-viability
288
. In the lipid-II independent 
pathway, micromolar concentrations of cationic nisin interact non-specifically to anionic 
phospholipid fractions of the membrane; hence the anionic lipid fraction must be in the 
range of 50-60 %
286
. Unlike the lipid-II dependent pathway, the cationic C-terminus of 
nisin interacts with anionic phospholipid head groups of membrane. The interaction 
initiates the permeabilization of the peptide through membrane, leading into short-lived 
pores causing the antimicrobial activity
286, 289
. Although, the C-terminus residues (hinge 
region and last two lanthionine rings) are in interaction with AgNP core in conjugate, 
which are not as strong as the N-terminus residues interaction with the core (Table A2, 
Appendix). Hence upon coming in proximity of bacterial membrane, from cationic N- and 
C-terminus, C-terminus must preferably be interacting with the membrane in order to 
execute the antimicrobial activity, as shown by the interfacially assembled nisin. 
In our study, the data altogether indicated that the conjugated nisin, if not 
following both the pathways, is predominantly following the lipid-II independent 
pathway. The lipid-II dependent pathway is not possible, since the simulation data 
indicated that in conjugate the N-terminus residues have relatively stronger interaction 
with the core than the C-terminus residues (Figure 3.33c-d and Figure A14, Appendix). 
Moreover, the studied bacteria lack the lipid-II fraction in its membrane, needed for the 
lipid-II dependent pathway
286
. Hence, the nanoparticle core in the conjugate will sterically 
hinder the peptide first two lanthionine rings interaction with the membrane fraction. 
Additionally, relatively accessible C-terminus residues of the conjugate are predominantly 
contributing for the non-covalent interaction with anionic membrane fraction of the 
bacteria, which originally initiate the peptide insertion (Stage 1, Figure 3.39). The C-
terminus residues are known to interact with bacterial membrane for lipid-II independent 
insertion, hence, the conjugates possibly onset the antimicrobial action in lipid-II 
independent pathway. Additionally, as the stoichiometry of conjugation suggests, and if 
the homogeneous coating is considered, each NP is having ~ 100 molecules of nisin. 
However, the effective number of nisin interacting with the membrane will be far less than 
100 molecules, considering the molecular crowding at the interface and the relative 
orientation of the nisin in conjugate compared to membrane interface. The effective 
numbers will definitely be higher than 5 molecules, since for nisin internalization 5 nisin 
molecules insert and pentamerise to initiate the permeabilization process (Stage 2, Figure 
3.39). In case of the conjugate, considering effective numbers of the interacting nisin 
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molecules, a single conjugate molecule is sufficient to initiate the pentamerization and 
permeabilization process.  
 
Figure 3.39: Schematic diagram showing detail mechanism of AgNP-nisin conjugates against 
bacteria. Stage 1: the non-covalent interaction between AgNP-nisin conjugate and bacterial 
membrane will bring the conjugate onto the membrane. Stage 2: the interaction results in ROS 
generation at the interface, and subsequently help in insertion of C-terminus lanthionine rings and 
hinge region into membrane. The insertion results in falling-off lipid molecules from the 
respective loci to maintain the surface tension. Stage 3: because of more than one peptide per 
conjugate is inserting at the loci of insertion, the insertion will immediately followed by 
internalization of the conjugate. The internalization of the conjugate results in membrane pore 
formation, resulting into cell death (a- in presence of sub-micromolar intact nisin, b-in presence of 
sub-micromolar the interfacially assembled nisin). 
The physico-chemical property of AgNP assist further in permeabilization of the 
conjugate through change in ROS-mediated surface fluidity
167
. The non-covalent 
interaction arising from different functional groups present over the conjugate interface 
and bacterial membrane cooperatively generates sufficient amount of energy to catalyse 
the conjugate permeabilization process (Stage 2, Figure 3.39)
290
. Different physico-
chemical property of the membrane interface, like (i) stretching and elasticity of 
membrane, (ii) thermal fluctuation of cell membrane, and (iii) hydrophobic exclusion of 
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polar surfaces by membrane, will resist the conjugate against the permeabilization. The 
resistive force could have split the conjugate into nanoparticle and peptide, either during 
or upon the permeabilization
93, 101
. However, confocal microscopy data (Figure 3.38) 
indicated that the conjugate interaction with membrane interface generates sufficient 
amount of energy to help the permeabilization without splitting the conjugate. The 
increase in surface tention with time at the loci of adhesion of AgNP-nisin conjugate and 
membrane causes the conjugate invaginate, leaving behind the pore/cavity of respective 
size (Stage 3, Figure 3.39). The cavity(s) results in rapid efflux of the vital cellular 
moieties leading to loss of cell viability
291
. However, sub-micromolar nisin interacts with 
bacteria, but it does not exert potential antimicrobial impact on membrane. In this case, the 
membrane must have instantly recovered the original texture from the distorted form 
caused by nisin only treatment (Stage 3, path a, Figure 3.39), hence insignificant 
antimicrobial activity observed. Upon internalization of conjugate, conjugate kill the 
bacteria by targeting and damaging various intracellular biomolecules in ROS mediated 
pathway, in addition to the nisin mediated cell death (Stage 3, path b, Figure 3.39)
260
. 
Additionally, as discussed in enzyme-based resistant bacteria like S. aureus, S. bovis, L. 
casei, nisinase clears the peptide and restores the lipid homeostasis
284
. The S. aureus result 
(Figure A17, Appendix) revealed that AgNP-nisin conjugates provide resistance against 
the nisinase activity, either by ROS-mediated irreversible modification of nisinase or by 
sterically hindering the enzyme binding to cleavage site. The data, altogether, indicated 
that the assembly not only enhances the efficiency of nisin, but also broadens the action of 
nisin against a different spectrum of microbes at sub-micromolar concentrations. Hence, 
the interfacial assembly of nisin at AgNP interface enhances the antimicrobial efficacy of 
the nisin. 
Findings from the study conclude that the non-covalent interactions play important 
role for interfacial assembly of nisin at AgNP interface, forming stable AgNP-nisin 
conjugates. The interfacial assembly is confirmed by the change in nanoparticle specific 
SPR signature, IR signatures for metal and peptide bonds, ellipticity of peptide bonds, and 
surface potential neutralization. The MD simulation study further supported the interfacial 
assembly, and indicated the interaction pattern at the interface with time. The interaction 
energy and interfacial ROS generation play important role in destabilizing the membrane 
to favour the conjugate permeabilization process. The cavity formed in membrane on the 
conjugate permeabilization and the intracellular ROS generation causes the cell non-
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viability. Taking altogether, the efficacy of nisin can be enhanced by interfacial assembly 
of nisin onto AgNP interface. Hence, the approach can be adopted as a potential 
antimicrobial formulation against broad spectrum of bacteria. 
3.6. Effect of globular protein interfacial assembly on 
conformational dynamics of the protein 
The three dimensional structure of protein, which is precisely regulated by a number of 
non-covalent interactions such as electrostatic interaction, van der Waals interaction, 
hydrogen bonds, hydrophilic/hydrophobic effects etc
74
, controls most of the functions of 
protein. In addition, the conformational changes of protein are associated with various 
properties such as function, transportation, assembly, aggregation propensity, cytotoxicity 
etc
74
. Hence, study of thermodynamics and kinetics of protein folding/unfolding has 
received enormous attention in past decades for manifestation of various biological 
applications ranging from genetic information to molecular diagnostics
74, 292
. It is 
important to note that, the interaction network of a protein can be easily 
misarranged/broken by changing slightly the physico-chemical environment, which results 
into partially unfolded or completely unfolded protein conformation. Sometimes the 
proteostatis network of the cell fails to check the perturbation of the interaction network 
resulting in the exposure of hydrophobic core of the protein, which drives the 
conformation of protein into self assembly of monomers leading to formation of amyloid 
fibrils
78
. These amyloid fibrils are unique type of protein aggregates with cross-β 
structure, generally associated with various degenerative diseases like Alzheimer’s 
disease, Huntington’s disease, Parkinson’s disease, amyloid polyneuropathy, diabetes 
type-2, Spongiform encephalopathy etc.
74, 78, 293
. 
 Inside the biological milieu, the nanoparticles come in myriad shape and size and 
interact with different biomolecules. Similarly, in biological milieu, various nanoparticles 
bind with proteins and form a complex known as protein corona
294
. However, various 
specific and non specific interactions at nanoparticle protein interfaces are responsible for 
various biological functions of protein
74
. The preferred interaction for a successful 
assembly of protein and nanoparticle are covalent or electrostatic interactions for 
successful application of protein nanoparticle bioconjugate in biosensing, imaging etc
74, 
295
. It is reported that when protein interacts with planner surfaces, significant changes to 
secondary structure happen, however high curvature of nanoparticles help the protein to 
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retain its native structure
53
. In addition, the presence of various interactions like 
electrostatic and hydrophobic interactions at the interface of nanoparticle and protein help 
in more or less conformational changes of protein, which also affect the function of 
proteins. 
Hence, this objective intends to explore the changes in conformational dynamics of 
a globular protein upon interaction with photocatalytic nanopaticle such as ZnONP, at two 
different pH (7.4 and 9), by taking lysozyme as model globular protein. Different 
biophysical studies demonstrated that the assembly onto ZnONP interface led into 
conformational rearrangement that hinders the amyloidogenic propensity of lysozyme in 
studied conditions. 
3.6.1. Interfacial assesmbly of lysozyme at ZnONP interface 
3.6.1.1. CD spectroscopic measurement 
The change in secondary structure of lysozyme at both pH upon interaction with ZnONP 
was explored using Far-UV-CD analysis. As reported, the CD bands at 208 and 222 nm 
are characteristic peaks for α-helical structure of proteins296. The peptide bonds present in 
-helix secondary structure arrangement has π→π* transition at 208 and 222 nm, which is 
represented by negative ellipticity by CD spectropolarimeter. As shown in figure 3.40, the 
peak intensity at 208 nm for both the pH became more negative with addition of different 
concentration of ZnONPs, indicating the increment of helical structure of lysozyme upon 
addition of ZnONP. However, the increment is independent of ZnONP concentration, no 
further change in regular structure was observed on increasing the ZnONP concentration. 
Additionally, the increment in helical content as compared to control happened at the 
expense of random coil region of the lysozyme, as indicated by deconvolution of the 
spectra using CDNN software
297
 (Figure A21, Appendix). The spectra also indicated that 
lysozyme is having more helical content at pH 7.4 than pH 9. The structural changes of 
lysozyme at secondary level were further explored using ATR-FTIR spectroscope, which 
demonstrated insignificant changes of lysozyme upon ZnONP interaction (Figure A22, 
Appendix). Hence, the data indicated that the presence of ZnONP helps the lysozyme to 
attain relatively more regular conformation than control. 
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Figure 3.40. Far-UV CD spectra of 10 μM lysozyme at pH 7.4 (a) and pH 9 (b) in absence and 
presence of different ZnONP concentrations.  
3.6.1.2. Effect of ZnONP on thermal denaturation of lysozyme 
The stability of lysozyme against thermal denaturation upon interaction with 
ZnONP was explored by observing the thermal denaturation curve of lysozyme at two pH 
conditions with a temperature range of 30 to 90 
o
C. Figure 3.41 showed the thermal 
denaturation curve of lysozyme in absence and presence of ZnONP at pH 7.4 (figure 
3.41a) and pH 9 (figure 3.41b). As shown in figure, the melting temperature of lysozyme 
was observed at 71 
o
C for pH 7.4, which remain unaffected with increasing fractions of 
ZnONP. However, at pH 9, the lysozyme melting temperature reduced to 67 
o
C. 
Interestingly, addition of varying concentrations of ZnONP to lysozyme solution at pH 9 
shifted the melting temperature to 70 
o
C, demonstrating the stabilization of lysozyme 
against thermal denaturation upon interaction with ZnONP. Additionally, the comparative 
analysis indicated that compared to control, increasing concentrations of ZnONP reduces 
the change in absorbance with temperature. The decrease in absorbance with increase in 
ZnONP concentration is only possible when the responsible residues for absorbance at 
280 nm is directly involved in interaction with the ZnONP interface, hence hindered the 
residues exposure to 280 nm wavelength. Hence, it can be concluded that the interaction 
of lysozyme with ZnONP interface has more stabilizing effect at pH 9 than pH 7.4, where 
the protein remain largely unperturbed with increasing concentrations of ZnONP. 
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Figure 3.41. Thermal denaturation of lysozyme in absence and presence of increasing ZnONP 
concentrations at pH 7.4 (a) and pH 9 (b). 
3.6.1.3. Intrinsic fluorescence based conformational dynamics 
Fluorescence spectroscopic measurements are gerenally carried out to analyze the 
conformational dynamics of protein at tertiary level. In this context, tryptophan acts as an 
intrinsic fluoroprobe, which is widely used as a probe to monitor the conformational 
changes of globular proteins, and to gain information regarding local chemical 
environments and dynamics. The fluorescence quantum yield is largely dependent on 
changes of tryptophan chemical environment. Hence, any change in the environment due 
to folding or unfolding may lead to the change in the quantum yield. In this study, 
tryptophan fluorescence measurements were carried out to investigate the conformational 
dynamics of lysozyme on interaction with ZnONP at different studied pH conditions. 
Figure 3.42 showed the tryptophan emission spectrum of lysozyme at pH 7.4 and pH 9. It 
is reported that, the emission spectrum of tryptophan is very sensitive to polarity of 
solvent, which emits maximum at 350 nm upon excitation at 280 nm
298
. However, 
sometimes the blue shift of emission maxima is generally observed when tryptophan goes 
from slightly polar to non-polar environment, like hydrophobic core
298
. It is very 
interesting to observe that, at pH 7.4, the emission maximum of tryptophan was observed 
at 342 nm, inferring that the tryptophan residue is buried inside the hydrophobic 
environment (Figure 3.42a). However, upon interaction with ZnONP, it was observed that 
only 10% fluorescence intensity of lysozyme decresed with red shift of emission 
maximum (λmax) 346 nm, i.e. by 4 nm only, as the protein encounters high ZnONP 
concentration. The observation indicated that lysozyme interaction with ZnONP interface 
insignificantly exposes the tryptophan to polar environment at pH 7.4, which may be 
ZnONP interface also. Additionally, at pH 9, the emission maximum blue shifted from 
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350 nm to 342 nm, i.e. by 8 nm, on interaction with ZnONP interface (Figure 3.42c). 
Unlike pH 7.4, at pH 9 the tryptophan residues are relatively in polar environment, which 
in presence of ZnONP interface buried into relatively non-polar environment resulting into 
blue shift of the emission maxima. Interestingly, as shown in figure 3.42, besides a red 
shift in emission maxima for control (lysozyme only) at pH 9 compared to pH 7.4, a 32% 
reduction in tryptophan quantum yield for control at pH 9.0 is also observed. The 
comparative analysis indicated that the lysozyme is in partially unfolded state at pH 9, 
compared to pH 7.4. Similarly, the change in tryptophan quantum yield is more drastic at 
pH 9 than pH 7.4. The tryptophan fluorescence study in absence and presence of varying 
concentrations of ZnONP interface indicate that the interface has relatively more 
significant effect on unfolded protein than a folded protein.  
 
Figure 3.42. (a) Lysozyme fluorescence emission spectrum at pH7.4 upon excitation at 280 nm, 
and (b) the change in emission spectra of lysozyme at various ZnONP concentrations at pH 7.4. (c) 
Tryptophan fluorescence emission spectrum in lysozyme excited at pH 9, and (d) changes of 
emission spectra of lysozyme at various ZnONP concentrations. 
3.6.1.4. ANS binding and Anisotropy Studies 
8-Anilinonaphthalene-1-sulfonic acid (ANS) has affinity for hydrophobic patches 
present on protein surfaces. On binding to hydrophobic patches, ANS show relatively 
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higher quantum yield and a blue shift in the emission maxima; higher the change is, 
stronger will be the binding
296
. The solvent exposure of the hydrophobic surface in 
lysozyme at both pH, in absence and presence of ZnONP was studied by ANS-binding 
experiments. Figure 3.43 shows the change in ANS fluorescence emission at 520 nm upon 
binding lysozyme and lysozyme-ZnONP complexes at both pH. It was observed that there 
was very little change in the fluorescence intensity for different lysozyme-ZnONP 
conjugates at pH 7.4, however at pH 9.0, lysozyme showed an increase in intensity with 
increase concentration ZnONP. This demonstrated that lysozyme interaction with ZnONP 
interface at pH 9.0 enhances the ANS accessible hydrophobic patches in lysozyme. 
 
Figure 3.43. Fluorescence emission spectra of ANS binding with lysozyme and lysozyme-ZnONP 
conjugates at (a) pH 7.4 and (b) pH 9.0. The solution was excited at 350 nm. 
 
Figure 3.44. Anisotropy and emission maxima of ANS in presence of lysozyme and lysozyme-
ZnONP conjugates at (a) pH 7.4 (b) 9.0. The protein was excited at 350 nm. 
Anisotropy measurements reveal the average angular displacement of the 
fluorophore that occurs between absorption and subsequent emission of a photon, which 
indicates the rigidity of the fluorophore environment. ANS anisotropy at pH 7.4 and pH 9, 
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when bound to lysozyme and lysozyme-ZnONP conjugates, was measured (Figure 3.44). 
There was negligible change in the anisotropy at pH 7.4, whereas at pH 9 there was 
significant increase in ANS anisotropy when bound to the conjugates. Additionally, the 
increase in ANS anisotropy at pH 9 found to be dependent of ZnONP interface 
concentration in conjugates (Figure 3.44b). 
Quenching of tryptophan fluorescence by acrylamide was carried out for pH 7.4 
and 9 in absence and presence of ZnONPs. Acrylamide is an appropriate choice as a 
quenching agent because it is a hydrophobic molecule. The extent of quenching by 
acrylamide can be estimated by Ksv and Kq, calculated using the Stern–Volmer equation 
(Figure 3.45). 
Fo / F= 1 + KSV [Q] =1 + kqτ0[Q]        (9) 
where Fo denotes the steady–state fluorescence intensity of lysozyme, F is the steady–
state fluorescence intensity of lysozyme in the presence of varying concentrations of 
acrylamide, KSV is the Stern–Volmer quenching constant, [Q] is the concentration of 
quencher, kq is the quenching rate constant, and τ0 is the average fluorescence lifetime of 
molecule without quencher, which is equal to 5.78 ×10
-9
 s for bio-macromolecules. 
 
Figure 3.45. The Stern–Volmer Plot of lysozyme fluorescence quenching using increasing 
concentrations of acrylamide in absence and presence of ZnONPs at, (a) pH 7.4 and (b) pH 9. 
As shown in figure 3.45, the Stern-Volmer plots mostly deviated from linearity 
towards the y-axis at very high acrylamide concentrations, > 200 mM, which indicated the 
involvement of both static and dynamic quenching. In the present work, we provide a semi 
empirical measure of the magnitude of the quenching in this system and investigated the 
quenching in terms of KSV and kq values at low quencher concentrations (< 200 mM). The 
good linear fitting with R
2
>.99 implied the suitability of the Stern-Volmer model below 
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the quencher concentration, to deduce the binding mechanism between acrylamide and 
lysozyme. The quenching parameters obtained by analysis of Stern–Volmer plots for both 
pH conditions are presented in Table.3.2. 
Table 3.2: Acrylamide quenching parameters against lysozyme and lysozyme-ZnONP conjugates 
at pH 7.4 and pH 9. 
 pH7.4 pH9.0 
 KSV (M
-1
) kq (M
-1
s
-1
) KSV (M
-1
) kq (M
-1
s
-1
) 
Lysozyme 15.78 2.73 x 10
9
 15.83 2.73 x10
9
 
1:5 16.1 1.78 x 10
9
 10.18 1.76 x 10
9
 
1:10 17 2.94 x 10
9
 11.23 1.94 x 10
9
 
1:20 18.5 3.2 x 10
9
 11.87 2.00 x 10
9
 
1:50 19 3.4 x 10
9
 12.83 2.22 x10
9
 
1:100 15.15 2.62 x 10
9
 12.17 2.11 x10
9
 
As shown in table 3.2, quenching rate constant, kq, for acrylamide quenching 
against lysozyme and lysozyme-ZnONP conjugates are ten folds less than the maximum 
scatter collision quenching rate constant generally observed for any quencher against 
biopolymer (2.0 × 10
10
 M
-1
s
-1
). Thus, the acrylamide dependent quenching is 
predominantly dynamic quenching below 200 mM of acrylamide concentration. However, 
the static terms contributed significantly to quenching only at higher concentration of 
acrylamide. Additionally, the relative quenching constant, Ksv, values of lysozyme and 
lysozyme-ZnONP conjugates in pH 7.4 and pH 9 indicated that the tryptophan quenching 
by acrylamide at lower concentration is relatively restricted at pH 7.4 than pH 9. Within 
the pH 7.4, the quenching constant is increasing with increase in ZnONP interface, which 
indicated that in pH 7.4 the interface sterially hinders the tryptophan dynamic quenching 
by acrylamide. Thus, the quenching data further supported the CD, tryptophan 
fluorescence, and ANS fluorescence data, indicating that lysozyme interaction with 
ZnONP interface has significantly postive impact on lysozyme conformation in pH 7.4 
than pH9. 
3.6.2. Antiamyloidosis propensity of ZnONP interface 
Lysozyme at pH 9 in presence of 100 M SDS is known to form amyloid fibrils.  At pH 9, 
partially unfolded lysozyme in presence of SDS attains an amyloidogenic conformation, 
which with time attains a mature amyloid fibril structure
299
. In order to check the effect of 
ZnONP interface on lysozyme amyloidois in presence of SDS thioflavin T (ThT) binding 
assay was performed. As reported, ThT is an amyloid specific dye, its quantum yield at 
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482 nm increases many fold in presence of a fibril
300
. Interesting, at pH 7.4, no significant 
increase in quantum yield at 482 nm was observed with time for either lysozyme or 
lysozyme-ZnONP conjugate in presence of 100 M SDS. Figure 3.46 showed the ThT 
fluorescence spectra of lysozyme at pH 9 in the absence and presence of different 
concentrations of ZnONP interface. However, the rise in the fluoroscenec intensity at pH 9 
was studied at different time intervals, and the characteristic aggregation curve showed a 
distinct growth phase along with a saturation phase, indicating the formation of lysozyme 
amyloid fibrils at pH 9 in presence of SDS. The effect of ZnONP on the lysozyme 
amyloidosis was studied by taking different ratios of lysozyme and ZnONP interface. 
Interestingly, a gradual decrease in ThT quantum yield at 482 nm is observed with 
increasing concentration of ZnONP interface. The observation indicated that the presence 
of ZnONP interface hinders the conformational transition to amyloidogenic conformation 
on addition of 100 M SDS, at pH 9. 
 
Figure 3.46. Thioflavin T binding assay showing the suppression of amyloidosis in presence of 
increasing ZnONP interface at pH 9. 
Far-UV-CD spectroscopic analysis is one of the important techniques to analyze 
the conformational changes of protein at secondary level
299
. In case of amyloid fibrils, the 
protein known to show conformational dynamics to a predominantly β-sheet structures299. 
As shown in figure 3.47, after addition of SDS to the nanoparticle-protein conjugates at 
pH 7.4, no subtaintial increase in β-sheet was observed infering that at physiological pH 
the studied concentration of SDS unabled to induce lysozyme amyloid. However, the 
analysis at pH 9 provided us important findings, where lysozyme amyloid fibrils are 
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formed upon addition of SDS. The deconvolution of CD spectra using CDNN software 
showed a decrease in -helix fraction and increase in the β-sheet fraction, further 
confirming the formation of amyloids as observed by ThT binding assay (Figure A , 
appendix). However, it was observed that with increase in ZnONP interface, -sheet 
fraction decresed significantly, at pH 9.  
 
Figure 3.47. Far-UV CD spectra of 10 μM lysozyme at pH 7.4 (a) and pH 9 (b), in absence and 
presence of different ZnONP interface concentrations and 100 μM SDS. 
The findings from CD-spectroscopic analysis were further confirmed using ATR-
FTIR spectroscope. As shown in figure A24 (Appendix), insignificant variation in 
secondary structure of lysozyme and lysozyme interfacially assembled on ZnONP at pH 7 
was observed, which was also in accordance with CD-spectroscopic analysis. Hence, the 
data indicated that 100 mM SDS has insignificant effect on the conformation of lysozyme 
at pH 7 in presence of SDS. However, as shown in figure, significant structural changes 
were observed at pH 9 in presence of SDS, decrease in intensity of absorbance at 1652 cm
-
1
 for SDS treated lysozyme compared to control clearly demonstrated the decrease in α-
helical content of the lysozyme. In addition, increase in intensity of absorbance at other 
peak positions like 1698 and 1683 cm
-1
 showed an increase in random coils and turns.  
3.6.2.1. TEM analysis 
The formation of lysozyme amyloids and the effct of ZnONP interface on the lysozyme 
amyloids were further explored by imaging the amyloids by TEM. As shown the figure 
3.48, the TEM image of lysozyme fibrils showed that the lysozyme in presence of SDS 
forms amyloid fibrils. However, it was very interesting to observe that no order aggregates 
(fibrils) were found in presence of ZnONP interface. Hence, the findings from the 
objective using biophysical tools like CD spectropolarimeter, fluorescence spectroscope, 
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and TEM concluded that the ZnONP interface interaction with lysozyme make the 
lysozyme conformation relatively more compact at pH 7.4, additionally inhibits the 
lysozyme conformational transition into amyloid in presence of SDS at pH 9. 
 
Figure 3.48. TEM image of lysozyme at pH 9 in presence of SDS showing ordered aggregates, i.e. 
amyloid fibrils (a), and disorder aggregates (b) in presence of ZnONP interface. 
3.6.3. Summary 
The objective demonstrated that lysozyme interfacial assembly onto ZnONP interface led to 
relatively more regular conformation in lysozyme. However, tryptophan and ANS 
fluorescence for interfacially assembled lysozyme indicated that at pH 7.4, insignificant 
conformational rearrangement observed with increasing ZnONP interface. Unlike pH 7.4, 
the lysozyme conformation drastically changed with increase in ZnONP interface at pH 9. 
Additionally, the conformational change in presence of ZnONP interface act against the 
amyloidogenic propensity of lysozyme in presence of SDS at pH 9. 
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Chapter 4 
Conclusion 
Based on the study carried out for the thesis, insights into the effects of photocatalytic 
nanoparticle interface on biomembranes and biomacromolecules were gained. The 
findings from the first objective demonstrated that the interfacial potential and functional 
groups play vital role determining the antimicrobial activity/cytocompatibility of 
nanoparticles. However, the findings from second objective strongly reported that the 
surface defects and crystallinity of the photocatalytic nanoparticle determine the rate of 
oxidative stress exerted by the nanoparticle leading to cytotoxic and antimicrobial 
activities of nanoparticle. The third objective concluded that the functional efficacy of 
antimicrobial peptide increased upon interaction with the phtocatalytic nanoparticles by 
ROS-mediated membrane depolarization and by assisting invagination of the conjugate. 
Whereas, fourth objective investigated the conformational dynamics and amyloidogenic 
propensity of lysozyme in presence of nanoparticle interface, which indicated that the 
interfacial interaction inhibits the SDS-mediated lysozyme amyloidogenic propensity at 
pH 9, without affecting the protein native conformation at pH 7.4. 
Scope for Further Research 
The following studies are, hereby, proposed for further extension of the work: 
1. The role of interfacial potential of other nanoparticle upon mammalian cells vs 
cancerous cells can be explored, which might have diverse applications from diagnostic to 
therapeutic applications. 
2. Like functionalization of ioron oxide nanoparticles, other attempts can be taken to 
functionalize nanoparticles with different biocompatible agents to make cytotoxic 
nanoparticle a cytocompatible for biological applications. 
3. The conformational and functional dynamics of other amyloidogenic peptides, like A 
peptide can be explored upon interfacially assesmbly at different photocatalytic 
nanoparticles. The positive outcomes might be used as diagnostic and therapeutic 
purposes. 
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Appendices 
 
 
Figure A1. ATR-FTIR absorption spectra of ZnONPs synthesized at 300, 500, and 700 oC 
calcinations.  
 
Figure A2. SAED patterns of ZnONPs synthesized at (a) 300, (b) 500, and (c) 700 oC calcinations 
respectively. 
 
Figure A3: EDX images of ZnO nanoparticles synthesized at 300. 500, and 700 oC calcinations. 
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Table A1. Mass and atom percentage of Zn and oxygen in synthesized ZnONPs. 
Elements Mass % Atom % 
300 500 700 300 500 700 
Zn 77.92 78.78 82.7 46.33 47.6 53.91 
O 22.08 21.22 17.3 53.67 52.4 46.09 
Total 100 100 100 100 100 100 
 
Figure A4. FE-SEM micrographs of hydrozincite demonstrating unspecific structure (a) low 
magnification, (b) high magnification, (c) XRD spectra of hydrozincite. The intermediate formed 
was analyzed by X-pert high score software and found to be hydrozincite having reference code-
72-1100. 
For the synthesis of ZnO nanoparticles, zinc acetate dihydrate as metal and urea as 
reducing agent were taken, and the possible mechanism for synthesis of ZnONP from zinc 
acetate dihydrate and urea is illustrated as follows  
(NH2)CO+H2O  2NH3+ CO2    Eq (1) 
CO2+H2O   2H
+
+CO3
2-               
Eq
 
(2) 
NH3 +H2O                         NH4
+
+OH
-             
Eq (3) 
5Zn
2+
+2CO3
2- 
+6OH
-                      
Zn5(CO3)2(OH)6                 Eq (4) 
Zn5 (CO3)2(OH)6                                5ZnO+2CO2↑+3H2O       Eq (5) 
At experimental temperature (115 
o
C in our experiment), urea decomposes to NH3 
and CO2 (Eq. (1)), which combine again to produce carbonate (CO3
2-
), ammonium ion 
(NH4
+
) and hydroxide (OH
-
) ions (Eq. (2) and Eq. (3)). Under basic conditions, the 
intermediate complex hydrozincite, Zn5(CO3)2(OH)6 (Eq. (4)), is formed by the 
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combination of free CO3
2-
 ion and Zn
2+
 ion. Upon calcinating at 300, 500 and 700 
o
C, the 
complete conversion of hydrozincite leads to formation of ZnONP (Eq. (5)). Here it is 
important to note that the intermediate hydrozincite formed does not possess any specific 
shape or crystal structure (Figure A4). 
 
Figure A5. Morphological changes of Gram positive bacteria (B. subtilis, B. thuringiensis and S. 
aureus) at 100 µg/mL concentration of p-ZnONP by phase contrast microscopy. Untreated cells of 
B. subtilis (a), B. thuringiensis (b), and S. aureus (c) show intact surface morphology, whereas p-
ZnONP treated cells show aggregation of cells (B. subtilis (d), B. thuringiensis (e), and S. aureus 
(f)), confirming bacterial cell membrane lysis.  
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Figure A6. Morphological changes of Gram negative bacteria (E. coli, S. flexneri and P. vulgaris) 
at 50 µg/mL concentration of p-ZnONP by phase contrast microscopy. Untreated cells of E. coli 
(a), S. flexneri (b), and P. vulgaris (c) show intact surface morphology, whereas p-ZnONP treated 
cells show aggregation of cells (E. coli (d), S. flexneri (e), and P. vulgaris (f)) confirming bacterial 
cell membrane lysis.  
 
Figure A7. Morphological changes of Gram-positive bacteria (B. subtilis, B. thuringiensis and S. 
aureus) at 100 µg/mL concentration of p-ZnONP by SEM. Untreated cells of B. subtilis (a), B. 
thuringiensis (b), and S. aureus (c) show intact surface morphology, whereas p-ZnONP treated 
cells show aggregation as well as membrane rupture of cells (B. subtilis (d), B. thuringiensis (e), 
and S. aureus (f)) confirming bacterial cell membrane lysis.  
 
Figure A8. Morphological changes of Gram negative bacteria (E. coli, S. flexneri and P. vulgaris) 
at 50 µg/mL concentration of p- ZnONP by SEM. Untreated cells of E. coli (a), S. flexneri (b), and 
P. vulgaris (c) show intact surface morphology, whereas p-ZnONP treated cells show aggregation 
as well as membrane rupture of cells (E. coli (d), S. flexneri (e), and P. vulgaris (f)) confirming 
bacterial cell membrane lysis.  
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Figure A9. TEM micrograph of n-IONP and p-IONP showing the ultra-fine iron oxide 
nanoparticles having size of 0.1 nm (a) and 0.3 nm (b) respectively , and nanoparticles of size ~ 90 
nm IONP (c). 
 
 
Figure A10. Cytotoxicity of both n-IONP and p-IONP against Human Embryonic Kidney 293 
(HEK 293) cell line using Alamar Blue dye reduction assay. Both the nanoparticles show 
cytocompatible nature against the studied cell line. 
 
Figure A11. Histograms showing cell cycle analysis of HT1080 cells. (a) Control representing 
normal distribution of different phases like subG1, G1, S and G2/M, and upon treatment with 
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ZnONP synthesis at (b) ZnONP 300 oC, (c) 500 oC, and (d) 700 oC calcinations. The data revealed 
a gradual increase population in G1 phase confirming the induction of apoptosis.  
 
Figure A12. ATR-FTIR spectra of AgNP, and AgNP-nisin conjugate (1:1). The presence of 
prominent peaks at 545, 516 cm-1 for AgNP and at 544, and 517 cm-1 for conjugate confirm the 
presence of Ag-Ag/Ag-O bonds in both the samples.  
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Figure A13. FE-SEM representative image of AgNP (a) and AgNP-nisin conjugate (1:1) (b). The 
statistical calculation of size for 50 NPs in images indicated an average diameter of 17.87 +/- 0.8 
nm and 19.12+/-0.81 nm for intact AgNP and AgNP-nisin conjugate, respectively. Crystalline 
nature is confirmed by SAED patterns of AgNP (c) and AgNP-nisin conjugate (1:1) (d). Whereas, 
EDX spectra of AgNP (e) and AgNP-nisin conjugate (1:1) (f) respectively, proved the presence of 
the peptide in AgNP-nisin conjugate. 
Table A2. Distance of interacting residues of nisin from AgNP core in the conjugate.  
Residue Number Initial Mid End 
1 7.7 7.3 7.5 
2 7.0 7.0 7.0 
3 3.4 3.1 3.0 
4 3.0 3.2 2.9 
22 7.9 8.2 7.7 
23 7.9 8.0 8.0 
24 5.2 6.3 5.4 
25 5.9 4.7 4.7 
26 9.7 9.0 9.0 
31 7.4 7.3 7.0 
32 9.7 9.4 9.2 
33 11.3 10.8 10.5 
34 13.3 12.8 12.8 
 
 
Figure A14. Snapshots of AgNP-nisin conjugation at different time interval, (a) 10 ns, (b) 20 ns, 
(c) 30 ns, and (d) 40 ns in a 50 ns production run. 
Appendices 
136 
 
Figure A15. Growth kinetics of B. subtilis in presence of different concentration of nisin. 
To clearly spel out the enhanced antimicrobial activity of AgNP-nisin conjugates 
than nisin or AgNP, the growth kinetics of B. subtilis in presence of different 
concentrations of intact nisin was observed. As shown in figure A15, we observed that 
upto 5.2 µg/mL of nisin concentration, the growth inhibition of B. subtilis was 
insignificant. However, a brief comparison with growth kinetics of B. subtilis in presence 
of AgNP-nisin conjugates indicated that very concentration (85 nm) of nisin conjugated 
with AgNP showed significant antimicrobial activity against B. subtilis cells. Hence, 
AgNP-nisin conjugates are found to be stronger antimicrobial agent than intact nisin 
peptide against B. subtilis. 
 
Figure A16. Growth kinetics of Proteus vulgaris in presence of AgNP-nisin conjugates. 
 
Figure A17. Growth kinetics of Staphylococcus aureus in presence of AgNP-nisin conjugates. 
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Figure A18. Percentage of live and dead cells of B. subtilis (a), and E. coli (b) upon treatment with 
nisin, AgNP, and AgNP-nisin conjugates, determined statistically from fluorescence microscopy 
images, using Image J software. 
 
Figure A19. Panel a-fluorescence image of (a-i) B. subtilis, (a-ii) B. subtilis with nisin, and (a-iii) 
B. subtilis with AgNP. Panel b- fluorescence image of (b-i) E. coli, (b-ii) E. coli with nisin, and (b-
iii) E. coli with AgNP. 
 
Figure A20. UV-Visible absorption spectra of lysozyme in absence and presence of increasing 
fractions of ZnONPs in conjugate at (a) pH 7.4, and (b) pH 9. 
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Figure A21.The secondary structure composition of lysozyme at pH 7.4 (a) and pH 9 (b) upon 
ZnONP interaction determined from CD spectra using CDNN deconvulation software.  
 
Figure A22. ATR-FTIR spectra of lysozyme in absence and presence of different fractions of 
ZnONP at (a) pH 7.4, and (b) pH 9. 
 
Figure A 23.The secondary structure composition of lysozyme at (a) pH 7.4 and, (b) pH 9 upon 
ZnONP interaction in presence of SDS, determined from CD spectra using CDNN deconvolution 
software.  
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Figure A24. ATR-FTIR spectra of lysozyme in absence and presence SDS upon conjugation to 
ZnONP at (a) pH 7.4 and (b) pH 9. 
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